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Eukaryotic cells have evolved a complex set of regulatory proteins to 
maintain genome stability by regulating DNA replication once and once per 
cell cycle. Despite intensive investigation, a precise understanding of the 
proteins that are phosphorylated during the initiation phase of DNA 
replication remains to be identified. Here we investigate the roles of cyclin E 
and cyclin A in the G1 to S-phase transition and reconstitute initiation of 
DNA replication in cyclin depleted nuclei using an in vitro DNA replication 
system. 
Using a murine 3T3 fibroblast model, chemical and genetic inhibition 
of CDK activity was used to evaluate the role of specific cyclin complexes in 
post-quiescent cells. CDK inhibition reduced levels of CDC6, MCM2 and 
PCNA in all contexts. Evaluation of the role of individual cyclin-CDK 
complexes was performed by siRNA mediated depletion. Cyclin E1/E2 
depletion showed that Cyclin E regulates CDC6, MCM2 and PCNA at the 
transcriptional level; whereas Cyclin A regulates their accumulation though 
protection from the ubiquitin -proteasome system in late G1 phase. 
Furthermore, ubiquitination of CDC6 and MCM2 was confirmed using His-
tagged ubiquitin pulldown assays suggesting that the CDK and the UPS 
regulate their levels late G1 phase. 























Comparison of replication competence was performed using in vitro 
cell free DNA replication assays. Cyclin E depleted nuclei were unable to 
initiate DNA replication in S phase extracts; whereas cyclin A2 depleted 
nuclei retained full activity. Crucially, cyclin E depleted nuclei were unable to 
load CDK/DDK activated MCM2 proteins onto chromatin in G1 phase that 
correlated with replication competence in vitro. The data suggests that 
sustained cyclin activity is required to maintain pre-RC protein levels and 
facilitate formation of replication complexes in G1 phase. These results further 
suggest that perturbations in the CDK network results in destabilisation of 
replication proteins CDC6, MCM2, Ciz1 and PCNA that blocks replication 
complex assembly on chromatin, contributing to genomic stability. 
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Chapter 1: General Introduction 
Eukaryotic cells have evolved complex regulatory networks that 
control cellular growth and division. This process is called the cell cycle and 
incorporates an ordered system of biochemical switches regulated and 
governed by cyclin dependent kinases (CDKS). Through phosphorylation of 
target substrates CDKs drive each phase of the cell cycle to duplicate and 
segregate identical genetic components into daughter cells (Sclafani and 
Holzen, 2007). This process must be achieved with high fidelity and utilizes 
intricate intracellular signaling pathways and regulation of transcriptional 
programs to precisely regulate cellular division (Rhind and Russell, 2012). The 
cell cycle control system is of paramount significance in maintenance of cell 
numbers and tissue organization within the body. Understanding how these 
processes are regulated is important, as precise control of cellular division is 
required for stem cell maintenance (Furutachi et al., 2015), coordination of 
developmental processes (Jukam et al., 2017), and longevity (Kubben and 
Misteli, 2017) as deregulation of the cell cycle underpins cancer biology 
(Cecchini et al., 2012). 
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1.1The	cell	cycle	is	divided	into	four	phases	
	 The process of cellular division is an ordered series of events that can 
be divided into two main phases (i) Interphase, where the cell increases in 
size and duplicates its chromosome. (ii) Mitotic phases, where the 
chromosomes are resolved and segregated equally into two genetically 
identical daughter cells. Interphase can be further subdivided into G1, S and 
G2 phases (Figure 1.1). In G1 phase, cells are responsive to mitogenic and 
anti-mitogenic signaling. The balance of mitogenic/anti-mitogenic signals 
dictates whether cells continue through the cell cycle or enter a reversible 
non-proliferative state called quiescence (Daignan-Fornier and Sagot, 2011). In 
an anti-mitogenic environment, cells enter a state of inactivity or rest termed 
quiescence, where cells are in a metabolically quiet state (Figure 1.1). In 
mammals, >95% of cells are in a quiescent state, demonstrating the 
importance for maintenance of a non-proliferative population for homeostasis 
(Cheung and Rando, 2013; Mendelson and Frenette, 2014). 
In a mitogenic environment, cells exit G1 phase and replicate their 
DNA in the synthesis (S)-phase. After S-phase cells enter G2 phase or GAP2 
phase where the cell proofreads its genetic material to ensure that DNA 
replication has been successfully completed and prepares for cell division in 
M phase. Finally, cells enter the mitotic phase (M Phase) that is further 
divided into five distinct phases namely prophase, prometaphase, metaphase, 
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anaphase and telophase which is intrinsically linked to cytokinesis (Coffman, 
2004; Ivanchuk and Rutka, 2004; Jongsma et al., 2015; Kang et al., 2017; 
Schafer, 1998) 
 To ensure that cell cycle transitions occur at the right time, cells utilise 
the activity of cyclin dependent kinases, where specific cyclin-CDK complexes 
regulate the transition between each phase of the cell cycle. In addition, to 
ensure this process is completed accurately, cell cycle checkpoints assess each 
cell cycle phase is complete prior to cellular division. In eukaryotic cells, the 
cell-cycle control system controls cell-cycle progression at four major 
regulatory checkpoints (Bisteau et al., 2014; Lim and Kaldis, 2013). The first 
checkpoint is the restriction point in late G1 phase, where the cell commits to 
cell- cycle entry and chromosome duplication (Rhind and Russell, 2012). The 
second is the intra S-phase checkpoint mediated by ATR at sites of DNA 
damage leading to recruitment of factors to repair DNA prior to fork re-start 
(Iyer and Rhind, 2017; Rhind and Russell, 2012). G2/M checkpoint is the third 
checkpoint whereby cells arrest prior to early mitotic events that lead to 
chromosome alignment on the spindle in metaphase (Barnum and O'Connell, 
2014). Finally, the metaphase to anaphase transition is mediated by the 
APCCdh1 ubiquitin ligases that promote sister-chromatid separation, leading to 
the completion of mitosis and cytokinesis. The checkpoint mechanisms ensure 
that intra and extra-cellular signalling is adequate to promote cellular division 
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cycle, and that the genome is precisely duplicated prior to segregation into 
daughter cells (Lim and Kaldis, 2013). 
1.2	Cyclin	dependent	kinases	are	the	master	regulators	of	the	cell	cycle.		
The core members of the cell cycle control system are the cyclin and 
cyclin dependent kinases (CDKs). In mammalian cells, there are four principle 
cyclin proteins that play a central role in regulation of the cell cycle: cyclin D, 
cyclin E, cyclin A and cyclin B. Each cyclin has a specific CDK binding 
partner.  Cyclin D which is an early G1 cyclin forms a complex with CDK4 or 
CDK6 (Nurse, 1997). Cyclin E interacts with CDK2, which governs the G1-S-
phase transition (Stumpf et al., 2013). Cyclin A interacts with CDK2 and 
CDK1 and regulates S-phase which monitors DNA replication and ensures 
that the genome is copied once and only once, per cell cycle. Finally, cyclin B-
CDK1 governs the transition from G2 into M phase. The unidirectional 
progression through the mitotic cell cycle is achieved through oscillations in 
cyclin levels with sequential accumulation and destruction of each cyclin 
subunit (Figure 1.1) (Enders, 2012; Obaya and Sedivy, 2002). 
 


























A: Activity of different cyclins and CDK complexes in the four phases of cell 
cycle. Early G1 phase is regulated by cyclin D-CDK4/6; whereas late G1 phase 
regulated by cyclin E-CDK2; S-Phase is regulated by Cyclin A-CDK2 before 
cyclin A-CDK1 regulates late S-phase and G2 phase; G2 phase to metaphase is 
regulated by Cyclin B-CDK1. B: The Cell cycle is divided into four phases 
namely G1, S, G2 and M phase. Interphase consists of G1, S and G2 phases 
where cells prepare itself to divide into two daughter nuclei. G1 phase cell 
prepares itself to undergo DNA replication. In S-phase, the genome is 
duplicated. In G2 phase post DNA replication cells prepare to enter M Phase. 
In M-Phase (mitosis) cell divides into 2 daughter cells. (i) Somatic cells are 
able to enter reversible (quiescent) or irreversible (senescent and 
differentiated) G0 states from the G1 phase of the cell cycle before the 
restriction point (R-point). Once cells reach the R-point, they are committed to 
the next round of the cell cycle (Cheung and Rando, 2013) or (ii) Following 
mitosis, cells either maintain Rb hyper-phosphorylation and stay in the cell 
cycle or they lose Rb phosphorylation and enter a transient G0-like state 
(Cappell et al., 2016) 
Figure 1-1Cell cycle stage specific cyclin-CDK complexes regulate cell 
cycle transitions. 
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1.3	Regulation	of	Restriction	point	and	the	G1/	S	transition	
For cell division to occur, extracellular signalling through mitogen 
signalling is required. For example EGF receptor is activated through EGF 
ligand binding, autophosphorylation and activation of the Ras GTPase 
pathway. Ras then promotes activation of the mitogen activated protein 
kinase (MAPK) cascade leading to activation of c-myc and cyclin D expression 
(Johnson and Skotheim, 2013; Larsson et al., 1985). Activation of Myc 
promotes cyclin D expression and enables formation of Cyclin D-CDK4 or 
CDK6 complexes (Cyclin D-CDK4/6) to form. Cyclin D-CDK4/6 is a principle 
regulator of the restriction point that ensures that cell divide only in suitable 
mitogenic signalling environments (Leontieva and Blagosklonny, 2013). 
The G1 checkpoint or restriction phase is regulated by the Rb-E2F 
pathway. Rb binds and inactivates the E2F1-3 family transcription factors and 
E2F activation is dependent upon CDK mediated phosphorylation of the 
retinoblastoma protein (Figure 1.2) (Bertoli et al., 2013; Giacinti and Giordano, 
2006; Hatakeyama and Weinberg, 1995; Weinberg, 1989). Cyclin D-CDK4/6 
mono-phosphorylates one of the 14 sites of Rb in early G1-phase (Narasimha, 
2014). Mono-phosphorylation of the retinoblastoma protein (Rb) enables weak 
transcription of E2F1-3 family regulated genes, required for DNA replication, 
including cyclin E (Choi et al., 2012; Geng and Sicinski, 2013; Narasimha et al., 
2014). Cyclin E binds to and activates CDK2 required to hyper-phosphorylate 
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Rb and to fully activate E2F1-3 forming a positive feedback loop promoting S-
phase gene expression. This results in an increase in E2F –dependent genes 
that are required for S-phase entry and the initiation of DNA replication 
(Deshpande et al., 2005; Hanashiro et al., 2008; Herrera et al., 1996; Narasimha 
et al., 2014; Williams et al., 1994; Yu and Sicinski, 2004).  
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Sustained mitogen stimulation enables Cyclin D-CDK4/6 mediated mono-
phosphorylation of Rb. Monophosphorylation of Rb enables low level 
activation of E2F mediated transcription of cyclin E along with other proteins 
involved in G1-S transition and initiation of DNA replication. Cyclin E-CDK2 
further hyper-phosphorylates Rb enabling smooth transition of cells post 
restriction point by origin licensing and feedback mechanism degrading 
CDK2 inhibitor protein p27. As the cells enter cell cycle from quiescence (G0) 
and progress into S-phase from early G1 to late G1 kinase activity regulating 
E2F and Rb phosphorylation allows smooth passage of cells through 
restriction point. (Adapted from Matson and Cook, 2017) 
  
Figure 1-2 Transcriptional regulation of cyclin expression bypasses the 
restriction point. 
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The restriction point is a bistable switch mechanism that requires 
increasing CDK activity to bypass the checkpoint imposed by the Rb-E2F 
pathway, and CDK inhibitor proteins p21 and p27 (Kollarovic et al., 2016; 
Zhang, 2013). To bypass the restriction point mitogenic stimulation must be 
sustained to enable an increase in CDK activity that inactivates Rb and leads 
to degradation of p27, leading to an increase in CDK activity. p27kip1 is a 
CDK2 regulator that directly inhibits CDK2 kinase activity. p27 is a substrate 
of cyclin E/CDK2  that is abundant in quiescent and G1 cells. p27 levels are 
reduced at the G1/S transition, as increasing cyclin E-CDK2 activity promotes 
phosphorylation of p27 leading to its degradation by polyubiquitylation by 
the Skp Cullin F-box (SCF) complex (Chen et al., 2012).  The inactivation of Rb 
and the degradation of p27 enforce bypass of the restriction point and 
facilitates the quantitative increase in cyclin dependent kinase activity that 
regulates all other cell cycle phases, independently of mitogen stimulation 
(Kollarovic et al., 2016; Narasimha et al., 2014; Zhang, 2013).   
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1.4	CDK	activity	 is	regulated	by	multiple	pathways	 to	 facilitate	 increasing	
activity	through	the	cell	cycle.	
Multilevel regulation of DNA replication by Cyclin-CDK complex 
ensures that DNA replication takes place once and only once per cell cycle. 
Mechanisms include (i) Transcriptional regulation of G1 cyclin expression by 
the Rb-E2F pathway (ii) Regulation of CDK inhibitor proteins levels e.g. p21, 
p27 (Lim and Kaldis, 2013). (iii) Inhibitory phosphorylation of CDK1 and 
CDK2 by Wee1 which inactivates the complex (Hengstschläger et al., 1999). 
(iv) Activation of CDK by CDK activating Kinases (CAK) (v) Ubiquitin -
Proteasomal mediated degradation of cyclin subunits via coordinated action 
of APC/C and SCF E3 ligases maintain cyclin CDK activity (Nakayama and 
Nakayama, 2006). 
Cyclin dependent kinases serve as the key regulators of replication 
licensing by limiting it to G1 phase. During G1 phase CDK activity remains 
low, allowing replication factors to load at putative origins. During the 
transition from G1 to S-phase CDKs activate the factors necessary for origin 
firing there by initiating DNA replication in S-Phase. High CDK activity is 
inhibitory to the formation of new pre-RCs (Fisher, 2011; Pacek et al., 2006). 
CDK is therefore responsible for both removing the license and preventing 
relicensing in S-phase and beyond.  
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 In addition to the CDKs, cells also utilize the activity of the Dbf4 
dependent kinase (DDK), Cdc7 that requires Dbf4 binding for activation 
(Alver et al., 2017; van Deursen et al., 2012) analogous to the catalytic 
activation of CDKs through cyclin binding. Periodic stabilization of and 
destruction of the DBF4 protein during cell cycle regulates DDK activity, with 
increasing levels during S-phase transition (Blow and Laskey, 2016; Poh et al., 
2014). Cdc7, which appears to be already bound on to the origin is activated 
by Dbf4, as DDK acts at individual origins throughout S –phase to activate 
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1.5	Temporal	regulation	of	DNA	replication	complex	assembly.	
DNA replication is a sophisticatedly regulated process that imposes the 
once per cell cycle duplication of the genome. Eukaryotic and prokaryotic 
DNA replication machinery are loosely conserved, but there are significant 
differences in the organisation and structure of their genomes. Prokaryotic 
genomes are covalently closed, forming a circular chromosome that can be 
duplicated often with a single origin of replication (Nielsen and Lobner-
Olesen, 2008). This approach would be inefficient and time consuming when 
considering the respective genome as E. coli has a ~4Mbp genome versus a 3 
gigabase human genome. To overcome the logistical challenge of copying 
large, linear genomes, eukaryotes utilise multiple replication origins that are 
typically spaced ~ 50-100 kilobases apart (Cayrou et al., 2015; Cvetic and 
Walter, 2005; Gilbert, 2004). There are approximately 30-50,000 putative 
replication origins in the human genome (Chagin et al., 2016; Leonard and 
Mechali, 2013; Nasheuer et al., 2002) ensuring that the entire genome is 
replicated efficiently. To guarantee that the genome is accurately replicated, 
cells have established mechanisms that separate replication origin 
specification, licensing and activation. The separation of these steps is 
regulated by cyclin dependent kinase activity and the activity of inhibitory 
proteins such as geminin that prevents replication origin specification in all 
phases of the cell cycle except G1 phase. Geminin is also supported by the 
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ubiquitin proteasome system that regulates protein accumulation and restricts 
key regulator expression to specific stages of the cell cycle.    
1.5.1.	Specification	of	replication	origins	
The specification of DNA replication origins begins by recognition of a 
putative replication site by binding of a complex of proteins called the origin 
recognition complex in eukaryotes. This is a conserved feature of DNA 
replication and other examples include the OriC sequence of E. coli and the  
Autonomously Replication Sequences (ARS) in S. cerevisiae (Leonard and 
Mechali, 2013).  Bacterial and yeast replication origins show DNA sequence 
specificity, whereas metazoan origins do not display high sequence specific 
requirements (Evertts and Coller, 2012; Leonard and Mechali, 2013; Zhou et 
al., 2005). OriC and ARS sites can direct replication initiation if they are 
moved to ectopic sites in the genome, indicating that these initiation sites are 
genuine replication origins (DePamphilis, 1999; Aladjem, 1998; Altman et al., 
2004; Robinson et al., 2005; Zhou et al., 2005; Cayrou et al., 2012). Metazoan 
origins are similar to fission yeast origins but lack a defined consensus 
sequence and putative origins of replication are encoded by sequences from 
one to a few kilo-bases in length (Aladjem et al., 1998; Evertts et al., 2012). 
There are studies reporting that metazoan origins are AT rich sequences 
(MacAlpine, 2004; Cayrou, 2012). DNA sequences are not the only factors 
governing recruitment of ORC, other factors including chromatin structure 
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and gene transcription have significant influence on the selection of DNA 
replication origins and timings when origins are activated to initiate DNA 
replication (Aggarwal et al., 2004; Kohzaki et al., 2005; Leonard et al., 2013).  
In budding yeast, the ARS specifies the site that ORC associates with to 
promote replication complex assembly. In contrast mammalian replication 
origins do not have specific ARS motifs and display asymmetric AT-rich 
sequences. Unlike yeast systems purified human ORC complexes display 
limited sequence specificity and ATP hardly affects the interaction of ORC to 
DNA. The binding of metazoan ORC to DNA is regulated by chromatin 
conformation and epigenetic modifications (Vashee et al., 2003; Remus et al., 
2004; Rampakakis et al., 2009; Dorn et al., 2011; MacAlpine et al., 2013; 
Leonard et al., 2013).   
1.5.2	Formation	of	the	pre-replication	complex	(pre-RC)	
The ORC complex promotes loading of additional factors that mark 
putative replication origins and facilitate the higher order protein complex 
assembly required to copy DNA (Yeeles et al., 2015). Replication origin 
specification requires low CDK activity. Hence, origin licensing can begin 
as early as telophase, as nuclear envelopes begin to form around the 
segregated mitotic chromosomes, although it is not clear if licensing begins 
at this stage in all species or cell types (Dimitrova et al., 2002; Xouri et al., 
2007; Symeonidou et al., 2013). Licensing continues throughout G1 and 
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ceases at the G1/S-phase transition. The minimal factors contributing to pre-
RC assembly are Origin Recoginition complex (ORC), Cell division cycle 6 
(CDC6), Minichromosome maintenance proteins 2-7 (MCM2-7) and CDT1 
(Maine et al., 1984; Cocker et al., 1996; Gillespie et al., 2001; Remus et al., 
2009; Riera et al., 2017).  
Eukaryotic ORC is a heterohexamer composed of six distinct 
subunits, Orc1 through Orc6. ORC is the only licensing component that 
directly binds origin DNA, and it is required for the nucleation of the pre-
RC (Bryant and Aves, 2011; Patel et al., 2006; Stillman, 2005). CDC6 is a 
monomeric protein that is recruited to DNA by protein–protein interactions 
with ORC (Bryant and Aves, 2011; Leonard and Mechali, 2013). CDC6 and 
the Orc1–Orc5 subunits are members of the AAA+ family of ATPases which 
are prevalent in many DNA metabolic processes (Li et al., 2008; Bell, 2014; 
Deegan et al., 2016). ORC recruits CDC6 to chromatin leading to 
recruitment of CDT1 bound to the MCM complex completing formation of 
the pre-RC (Masai et al., 2010; Siddiqui et al., 2013). CDT1 interacts directly 
with the MCM complex in solution and with both ORC and CDC6 (Cook et 
al., 2004;  Chen et al., 2007; Zhang et al., 2010; Fernandez-Cid et al., 2013). In 
the absence of CDT1, MCM complexes are never recruited to DNA (Coster 
et al., 2014; Mehanna and Diffley, 2012; Yuan et al., 2017). In that regard, 
one likely role for CDT1 in replication licensing is as a molecular bridge or 
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‘courier’ to deliver soluble MCM complexes to DNA-bound ORC/CDC6. In 
support of that model, recent single molecule studies using purified yeast 
licensing proteins discovered that CDT1 is rapidly released upon successful 
loading of each MCM complex. By following fluorescently labelled proteins 
(Ticau et al., 2015) showed CDT1 and CDC6 release between the two rounds 
of MCM loading. This rapid shuttling between the bound and soluble states 
for both CDT1 and CDC6 suggests that each molecule could participate in 
many origin licensing events. Perhaps for this reason, the levels of both 
CDC6 and CDT1 are highly regulated during the cell cycle to prevent 
inappropriate origin licensing.  
The correct loading of MCM double hexamers renders an origin 
competent for subsequent replication initiation, or ‘firing’, during S-phase 
(Deegan and Diffley, 2016). MCM2-7 does not display helicase activity in 
G1-phase as additional factors are required to facilitate helicase activation. 
Somewhat surprisingly, eukaryotic cells load many more MCM double 
hexamers than the number of DNA-bound ORCs (Edwards et al., 2002). At 
least 10-fold more origins can be licensed than are strictly required for 
complete replication under normal circumstances, though the degree of 
origin licensing likely varies among cells, tissues, and species (Woodward 
et al., 2006; Powell et al., 2015).  
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The MCM complex is a hexameric ring in solution before it is loaded 
(Ilves et al., 2010; Boskovic et al., 2016). MCM loading is therefore not a 
process of assembling the hetero-hexamers on DNA from their component 
subunits, but rather, loading pre-assembled hexamers onto DNA (Yuan et 
al., 2017). DNA passes through a side “gate” between the Mcm2 and Mcm5 
subunits, and much speculation currently swirls around the mechanism 
and dynamics of MCM gate opening and closing (Costa et al., 2008; 
Bochman et al 2010; Samel et al., 2014). Moreover, the MCM double 
hexamer central channels contain double-stranded DNA in G1 but the 
active MCM helicase at replication forks encircles single-stranded DNA and 
displaces the second strand (Boos et al., 2012; Graham et al., 2016).  
In vitro, loaded MCM double hexamers can slide along DNA away 
from ORC, leaving space near ORC for another round of MCM loading (Ervin 
et al., 2009; Remus et al., 2009; Coster et al., 2014), and recent results suggest 
that MCMs may also slide in vivo (Di Gregorio et al., 2015; Powell et al., 2015). 
In a typical S-phase, some MCM complexes that had been loaded in G1 are 
activated as part of the regular replication program, whereas others initiate 
replication in response to nearby stalled or damaged replication forks to 
ensure replication completion. Origins that are only utilized under the latter 
conditions of replication stress are termed “dormant” origins, and they 
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safeguard the genome against under-replication (Ibarra et al., 2008; McIntosh 
et al., 2012). 
1.5.3	Formation	of	Pre-Initiation	Complex	(Pre-IC)	
The mechanism for pre-IC formation is conserved in eukaryotes. The 
pre-IC consists of Cdc45, MCM2-7 and GINS (CMG) complex that constitute 
the replicative helicase, which is associated with the replisome during S phase 
(Villa et al., 2016). The loading of the CMG complex is facilitated by MCM10, 
which associates directly with MCM2-7 in a low affinity complex. This 
complex then serves to facilitate associations with the CMG complex resulting 
in formation of a higher affinity complex (Douglas and Diffley, 2016). 
Association of MCM10 to the pre-RC complex facilitates recruitment of 
initiation factors leading to the formation of pre-initiation complex (pre-IC). 
Therefore, MCM10 coordinates the assembly and activation of the helicase via 
CDK2 and DDK mediated phosphorylation of the helicase. This critical 
mechanism ensures that MCM2-7 double hexamer complexes are assembled 
and activated in a coordinated manner (Douglas and Diffley, 2016; Perez-
Arnaiz et al., 2016). 
In S. cerevisiae Dbf4-dependent kinase activates the CMG complex 
(Heller et al., 2011) and facilitates higher order complex formation that 
enables CMG recruitment. CDK-mediated phosphorylation of Sld2 and Sld3 
promotes Dpb11 binding, CMG loading and activation of MCM2-7 helicase 
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activity (Chuang et al., 2009; Takeda et al., 2005; Tanaka et al., 2007; Zegerman 
and Diffley, 2007). Sld3 (Treslin- homologue) coordinates CDC45 recruitment 
to MCM2-7 with DDK phosphorylation of MCM2 during S phase (Bruck and 
Kaplan, 2015). These mechanisms are conserved in Metazoa as the Sld3 
homologue Treslin, binds to TopBP1 (Dpb11) after CDK-mediated 
phosphorylation in human and Xenopus systems (Kumagai et al., 2010; 
Kumagai et al., 2011; Boos et al., 2011).  
Origin firing requires phosphorylation events from CDKs and a 
replication-specific kinase, DDK. These kinases promote the recruitment of 
additional essential helicase components, CDC45 and GINS, to activate 
DNA unwinding (Labib 2010; Ilves et al., 2010; Tanaka et al., 2013). The 
loading of the CMG complex is a critical step in the regulation of origin 
activation. Therefore, higher eukaryotes have evolved degenerate 
mechanisms to complete pre-IC formation mediated by DUE-B, GEMC1 and 
MDM2 binding protein (MTBP). DUE-B interacts with CDC45 in a DDK 
regulated process to promote recruitment of the CMG complex to chromatin 
(Chowdhury et al., 2010; Gao et al., 2014). Similarly, GEMC1 recruits CDC45 
to chromatin in a cyclin E-CDK2 dependent step required for initiation of 
DNA replication (Balestrini et al., 2010). The efficiency of CMG recruitment is 
enhanced by MTBP, which is required for efficient CMG loading and 
initiation of DNA replication (Boos et al., 2011; Boos et al., 2013). Each 
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mechanism appears to be required for the efficient loading and activation of 
the replisome and contribute to mechanisms that ensure that DNA replication 
occurs once per cell cycle.  
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DNA replication is multi-step process involving loading and unloading of 
various proteins in timely manner in G1 phase. First step involves formation 
of pre-RC which is initiated by recruitment of ORC onto putative replication 
origins. CDC6 and CDT1 then interact with ORC in ATP dependent manner 
in order to recruit MCM2-7 complex (Helicase) onto the chromatin leading to 
the formation of pre-RC. MCM10, CDC45 along with GINS are recruited on to 
pre-RC to form Pre-initiation complex. Recruitment of these proteins is 
facilitated by cyclin E-CDK2. Completion of the pre-RC at the origin is 
referred to as replication licensing. Cyclin E-CDK2 phosphorylates CDC6 
protecting from APC/CCdh1 mediated ubiquitination. Cyclin E-CDK2 along 
with Dbf4 dependent kinase (DDK) enables recruitment of replisome factors 
which leads to helicase activation by phosphorylating MCM 2-7 complexes.  
Cyclin A-CDK2 then facilitates loading of polymerase with PCNA and results 
in Replisome formation. Ciz1 binds to the pre-replication complex via CDC6 
interactions during G1 phase and coordinates with cyclin A-CDK2 to promote 
initiation of DNA replication (adapted from Pauzaite, 2016).  
Figure 1-3 Replication Licensing. 
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1.5.4	Helicase	activation	and	Replisome	Formation	
The CDK –mediated recruitment of DNA polymerases and accessory 
factors is the final step in initiation of DNA replication. The process of DNA 
replication requires three replicative polymerases—Pol α, Pol δ, and Pol ε—
which associate with the processivity factor proliferating cell nuclear 
antigen (PCNA) (Stillman, 2005; Takeda et al., 2005). RNA primers on both 
leading strand and lagging strands are synthesised by DNA polymerase α 
(Pol α) that can then be utilized by processive DNA polymerases δ and ε. 
DNA polymerases α and ε perform leading-strand synthesis and Pol α and 
Pol δ perform lagging-strand synthesis with high nucleotide selectivity and 
efficient proofreading (Simon et al., 2014). Ctf4 is required for sister 
chromatid adhesion and for the stable assembly of the CMG complex and 
polymerases in the replisome (Samora et al., 2016; Takeda et al., 2005). The 
leading strand Pol ε is positioned ahead of CMG helicase, whereas Ctf4 and 
the lagging-strand polymerases Pol α/δ are behind the helicase (Takeda et 
al., 2005; Villa et al., 2016; Stillman et al., 2015; Sun et al., 2016). DNA 
polymerases have a semi closed hand structure, which allows them to load 
onto DNA and translocate (Leman and Noguchi, 2013; Meli et al., 2016). This 
structure permits DNA polymerases to hold the single-stranded template, 
incorporate dNTPs at the active site, and release the newly formed double 
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strand. However, the conformation of DNA polymerases does not allow for 
their stable interaction with the template DNA (Leman et al., 2013). 
DNA polymerases require additional factors to support DNA 
replication in vivo and strengthen the interaction between template and 
polymerase, DNA sliding clamps, aid template binding and increase 
processivity of the polymerases. In eukaryotes, this sliding clamp is a homo-
trimer known as proliferating cell nuclear antigen (PCNA), which forms a 
ring structure (Bell and Dutta, 2002; Saner et al., 2013) . The PCNA ring has 
polarity with a surface that interacts with DNA polymerases and tethers them 
securely to DNA. PCNA-dependent stabilization of DNA polymerases has a 
significant effect on DNA replication because it enhances polymerase 
processivity up to 1,000-fold (Bravo et al., 1987; Prelich et al., 1987; Zhuang, 
2010; Leman, 2013). Such stimulation of replication activity makes PCNA an 
essential cofactor	in vivo.	PCNA also has the distinction of being one of the 
most common interaction platforms in the replisome to accommodate 
multiple processes at the replication fork (Moldovan et al., 2007). Therefore, 
PCNA is often viewed as a regulatory cofactor for DNA polymerases (Bell, 
2014; Duzdevich et al., 2015). 
PCNA fully encircles DNA and must be loaded onto DNA at the 
replication fork. At the leading strand, this is a relatively infrequent process, 
because DNA replication is essentially continuous until termination (Leman 
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and Noguchi, 2013; Stillman, 2015). However, at the lagging strand, Pol δ is 
continually loaded at the start of each Okazaki fragment (Balakrishnan and 
Bambara, 2011). This constant initiation of Okazaki fragment synthesis 
requires repeated PCNA loading for efficient DNA replication. PCNA loading 
is accomplished by the replication factor C (RFC) complex, which is 
comprised of five AAA+	ATPases (Downey et al., 2010; Cai et al., 1998). RFC 
recognizes primer-template junctions and loads PCNA at these sites (Podust 
et al., 1995; Bloom et al., 2009). The PCNA homotrimer is opened by RFC 
using energy from ATP hydrolysis and is then loaded onto DNA in the 
proper orientation to facilitate its association with the polymerase (Zhang et 
al., 1999; Yao et al., 2006; Bloom et al., 2009; Thompson et al., 2009). Clamp 
loaders can also unload PCNA from DNA, an important mechanism during 
DNA replication termination (Yao et al., 2006; Thompson et al., 2009). 
Together these complexes mediate high fidelity duplication of the genome. 
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1.6	 Proteasomal	 degradation	 pathway	 plays	 important	 role	 in	 cell	 cycle	
regulation		
 To enforce the unidirectional progress through the cell cycle, cyclin 
dependent kinase activity is coordinated with the ubiquitin –proteasome 
system (UPS) leading to smooth transition between cell cycle phases. The 
combined activity of the UPS and cyclin –CDK network guarantees timely 
duplication of the genetic material and its equal segregation in to daughter 
cells, maintaining genome integrity and cell viability. Deregulation of protein 
ubiquitination or degradation processes can lead to aberrant cell proliferation 
and cancer (Nakayama and Nakayama, 2006).  
Ubiquitin is a small (8kD) protein consisting of 76 amino acids and is 
highly conserved. Ubiquitin is covalently attached to target substrates by a 
cascade of enzymatic reactions leading to polyubiquitination and targeting to 
the 26S proteasome for degradation. Ubiquitin activating enzyme (E1) 
covalently autoubiquitylates itself to begin the process of transferring 
ubiquitin via E2 and E3 ligases to target substrates (Yu, 2011). Ubiquitin 
conjugating enzyme (E2) then transfers the activated ubiquitin molecule to the 
lysine residue on substrate with the help of ubiquitin ligase enzyme (E3). In 
some cases, E3 ligases work in coordination with set of adaptor proteins or 
substrates known as cullins (Choudhury et al., 2016). These ligases contain a 
RING (really interesting new gene)-finger domain, which is responsible for 
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interaction with E2 (Micel et al., 2013). Multiple ubiquitination cycles result in 
poly-ubiquitinated substrates by linking ubiquitin to Lysine-48 (K48, or K-11- 
another potential target lysine) (Grice and Nathan, 2016) resulting in poly-
ubiquitin chain on the substrate which is recognized by proteasome. The 
multi-subunit 26S proteasome recognizes poly-ubiquitinated substrates and 
unfolds the polypeptide leading to its degradation into small peptides (Lub et 
al., 2016). This reaction takes place within the cylindrical core of proteasomal 
complex in ATP dependent manner (Bassermann et al., 2014; Teixeira and 
Reed, 2013).  
Ubiquitin molecules are transferred to E1 enzyme, in an ATP dependent 
process. Ubiquitin is then transferred to E2 enzyme and subsequently 
transferred to target protein with the help of E3 enzyme. Where the target 
protein is poly-ubiquitinated and it is subjected to degradation via 26S 




Figure 1-4 Ubiquitin mediated Proteasomal degradation of target 
proteins	
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 Cell cycle regulation via proteasomal mediated pathway involves one 
large subfamily of RING-finger E3 ligases comprising the cullin-RING ligases 
(CRLs). This includes two structurally similar enzymes: (a) the anaphase 
promoting complex/cyclosome (APC/C) and (b) Skp/cullin/F-box containing 
complexes (SCF) (Figure 1.6).   
A: APC/C complex with its subunits B: Skp-cullin F-box complex with its 
subunits and is active from S-Phase through transition from G2- M phase. 
APC/C is active from M phase to G1 phase; where its activity is decreased by 
inhibitors like Emi1. 
 
The APC/C complex is a prominent E3 ubiquitin ligase involved in cell 
cycle regulation. It consists of fourteen different subunits including APC/C11 
RING-finger protein that interacts with an E2 enzyme to which APC/C2 
cullin-like subunit serves as scaffold. Ube2S is one of the enzymes responsible 
for elongation and specificity of ubiquitin chains on APC/C substrates (Zhao 
et al., 2013). APC/C has two co-activators: Cdc20 (also known as Slp1 and Fzy) 
and Cdc20 homolog 1 (Cdh1) (also known as Fzr1), which define substrate 
Figure 1-5 APC/C and SCF: major E3 ubiquitin ligases regulating cell cycle 
progression 
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specificity and associate with the APC/C core at defined stages of the cell 
cycle. While SCF ligases can be active throughout the cell cycle, APC/C 
activity is restricted to the time between metaphase and the end of the next G1 
phase (Bassermann et al., 2014). 
One of the mechanisms by which adaptor proteins work is by 
recognition of short destruction motifs (D-box and KEN-box) on target 
substrates through C-terminal domains composed of WD40 repeats. Cdc20 
preferentially recognizes D-box, whereas Cdh1 recognizes both D-box and 
KEN-box motifs. APC/C is further regulated by APC/C inhibitors, such as 
Emi1 and phosphorylation of the APC/C core (Nakayama and Nakayama, 
2006). 
Among various targets of APC/CCdh1 DNA replication protein CDC6 is 
one of the proteins that is degraded via this proteasome machinery (Mailand 
and Diffley, 2005). This further regulates the transition of G1/S phase by 
ensuring that replication licensing occurs and CDK activity is maintained at a 
low level. Cyclin D1 levels are controlled by APC/CCdh1 by negatively 
regulating Ets2, a transcription factor involved in Ras-Raf –MAPK signalling 
(Bassermann et al., 2014). APC/CCdh1 activity also poly-ubiquitinates positive 
cell cycle regulators including Skp2 (Bashir and Pagano, 2004). Specifically, 
Skp2 (S-phase kinase-associated protein, aka Fbl1) is targeted for proteolysis 
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to avert premature formation of the SCFSkp2 complex, which promotes cell 
cycle progression by mediating the degradation of CKIs (Bassermann et al., 
2014). Importantly, the Cdc25A phosphatase, which promotes S-phase entry 
and mitosis by dephosphorylating and thus activating CDK2 and CDK1, is 
also kept at low levels during early G1 phase by APC/CCdh1 (Bassermann et al., 
2014; de Boer et al., 2016). 
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1.7	Proteasome	mediated	regulation	of	DNA	replication	
Regulation of DNA replication relies precisely on following principles. 
First, the assembly of pre-RCs is restricted to a period of high APC/C and low 
CDK activity. APC/C promotes pre-RC assembly by eliminating cyclins and, 
in metazoans, geminin. Second, pre-RC assembly is generally inhibited by 
multiple mechanisms. Cells have evolved multiple mechanisms to ensure 
inhibition of pre-RC assembly including: UPS mediated proteolysis, nuclear 
export, inactivation by CDK mediated phosphorylation and inhibitor binding 
e.g geminin mediated inhibition of replication complex assembly. Therefore, 
cells use multiple pathways to prevent licensing at other phases of the cell 
cycle as this will result in re-replication of the genome. The combined 
activities of the CDK network and the UPS ensure that key regulators 
accumulate and are destroyed according to need. These mechanisms ensure 
that replication licensing is restricted and occurs only from telophase to 
restriction point to maintain genome stability.  
Orc2–6 (together with CDC6) remain bound to chromatin during G1, S 
and G2 phases, the Orc1 subunit is released from chromatin during S-phase 
(Kreitz et al., 2001; Mendez et al., 2002; Li et al., 2002). Orc1 was degraded in a 
SCFSkp2-dependent manner which presumably requires CDK phosphorylation 
of ORC (Mendez et al., 2002). Using a hamster cell line, Orc1 was not 
degraded, but instead was released from chromatin during S-phase when it 
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accumulated as either a mono-ubiquitinylated or di-ubiquitinylated form (Li 
et al., 2002). Finally, overexpression of cyclin A or K cyclin from Kaposi 
sarcoma-associated herpesvirus induces the relocalisation of Orc1 to the 
cytoplasm (Laman et al., 2001).  
In mammals, the APC/C plays an important role in regulating pre-RC 
assembly. CDC6 is absent from early G1 and quiescent cells in many (but not 
all) cell lines (Mendez et al., 2000; Petersen et al., 2000; Alexandrow et al., 
2004). Overexpression of Cdh1 is sufficient to induce CDC6 degradation in 
human cells (Petersen et al., 2000; Mailand and Diffley, 2005), suggesting that 
APC/CCdh1 is important in regulating CDC6 proteolysis. CDKs also appear to 
play a role in inhibiting inappropriate pre-RC assembly. When CDKs are 
inhibited in G2 phase, either by treatment of cells with 6-DMAP or genetic 
ablation of CDK1, MCM2-7 rebinds and chromatin is re-licensed (Coverley et 
al., 1996; Coverley et al., 1998; Fujita et al., 1998; Diffley, 2004). In addition to 
being an APC/C substrate, CDC6 can also be targeted for proteolysis by cyclin 
A–CDK2 (Coverley et al., 2000). This proteolysis only affects soluble forms of 
CDC6, while forms that are bound to chromatin persist through S and G2 
phases (Coverley et al., 2000; Fujita et al., 1999; Mendez et al., 2000; 
Alexandrow et al., 2004). CDKs can also regulate the nuclear localisation of 
ectopically expressed CDC6 (Delmolino et al., 2001), which is nuclear in G1 
phase but redistributes to the cytoplasm in S and G2 phases. This 
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relocalisation requires CDK sites in the amino terminus of CDC6. Expression 
of cyclin A (but not cyclin E) regulates relocalisation of CDC6. Thus, the pool 
of CDC6 which is not bound to chromatin may be targeted for proteolysis 
and/or nuclear export by CDKs.  
Origins are licensed by the DNA loading of MCM complexes in late G1. 
During early G1, MCM loading is blocked through the APCCdh1-mediated 
destruction of CDC6. CDK mediated phosphorylation of CDC6 prevents its 
degradation by APCCdh1 mediated polyubiquitination. In late G1, MCM 
complexes are loaded at origins by the combined action of ORC, CDC6, and 
CDT1. Once cells enter S-phase, CDC6 is phosphorylated at Ser106 
phosphorylation, which promotes CDC6 nuclear export. Three overlapping 
mechanisms suppress CDT1 activity during S-phase (Figure adapted from 
Rizzardi and cook, 2012). 
 
CDT1 is regulated by two mechanisms, first by proteolytic degradation 
by SCFSkp2 (Sugimoto et al., 2004; Nishitani et al., 2004) and second, by 
inhibiting a novel DNA binding activity of CDT1 (Sugimoto et al., 2004). CDK 
Figure 1-6 DNA replication licensing and initiation is controlled by cyclin 
– CDK and ubiquitin ligases.	
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inactivation in anaphase promotes the re-accumulation of CDT1 on chromatin 
(Sugimoto et al., 2004) and overexpression of CDT1 together with CDC6 
induces re-replication (Vaziri et al., 2003). These examples demonstrate the 
importance of the UPS in regulation of the pre-RC proteins to ensure that 
replication licensing can only occur in G1 phase of the cell cycle (Figure 1.7) 
Another E3 ubiquitin ligase required for proper cell cycle progression 
is CRL4Cdt2which is known to have role in regulation of PCNA (Rizzardi et al., 
2015). This complex is composed of Cul4, Roc1/2, an adaptor protein DDB1, 
and a substrate receptor or DCAF (DDB1- and Cul4-associated factor) that 
interacts directly with DDB1. There are at least 20 known DCAFs encoded in 
the human genome (Havens and Walter, 2011). The DCAF Cdt2 (Cdc10-
dependent transcript 2) is unique among DCAFs in that its interaction with 
substrates is dependent on the substrate first interacting with DNA-loaded 
PCNA (Havens and Walter, 2011). Proteins that interact with PCNA contain a 
motif known as a PCNA-interacting protein box (PIP box) (Burgess et al., 
2013; Masuda et al., 2015). Interestingly, PCNA must be loaded onto DNA by 
the RFC complex to promote interaction between the substrate and Cdt2, 
although the basis for substrates to distinguish soluble PCNA from DNA-
loaded PCNA is not yet clear (Havens et al., 2009; Shiomi et al., 
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2012). Through the requirement for substrate interaction with PCNA, 
CRL4Cdt2-mediated proteolysis is coupled to DNA replication during S-phase. 
In contrast to APC/C, the SCFSkp2 ubiquitin ligase complex becomes 
active later at the G1/S transition and remains active throughout S-phase. The 
SCF complex is composed of only 4 subunits: Cul1 (cullin scaffold), Roc1 
(RING-domain protein), Skp1 (adaptor protein), and one of many F-box 
protein substrate adaptors. Skp1 associates with many different F-box 
proteins that confer substrate specificity. During G1, APCCdh1inhibits 
SCFSkp2 activity through ubiquitination and degradation of Skp2; this 
degradation is dependent on the N-terminal D-box of Skp2 (Bashir et al., 2004; 
Rodier et al., 2008). Later in G1, however, Skp2 is phosphorylated at Ser64/72 
by Cyclin E-CDK2, and Skp2 continues to be phosphorylated, but by Cyclin 
A-CDK2 in S-phase. Phosphorylation at Ser64, and to a lesser extent at Ser72, 
prevents Skp2 ubiquitination by APCCdh1 (Wei et al., 2004; Bashir et al., 2004; 
Rodier et al., 2008). Once active, SCFSkp2 promotes S-phase progression and 
contributes to the inhibition of origin licensing during S-phase.	
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1.8	The	quantitative	model	of	CDK	mediated	cell	cycle	regulation	
Cyclin-dependent kinases are the key regulators of the cell cycle and 
their oscillating activity contributes to separation of replication licensing from 
replication origin firing, thereby restricting replication of their genome once 
per cell cycle (Reusswig et al., 2016). In cycling cells, pre-RC assembly begins 
during late mitosis (Diffley et al., 1994; Rowley et al., 1994) as the CDK 
activity drops due to anaphase promoting complex/cyclosome activation, 
cyclin degradation and phosphatase activation. In quiescent cells re-entering 
the cell cycle, pre-RC formation is facilitated by the activity of CDK and DDK 
during G1 phase (Bruck and Kaplan, 2015; Coverley et al., 2002; Geng et al., 
2007; Mailand and Diffley, 2005). In both quiescent and cycling cells, 
separation of the replication licensing phase from the activation of replication 
origins is mediated by rising CDK activity (Figure 1.8). This quantitative 
model of CDK function defines thresholds that demarcate boundaries within, 
and between, stages of the cell cycle (Coudreuse and Nurse, 2010; Uhlmann et 
al., 2011). 
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Cyclin –CDK activity oscillates through the cell cycle defining key transition 
thresholds, threshold at S-Phase (TS) and mitosis (TM) that mark the G1/S 
transition and G2/M transition respectively. CDK activity also regulates 
temporal regulation of the replication licensing phase from the replication 
initiation phase where licensing is actively inhibited by high CDK activity. 
(Figure adapted from Uhlmann et al., 2011). 
CDK activity temporally regulates replication origin specification and 
pre-RC assembly, restricting these events to early G1 phase when CDK 
activity is low. As CDK activity rises during mid- to late-G1 phase this 
process is inhibited. Inhibition of pre-RC formation is mediated by steric 
exclusion of pre-RC assembly by direct cyclin binding (Chen and Bell, 2011; 
Mimura et al., 2004; Wilmes et al., 2004) or CDK phosphorylation of the pre-
RC components Orc2/6, CDC6 and CDT1 (Diril et al., 2012; Mimura et al., 
2004; Takara and Bell, 2011). Phosphorylation of Orc2/6, CDC6 and CDT1 
results in relocalization to the cytosol or ubiquitin proteasome system-
mediated destruction that prevents inappropriate re-licensing at high CDK 
activity (Chen and Bell, 2011; Drury et al., 2000; Johansson et al., 2014; Walter 
Figure 1-7 Quantitative model of CDK activity defining cell cycle 
transitions. 
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et al., 2016). In addition, if CDK activity is too high, phosphorylation of DNA 
pol α prevents DNA replication at the G1/S transition (Voitenleitner et al., 
1997; Voitenleitner et al., 1999). Therefore, CDK activity contributes to the 
regulation of origin assembly, activation of replication origins and prevention 
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1.9	Specificity	and	degeneracy	in	cyclin	E	and	cyclin	A	activities.	
The quantitative model of CDK activity suggests that an increase in 
CDK activity should be sufficient to progress through the cell cycle (Nurse, 
1996). In fission yeast this was demonstrated using a cdc13-cdc2 fusion 
protein that could recapitulate all events in the mitotic cell cycle in S. pombe 
(Coudreuse and Nurse, 2010). In mammalian contexts, the quantitative model 
is more complex as no single cyclin-CDK complex can regulate the entire cell 
cycle. However, there are degenerate activities mediated by CDK1 as the 
CDK2/4/6 ablated mouse fibroblasts were able to complete a mitotic cell 
(Santamaria et al., 2007).  
1.9.1	Role	of	cyclin	E-CDK2	in	cell	cycle	progression	
Cyclin E-knockout mouse models have been one of the key sources of 
experimental evidence in understanding the role of cyclin E-CDK2 in cell 
cycle progression (Parisi et al., 2003; Geng et al., 2003).   These studies 
identified the essential function of cyclin E in development as supporting 
endo-replication in the generation of poly-ploid cells like megakaryocytes, 
which generate platelets and trophoblast giant cells, necessary for placental 
formation (Parisi et al., 2003; Geng et al., 2003); conversely using tetraploid 
complementation, cyclin E is dispensable for development of the embryo 
proper (Geng et al., 2007). Notably, the critical substrate for cyclin E-CDK2 
during endo-replication is not known, in part because a full accounting of the 
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molecular determinants of endo-mitoses relative to diploid cell cycles is not 
yet established. It should be noted that cyclin E-knockout embryos also 
exhibited frequent, severe developmental defects affecting the atrioventricular 
cushions and aortic arches (Geng et al., 2003). Further, since knockout mice 
were unable to be studied into adulthood, a reasonable speculation is that 
other abnormalities would have been observed as a result of cyclin E ablation, 
especially in continuously proliferating tissues, such as hematopoietic and 
epithelial cells. 
Cyclin E-knockout mouse embryonic fibroblasts (MEFs) proliferate 
normally under conditions of continuous cell cycling; however, these cells are 
unable to re-enter the cell cycle from the quiescent state due to impaired 
minichromosome maintenance (MCM) protein loading onto replication 
origins during G0-to-S-phase progression (Geng et al., 2003). In subsequent 
work, the Sicinski group sought to identify the critical function of cyclin E 
that supports cell cycle re-entry from G0. They found that an engineered 
cyclin E mutant defective for CDK activation was competent for loading 
MCM2 onto chromatin during the G0-to-S-phase transition (Geng et al., 
2007). Thus, these results indicate that the essential cyclin E function in cell 
cycle progression past quiescence is kinase-independent. Reed and co-
workers have contended that cyclin E-CDK2 kinase activity is required for 
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MCM2 loading by promoting the accumulation of CDC6 and Cdc7 mRNAs, 
possibly through cyclin E-CDK2-mediated E2F transcriptional activation 
(Chuang et al., 2009; Barr et al., 2016). They further reported that Dbf4-Cdc7 
kinase phosphorylation of MCM2 at serine-5 is critical for its loading onto 
chromatin during G0-to-S transit. 
Cyclin E-CDK2 directly promotes origin licensing by phosphorylating 
CDC6, thus protecting it from APC/C-dependent proteolysis (Mailand and 
Diffley, 2005) These findings are also at odds with the results obtained from 
studies of cyclin E-null MEFs, which show no defects in chromatin loading of 
CDC6 and CDT1 during G0-to-S progression (Geng et al., 2007).  Moreover, 
CDC6 and mitogen-activated protein kinase (MAPK) in some cells appear to 
cooperate in recruiting active cyclin E-CDK2 complexes to chromatin to 
stimulate S-phase entry (Lunn et al., 2010). Differences in cell types, 
experimental manipulations of cyclin E expression and/or synchronization 
strategies may explain some of the disparate results among these studies. 
Ultimately though, the models proposed for a critical cyclin E function in 
regulating S-phase entry following quiescence that is kinase-dependent vs. 
one in which it is kinase-independent seem mutually exclusive. Further 
impetus to understand the basis of kinase-independent functions of cyclin E is 
provided by another provocative finding that emerged from the studies of 
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cyclin E-knockout MEFs; namely, that their resistance to Ras-induced 
transformation is reversed by re-expression of the kinase-dead cyclin E 
mutant (Geng et al., 2007). Determining the critical function of cyclin E in 
supporting transformation has obvious therapeutic implications, as 
envisioning a therapy to inhibit a kinase-independent function of cyclin E 
likely presents greater challenges than one that targets CDK2 activity. 
1.9.2	Role	of	cyclin	A-CDK2:	
Cyclin A is important in the metazoan cell cycle for the onset of both 
DNA replication and mitosis. 	Cyclin A	genes have been found in all 
multicellular organisms, including humans (Pines and Hunter, 1990).  While 
only a single	cyclin A	gene is present in the genomes of	C. 
elegans	and	Drosophila,	mammalian cells express two A-type cyclins, A1 and 
A2 (Nieduszynski et al., 2002). Cyclin A1 is expressed almost exclusively in 
the testes and during meiosis in the male germline (Sweeney et al., 1996; Yang 
et al., 1997) and male knockout mice lacking cyclin A1 are sterile because of 
an arrest in meiotic prophase at the diplotene stage, just before the first 
meiotic division (Liu et al., 1998). The second mammalian A-type cyclin, 
cyclin A2 is ubiquitously expressed in all proliferating cells and is generally 
considered to be the mammalian S-phase cyclin (Pine and Hunter 1990; Yam 
et al., 2002; Hochegger et al., 2008).	 Elimination of cyclin A function by 
microinjecting antibodies against cyclin A or by expressing antisense cyclin A 
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RNA has been shown to inhibit DNA synthesis and mitosis (Girard et al., 
1991; Pagano et al., 1992). Also, precocious expression of cyclin A in G1	cells 
accelerated their S-phase entry, indicating that cyclin A is rate limiting for the 
G1-to-S (G1/S) transition (Resnitzky et al., 1995). Deletion analyses of	Xenopus 
laevis	cyclin A (Kobayashi et al., 1992) have shown that it can be separated 
into three domains: the N-terminal domain, which is essential for periodic 
degradation of the cyclin A protein; the central cyclin box domain; and the C-
terminal domain, whose function is largely unknown. X-ray crystallography 
of the human cyclin A-CDK2 complex has revealed that cyclin A interacts 
with CDK via the cyclin box domain and that the C-terminal domain is 
basically free of the CDK interaction (Jeffrey et al., 1995). In addition, a 
conserved substrate-docking site in the cyclin box domain has been identified 
(Schulman et al., 1998). This site is implicated in binding to various cyclin-
CDK substrates through their cyclin-binding motifs (RXL motifs) but is not 
likely to contribute to substrate specificity, since the docking site and the RXL 
motifs are widely conserved among different cyclins and substrates (Miller et 
al., 2001; Roberts et al., 2012). In contrast, the C-terminal domain contains 
several clusters of charged amino acid residues on the protein surface and 
could therefore be involved in the interaction with a specific target protein. 
During cell-cycle progression, cyclin A2 is induced at the beginning of 
the S-phase (Erlandsson et al., 2000; Girard et al., 1991). Once induced, cyclin 
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A2 binds and activates its catalytic partners, cyclin-dependent kinases CDK2 
and CDK1. These cyclin A2-CDK complexes phosphorylate critical proteins 
that play role in DNA synthesis, thereby driving S-phase progression (Yam et 
al., 2002). Cyclin A2 is expressed throughout the S and G2 phases, and is 
rapidly degraded upon entry of cells into mitosis (Geley et al., 2001). CDK2 
null mouse embryonic fibroblasts (MEFs) have decreased cyclin A kinase 
activity when compared with wile type MEFs after release from quiescence 
(Berthet et al., 2003), suggesting that cyclin A is not compensating for CDK2 at 
the G1/S. In addition, cyclin A associated kinase activity alone is not able to 
rescue the deficiency of cyclin E after release from quiescence. Cyclin E1-/-E2-
/- MEFs do not enter the cell cycle despite that their cyclin A activity is similar 
as in wild-type MEFs (Geng et al., 2003). A more striking observation is the 
fact that cyclin A associated kinase activity is present in CDK2 null spleen 
extracts from young mice and in primary CDK2 null MEFs but is undetectable 
in CDK2 null spleen extracts from adult mice and in immortalized CDK2 null 
MEFs (Berthet et al., 2003). Similarly, when CDK2 is knocked down in human 
immortalized colon cancer cell lines there is no detectable cyclin A associated 
kinase activity (Tetsu and McCormick, 2003). This suggests that in embryos 
(or primary embryonic cells) the regulation of cell cycle is dependent on 
cyclin A, while in adult mice (or immortalized cell lines), new pathways 
evolve that replace the essential function of cyclin A or it’s associated kinases. 
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Indeed, cyclin A2 is essential for mouse development and its ablation results 
in embryonic lethality (Murphy et al., 1997).  
While redundancy may provide the means for change, what is less 
clear is whether the different regulation seen in different cells has any deeper 
significance. It is likely that differences in cell cycles may require different 
types of regulation. For example, in early metazoan embryos, the first 
divisions occur without transcription, eliminating one level of potential 
regulation. Additionally, differences in the regulation of quiescence in 
different cell types may be important in understanding differences in pre-RC 
regulation. It may be more important for metazoans to ensure that pre-RCs do 
not assemble at origins in cells during quiescence, as the quiescent state may 
need to be maintained for many years. Whereas reassembly of pre-RCs upon 
re-entry into the cell cycle appears to be straightforward in budding yeast, 
because CDC6 and Mcm2–7 are re-synthesized prior to the synthesis of the G1 
cyclins (Coster et al., 2014; Yeeles et al., 2017), the same does not appear to be 
true in mammalian cells, where licensing in mitosis differs from that in cells 
re-entering the cell cycle from quiescence in the requirement for cyclin E 
(Geng et al., 2007). 	
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1.10	Aims	and	Objectives	
The cell cycle is controlled by multiple cyclin dependent kinases (CDKs) 
that ensure that the genome is duplicated once and only once per cell cycle. 
Cyclin E and cyclin A show both functional degeneracy and functional 
specificity in certain contexts. Using a combination of cell based approaches 
and cell free DNA replication assays this project aims to: 
1. Evaluate specific cyclin-CDK2 complexes in regulation of G1/S 
transition using quiescent mouse embryonic fibroblasts.  
2. Investigate how cyclin E and cyclin A promote accumulation of pre-RC 
proteins in G1 phase 
3. Evaluate whether the ubiquitin proteasome system regulates 
accumulation of replication proteins  
4. To identify and analyze role of cyclin E-CDK2 and cyclin A-CDK2 in 
Initiation of DNA replication using in vitro replication assay. 




Chapter 2: Material and Methods 
2.1	Cell	Culture	
NIH 3T3 cells were freshly revived from frozen stocks provided by Dr. 
Nikki Copeland and maintained in (D-MEM) Dulbecco’s modified eagle 
medium from GIBCO is supplemented with 10 % fetal bovine serum and 1 % 
Antibiotic (GIBCO DMEM (1x) Glutamax (TM) supplemented with 1g/L D-
glucose and Pyruvate). To passage NIH 3T3 cells, media was removed, cells 
were washed with PBS (NaCl 0.138 M; KCl - 0.0027 M); pH 7.4), followed by 
incubation with 1X trypsin- EDTA (0.05% w/v trypsin, 0.2g EDTA GIBCO) for 
maximum of 5 minutes. Depending upon the cell density cells were then 
passaged 1:2 – 1:4 into 15 cm Nunclon delta dishes, maintaining cells at a 
density of 30-60 % confluence. Cells were passaged at least once every 48 
hours. HeLa cells were cultured similar to NIH3T3 cells, with DMEM media 
supplemented with 10 % fetal bovine serum and 1% penicillin / streptomycin 
(GIBCO). 
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2.2	 Quiescence	 mediated	 Cell	 Synchronization	 by	 contact	 inhibition	 and	
serum	starvation	in	3T3	cells.	
3T3 cells were passaged and allowed to reach 100 % confluency within 
48 hours passaging. Once cells reached confluence fresh media was added 
onto the plate and cells cultured for a further 48 hours to 72 hours. Cells were 
then released by passaging one confluent plate into four 15 cm plates and one 
9 cm plate with coverslips to reduce the cell density and allow the cells to re-
enter cell cycle. Cells were grown on coverslips for analysis of S phase 
population using incorporation of EdU a thymidine analogue. In addition, for 
analysis of transcript levels, cells were grown on 9 cm plate were harvested 
for RNA isolation used for quantitative PCR. 
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2.3	Synchronization	of	HeLa	cells	in	S-Phase	using	double	thymidine	block	
To prepare a synchronised S-phase population of HeLa cells 20 X 15 cm 
dishes of cells were cultured at 30%-40% confluency and incubated with 2.5 
mM thymidine (Sigma Aldrich). HeLa cells were incubated with media 
containing 2.5 mM thymidine for 24 hours, cells washed with 1x PBS and 
fresh DMEM media added without Thymidine for 8 hours. Subsequently, 
cells were then incubated with DMEM containing 2.5 mM thymidine for 
second thymidine incubation for 16-20 hours, cells washed with 1x PBS and 
fresh DMEM media added for 1 hour to release synchronised cells into S 
phase from thymidine block. These cells were then used for preparation of S –
phase cytosolic extracts used in cell free replication assay (Section 2.14). 
2.4	SiRNA	transfection	in	3T3	cells. 
Mouse fibroblasts 3T3 cells were synchronised as described (section 
2.2) and transfected with siRNA using Lonza nulceofector 2B with pre-
designed validated silencer select siRNAs (Ambion/Life Technologies) by 
addition of 50 µM siRNA suspended in Kit R reagent (Lonza). Details for 
siRNAs are shown in Table 2.1 for cyclin A (Ccna2), Cyclin E (Ccne1 and 
Ccne2), Cdh1 and DHX9. Cells were prepared for transfection using the 
following method: cells were washed with 1x PBS and incubated with 2x 
Trypsin-EDTA for 5 minutes. To detach the cells were mixed with equal 
volume of media and cells were harvested by centrifuging at 500 x g for 5 
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minutes.  Supernatant was carefully decanted, cells centrifuged at 500 x g for 1 
minute to remove excess medium and cells were then re-suspended in 
transfection mix. Synchronised transfection was optimised to use one 
confluent plate in 2 parallel reactions; (control siRNA and target siRNA); 
whereas for asynchronous cells an 80 % confluent cycling plate was used per 
transfection.  Transfection mix consists of 100µL of transfection reagent and 1 
µM of (max volume 5µL) siRNA. Cells with transfection mix were transferred 
into cuvettes used for electroporation. The electroporation unit used for this 
transfection was Lonza 2b NucleofectorTM on pre-set program for NIH 3T3 cell 
line (U-30). Cells were then immediately transferred into fresh media and 
equally distributed between plates for Western blot analysis, RNA 













Concentration Product type 
Mouse Ccne1 AM16708/160056 5nmol Silencer®-
Ambion® 
Mouse Ccne2 AM16708/161047 5nmol Silencer®-
Ambion® 
Mouse Ccna2 AM16708/66091 5nmol Silencer®-
Ambion® 
Mouse Cdh1 AM16708/161134 5nmol Silencer®-
Ambion® 
Mouse Dhx9 AM16708/160511 5nmol Silencer®-
Ambion® 
 
Table 2-1List of siRNAs used in siRNA knockdown 
 
2.5	Subcellular	fractionation		
Mouse 3T3 cells were washed with ice cold Cyto-Skeletal (CSK) buffer 
(CSK Buffer: 0.5M PIPES pH6.8, 300mM Sucrose, 100mM NaCl, 1M 
MgCl2.1mM DTT, 1X Complete Protease Inhibitor (Roche)). 1mM DTT and 
complete protease inhibitor cocktail tablet were added fresh just before 
harvesting cells. In addition to protease inhibitor, phosphatase inhibitor 
sodium orthovanadate (sigma Aldrich) of stock concentration 200mM was 
added to cell lysate to make up the final concentration of 1mM. Cells were 
then incubated in the CSK buffer for 5 minutes on ice and further incubation 
of 5 minutes at an angle to remove excess buffer. Cells were scrape harvested 
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and volumes standardised to maintain equal protein loads. Cell lysates were 
split into 2 tubes for total protein (whole cell extracts) and detergent soluble 
and insoluble (chromatin) fractions by incubating with 0.1 % Triton x 100 for 5 
minutes and harvested by centrifugation at 12000 rpm for 5 minutes. 
Supernatant was collected in fresh tube labelled as supernatant fraction 
containing cytosolic extract or pellet fraction containing chromatin fraction 
and mixed with 100µL 4X SDS Loading Buffer. All fractions were boiled at 
95°C for 10 minutes and stored at -20 °C until further analysis is performed by 
resolving on SDS –PAGE. 
2.6	 SDS-Polyacrylamide	 Gel	 Electrophoresis	 (SDS-PAGE)	 and	 Western	
Blotting	
Cell lysates with protein samples prepared in 1X Loading buffer were 
resolved on pre-cast 4-15% gradient gels, ran at 200V using Mini-PROTEAN 3 
system (Bio-Rad) for 30-40 minutes until samples resolved appropriately. 
Samples were run on 4-15% gel with 1X Tris –Glycine-SDS buffer (Running 
buffer). Samples were loaded on to gel with pre-stained protein marker 
precision plus protein standard-all blue (Bio-Rad). Resolved gels were then 
transferred on to nitrocellulose membrane with semi-dry transfer system. 
Protran Whatman nitrocellulose membrane and filter paper were hydrated in 
Transfer Buffer (60 mM Tris Base, 1mM CAPS, 10% Ethanol, 0.2 % SDS) is 
sandwiched from bottom to top in four layers of filter paper, equilibrated 
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nitrocellulose membrane, SDS-PAGE gel and four layers of filter paper. To 
transfer the proteins onto nitrocellulose 0.8mA/m2 current is applied for 2 
hours. Nitrocellulose membrane was washed and incubated with blocking 
buffer for 30 minutes at room temperature or overnight at 4 °C. Post blocking, 
the blot was incubated with primary antibody with appropriate dilution 
ranging from 1:250-1:1000 (Table 2.2), for 2 hours at room temperature or 
overnight at 4 °C with constant agitation. The membrane was than washed 
thoroughly in 1X TBST (Tris buffered saline + 0.1% v/v Tween20) with 1% 
BSA for 3 x 5 minutes which was followed by incubation with secondary 
antibody conjugated with horseradish peroxidase with the dilution of 1:5000 
for 1 hour at room temperature. The nitrocellulose membrane was washed 3 
times with TBST before visualisation of WESTAR CYANAGEN EtaC 
Chemiluminescent Substrate for Western Blot was added to the membrane 
and imaged using a Chemidoc (BIO-RAD) for varying exposure times 
depending upon the antibody. The saturation tool within ImageLab was used 
to ensure levels of protein are within the dynamic range for this equipment. 
Material used in SDS page and Western blotting are as follows: 
1) SDS Polyacrylamide gel (Huang et al.): Bio-RAD mini- PROTEAN 
TGXTM gradient gels (4-15%) with 15 wells comb with maximum 
volume of 15 µL.  
Chapter 2: Materials and Methods 
 54 
2) Membrane: Whatman Protran Nitrocellulose membrane from 
Healthcare Life Sciences 
3) 4X SDS- Loading buffer: 50mM Tris-HCl pH 6.8, 4% (v/v) SDS, 20% 
(v/v) glycerol, 1 % (v/v) β-mercaptoethanol, 0.06% (W/v) 
Bromophenol Blue dissolved in dH2O.	
4) 10 x Tris-Glycine SDS buffer: 250mM Tris Base, 1.92 M Glycine, 1% 
SDS pH 8.3.  
5) 1 x Transfer Buffer: 60mM Tris Base, 1mM CAPS, 10% Ethanol, 10% 
SDS. 
6) Blocking Buffer: 1% (W/V) Bovine Serum albumin in 1x Tris Buffer 
Saline and 0.1% Tween 20 (W/V). 
7) Wash Buffer: 1x Tris Buffer Saline and 0.1% (W/V) Tween 20.  
a. Detection Kit: WESTAR CYANAGEN Chemilluminescent 
Substrate for Western Blot 250mL kit.  
8) List of Antibodies used in Western blot is described in (Table 2.2) 
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Name Manufacturer Species Dilution Predicted 
Molecular 
Weight 





Cyclin A Sigma Mouse 
monoclonal 



















1:250 ~60 kD 
MCM2 
(BM-28) 
BD Transduction Mouse 
monoclonal 





1:500 ~110 kD 
DBF4 Abcam Goat 
Polyclonal 
1:500 ~77 kD 
Ciz1 (N741) Covalab Rabbit 
Polyclonal 
1:500 ~110 kD 
Anti-pT293 Covalab Rabbit 
Polyclonal 
1:200 ~150 kD 
Anti-pS331 Covalab Rabbit 
Polyclonal 





1:500 ~55 kD 
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1:500 ~27 kD 
 
Lamin A Abcam Rabbit 
Monoclonal 
 1:1000 ~75 kD 
Histone 3 Abcam Rabbit 
Monoclonal 





























1:500 ~110 kD 
 
Table 2-2 List of antibodies used in western blot. 
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2.7	EdU	Labelling	
To determine the number of S–phase cells, cells were labelled with 
ethynyl deoxyuridine (EdU) and labelled Click-iT imaging kit (Life 
Technologies). Cells were incubated with 10 µM (EdU) for minimum of 30 
minutes for first time point post release of cells from serum starvation. Cells 
cultured on coverslips are fixed at different time points post release ranging 
from 15 to 24 hours. At time points cells grown on coverslips were harvested, 
washed twice in PBS before fixing with 4 % paraformaldehyde (Pfander and 
Matos) by incubating it for 20 minutes at room temperature and subsequently 
washed with PBS. These coverslips were fixed and stored at -20 °C until 
further processed. Coverslips were then washed 3 times with blocking buffer 
consisting of 3% BSA in PBS. Cells were permeablised with 0.5% Triton X-100 
in PBS for 20 minutes. Post permeablisation cells were washed with blocking 
buffer and incubated in 20µL EdU labelling cocktail (1X Click-iT EdU reaction 
Buffer, Copper Sulphate (CuSO4), 1XClick-iT EdU Additive Buffer and Alexa 
Flour azide 555) for 30 minutes in dark in a humidified chamber. Post 
incubation coverslips were washed thrice with blocking buffer and twice with 
1XPBS. Coverslips were mounted with Vectashield with DAPI was used as 
nuclear counter stain. The slides were then used to count the positive nuclei 
using fluorescent microscope. Confocal Microscope was used to count 
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minimum of 100 nuclei per coverslip with DAPI and 568 filters on microscope 
to visualise blue nuclei and red spots within nuclei respectively. 
2.8	Confocal	imaging	
Cells labelled with EdU were imaged and counted under Ziess LSM 
510 Meta system upright confocal microscope in first two years of study and 
in final year Ziess LSM 880. EdU being incorporated in DNA marks 
proliferating cells when stained with Alexa fluor azide 555 emits red light 
when excited by 568 nm laser from the microscope. The red bright nuclei with 
DNA replication foci were termed as positive nuclei. Approximately 100 
nuclei for each experiment were counted as they were counter stained with 
DAPI and could be distinguished as positive or negative nuclei respectively. 
2.9	RNA	Isolation	
Transfected cells were harvested 24 hours post-transfection by washing 
them once with PBS, incubated in 1X trypsin to disassociate cells from the 
dish. Trypsin was quenched by addition of an equal amount of DMEM media 
supplemented with 10% serum and 1% antibiotic. This cell suspension was 
centrifuged at 500 x g for 5 minutes and supernatant was discarded. Pellet 
consisting of cells were frozen at -80 °C until RNA isolation was performed 
using PureLink RNA minikit (Ambion) as per manufacturer’s instructions. 
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The isolated RNA was measured using Nanodrop and used transcript 
abundance measured by RT-qPCR. 
2.10	Quantitative	Real	Time	Polymerase	Chain	Reaction	(q	RT-PCR)	
Quantitative Real Time Polymerase Chain Reaction (qRT-PCR) was 
performed using	 Express one-step SuperScript qRT-PCR SuperMix (Life 
Technologies). This kit is composed of 2 modules, Express RT module 
containing Reverse Transcriptase and RNAseOUTTM, and an EXPRESS qPCR 
SuperMix module with ROX. This approach was used to analyse the 
transcript levels of Cyclin A, MCM2, MCM10, PCNA, and CDC6. GAPDH or 
18s rRNA was used as internal control for transcript levels. Each reaction 
consists of 1 x superscript SuperMix, 50 ng-100 ng of Template RNA, 1x RT 
mix, Primers and DEPC water to make it up to the volume of 20µl. This 
reaction was made in triplicate for each of the genes and distributed in the 96 
well qPCR plates. This reaction was mixed well before and ran it for 40 cycles 
on qPCR thermal cycler. All qRT-PCR data is performed with 3 technical 
replicates for each experiment. Three independent experiments were used, 
with relative quantitation of transcript abundance relative to GAPDH 
showing mean and standard deviation is shown (n=3) as observed in chapter 
3. The list of TaqMan primers used are listed in Table 2.3.  
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TaqMan qPCR Primers Quantity, concentration 
Pcna Mm00448100_g1 75µL (20X) 
Mcm10 Mm00712529_m1 75µL (20X) 
Mcm2 Mm00484814_m1 75µL (20X) 
Ccna2 Mm00438063_m1 75µL (20X) 
GAPDH Hs02758991_g1 75µL (20X) 
Ccne1 Mm00432367_m1 75µL (20X) 
Ccne1 Mm00438077_m1 75µL (20X) 
Cdc6 Mm01301803_g1 75µL (20X) 
Ciz1 Mm00503766_m1 75µL (20X) 
Cdh1 Mm01247357_m1 75µL (20X) 
Dhx9 Mm00456021_m1 75µL (20X) 
 
Table 2-3 List of TaqMan primers used in qRT-PCR. 
 
2.11	His(6)	tagged	ubiquitin	plasmid	generation	
His-(6)-ubiquitin plasmid was obtained from Dr. Elaine Taylor. This 
plasmid was amplified by transformation and purified by QIAGEN miniprep. 
Transformation of plasmid was carried out by adding 1 µl of the plasmid to 
competent cells for 30 minutes on ice followed by heat shock for 2 minutes at 
42 °C, cells incubated for 5 minutes on ice and 250 µl pre-warmed SOC 
medium added to competent cells with incubation at 37 °C for 1 hour. 
Transformed bacteria were selected on LB agar plates with 100  µg/ml 
ampicillin. Colonies were picked next day and 5 ml LB broth with ampicillin 
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were inoculated for overnight mini-prep cultures. Qiagen mini-prep plasmid 
extraction was performed and isolated His(6)-tagged ubiquitin plasmid was 
transfected as described in following section.  
2.12	His(6)-Ub	mediated	pulldown	
3T3 cells were synchronized by contact inhibition and serum 
starvation. Synchronized cells were released intro fresh DMEM medium and 
transfected with His-tagged ubiquitin plasmid. These cells were allowed to 
enter cell cycle and transition from G1 phase to S phase. These cells were then 
incubated with Proteasome inhibitor for 4 hours prior to harvest. 24 hours 
after transfection cell were washed in 10 ml of lysis buffer, and incubated for 5 
minutes, following which plate was placed at angle of 45°and excess buffer 
was removed and cells were scrape harvested. Cells were collected in a 1.5 ml 
microfuge tube and volume made up to 200 µl with buffer, with 1 µl of PMSF 
(200 mM stock) and 10 µl of a 10 % triton X-100 solution. Incubated on ice for 
5 minutes and spun at 10000 x g for 5 minutes. Supernatant was collected in a 
second tube labelled low salt and pellet was suspended in 200 µl of the high 
salt buffer and incubated on ice for 5 minutes followed by centrifuge at full 
speed for 5 minutes. Spin columns were prepared with 30 µl Ni2+-NTA resin 
for each reaction. Beads were washed 3 times with 500µl of wash buffer prior 
to addition of the cell lysates. 200 µl of wash buffer was added to the cell 
extracts (total volume now ~400 µl) and 20 µl was removed for analysis on the 
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gel. This was the protein load (5% total). Bind for 1 hour on the mixer in cold 
room and wash the beads. Beads were washed in 500 µl of wash buffer and 
excess buffer was spun through into a collection tube at 1000 x g for 1 minute. 
Washing step was repeated 4 times.  60 µl of 4 x SDS-PAGE loading buffer 
was added to the beads in the tube, boiled for 10 minutes and allowed to cool 
before removing plugs and collecting the denatured proteins in a clean 
collection tube. This was the bound fraction for analysis by western blotting. 
2.13	Chemical	inhibition	of	CDK2	and	DDK	
3T3 cells were synchronized by contact inhibition and serum 
starvation. Cells were incubated with CDK2 inhibitor (Roscovitine) or DDK 
inhibitor (PHA 767491) after restriction point at around 20 hours post release. 
Roscovitine (30 µM) or PHA 767491 (10 µM) were incubated with cells for 
fours before cells were harvested in CSK buffer and fractionated into total 
fraction, cytoplasmic and chromatin associated fraction (Section 2.5). These 
fractions were then suspended in 4 x SDS loading buffer, boiled at 95°C and 
samples analysed on western blot. 
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T-9250 Working conc. 2mM 
 
Table 2-4 List of Drugs used in experiments as indicated. 
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2.14	Cell	free	DNA	replication	assay	
Cell free replication assay involves reconstitution of minimal 
components required to initiate DNA replication in vitro.  
i. Pre-Mix: Pre- mix consists of Buffers and dNTPs required for 
replication assay. Pre-Mix is stored at -80 in 15 µl aliquots. dNTPS were 
purchased from sigma Aldrich with concentration of 100 mM and were 
stored at -20 until used. Composition of Pre-Mix is as followed: 
 
Table 2-5 Components of pre-mix used in cell free replication assay. 




1M HEPES pH7.8 400mM 40mM 400µL 
1M MgCl2 70mM 7mM 70µL 
1M DTT 10mM 1mM 10µL 
2M Phosphocreatine 400mM 40mM 200µL 
0.5M ATP 30mM 3mM 60µL 
0.1M GTP 1mM 0.1mM 10µL 
0.1M CTP 1mM 0.1mM 10µL 
0.1M UTP 1mM 0.1mM 10µL 
0.1M dATP 1mM 0.1mM 10µL 
0.1M dGTP 1mM 0.1mM 10µL 
0.1M dCTP 1mM 0.1mM 10µL 
Ultra pure Water   200µL 
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ii. Creatine Phosphokinase (CPK) (Calbiochem) with stock concentration 
of 5 KU. This was stored in low milligram quantities at -20 and re-
suspended in CPK buffer (40mM HEPES pH 7.8 and 1mM DTT) fresh 
every time for the reaction. 
iii. Biotin -16-dUTP: Commercially purchased from Roche diagnostics at 
concentration of 50 nmol and was stored at -20. 
iv. Nuclear and cytosolic extract:  
Late G1 phase nuclear extract was prepared by synchronizing 3T3 cells 
by contact inhibition and serum starvation and harvested by homogenization 
in hypotonic buffer (1M HEPES pH 7.8, 1 mM MgCl2, 3 mM potassium 
acetate, 1 mM DTT) at around 17.5 hours post release. Nuclei were separated 
from cytosolic extract by centrifuging at 6000 rpm for 5 minutes at 4°C. Pellet 
fraction was re-suspended in equal quantities of hypotonic buffer and frozen 
into beads using liquid nitrogen for later use. G1 cytosolic extract wasthe 
supernatant fraction and was also stored into beads using liquid nitrogen 
ready to be used later. Cyclin E depleted and cyclin A depleted nuclei were 
prepared by transfection cyclin E1/E2 siRNA and cyclin A2 siRNA of 
synchronized 3T3 cells as described previously. Transfected cells were 
harvested after 24 hours of transfection and nuclear extracts were prepared in 
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hypotonic buffer and stored into beads by freezing in liquid nitrogen and 
stored for later use. S phase cytosolic extract was prepared by synchronizing 
HeLa cells in S phase by double thymidine block as mentioned previously. 
The cytosolic extract was stored in beads by freezing in liquid nitrogen and 
ready to be used later.  
v. Cell free Replication assay: 
Cell-free replication assay was performed as described by (Coverley et 
al., 2002; Coverley et al., 2005) and Copeland et al., 2010; Copeland et al., 
2015). Each reaction was constituted with nuclear extract and cytosolic extract 
along with master mix consisting of (1:10) pre-mix, (1:50) biotinylated dUTP 
(Roche), (1:50) CPK (Millipore) and (1:50) MgCl2. Each of the reaction was 
incubated for 30 minutes at 37 °C. After the reaction was complete 1/10th of 
the reaction mix was fixed with 4 % paraformaldehyde and transferred onto 
poly-D-lysine (Sigma-Aldrich) coated coverslips by spinning the reaction mix 
at 1500 rpm onto 30 % sucrose cushion. These coverslips were then washed 
with 1 x PBS three times, followed by washes with antibody buffer (detergent 
mix and 1% BSA). Coverslips were incubated with streptavidin-Alexa fluor 
555 (1:10000) for 30 minutes in dark. After the incubation coverslips were 
washed three times with antibody buffer (specify components) and three 
times with PBS. Coverslips were then mounted with Vectashield with DAPI 
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and analysed on Zeiss confocal microscope. The remaining reaction was 
incubated with 0.1 % Triton X-100 for 5 minutes on ice and fractionated into 
chromatin and cytoplasmic fractions by centrifugation at 14,000 rpm for 5 
minutes. Pellet fraction suspended in 4x SDS loading buffer and samples were 
analysed by western blot. Further to this, nuclear matrix fractionation was 
performed by suspending pellet fractions after first spin with high salt buffer 
(0.5 M NaCl in PBS) for 5 minutes on ice and spinning at 14,000 rpm. The 
pellet fraction of this spin was then suspended in 4 x SDS loading buffer and 








Analysis of the role of cyclin E 
and cyclin A-CDK2 in post-
quiescent fibroblasts 
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3.1	 Cell	 synchronization	 for	 analysis	 of	 temporal	 regulation	 of	 DNA	
replication	
The cell cycle is a series of regulated molecular events that govern 
DNA replication and mitosis resulting in generation of daughter cells from 
single parent cell. Each cell can either continue to proliferate or exit cell cycle 
via reversible process known as quiescence thereby entering G0 phase of the 
cell cycle (Coller, 2011; Zetterberg and Larsson, 1985). Quiescent cells are non-
proliferative that continuously repress transcription of genes required for cell 
cycle progression, but actively express anti-apoptotic, anti-senescence and 
anti-differentiation genes (Coller, 2011; Zetterberg et al., 1995).  
The decision to commit to cell cycle or to remain in quiescence is 
dependent on a functional restriction point. The Restriction point was first 
described by (Pardee, 1974), evaluating the timing of DNA synthesis in 
hamster fibroblasts after a cell cycle block and release. Restriction point or R-
point is defined as the point in the cell cycle when the cell commits 
irreversibly to S-Phase entry as extracellular stimulus is no longer required for 
completion of the cell cycle and hence also known as ‘point of no return’ 
(Pardee, 1974; Zetterberg et al., 1995). Prior to this point the cell requires 
sustained mitogen stimulus to proliferate and exit quiescence. 
Progression from past the G1 restriction point requires sustained 
mitogen signalling and a collection of interconnected and reinforcing 
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mechanisms that stimulate CDK2 activation leading to Cyclin E/CDK2 
activation resulting in activation of transcription of replication assembly 
proteins. CDK2 is believed to be cytoplasmic in some quiescent cells, which 
prevents its phosphorylation by nuclear kinases (Geng et al., 2007).  
To study the cell cycle, pharmacological agents that arrest cells at 
different phases are widely used. Mimosine, (Dijkwel, 1992), the plant derived 
drug which prevents initiation of DNA replication results in arrest in G1, is 
used as one of the synchronisation method. However, it affects the intrinsic 
levels of p53 and p21 and hence alters the analysis. Another example of drug 
used for synchronisation of cells in G1 phase is lovastatin (Javanmoghadam-
Kamrani, 2008), a mevalonate synthesis inhibitor; however, there are reports 
that it induces apoptosis. Hydroxyurea (Gerenday, 1997) or double thymidine 
(Galgano, 2006) treatment synchronise cells in S phase by targeting 
ribonucleotide reductase inducing replication stress. Nocodozole and 
colcemid arrest cells in M phase by acting as microtubule-disrupting agents 
(Olmsted et al., 1989). These drugs provide synchronous cell populations but 
each approach induces potential artefacts related to their mechanism of action 
that include metabolic perturbations and toxicity. Pharmacological agents 
used in manipulating the cells to synchronise have been shown to result in 
dissociation of nuclear and cytoplasmic cell-cycle processes, disruption in 
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metabolic state of the cell and cell death (Levenson and Hamlin, 1993; Merrill, 
1998). The artefactual nature of the drug treatments limits their use for 
analysis of physiologically relevant process. 
Several drug free methods have been established for synchronising 
cells from asynchronous cell populations. Centrifugal elutriation can isolate 
cells at any phase of cell cycle, and mitotic shake off can be used to isolate 
mitotic cells; however, yield of the cells is very low and hence cannot be used 
for variety of experiments. When choosing a synchronisation method it is 
necessary to consider cell type, the cell cycle phase, doubling time and the cell 
cycle duration (Langan et al., 2017; Memili et al., 2004; Jackman et al., 2001). 
Here we use the physiologically relevant contact inhibition and serum 
starvation approach to generate a synchronised post-quiescent population of 
cells to study cell cycle progression (Coverley et al., 2002; Copeland et al., 
2010). 
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3.2	Chapter	aims	
The cell cycle is controlled by multiple cyclin dependent kinases 
(CDKs) that ensure that the genome is duplicated once and only once per cell 
cycle. The proteins that are phosphorylated by cyclin E-CDK2 and cyclin A-
CDK2 remain to be fully identified. The aims of this chapter are to investigate 
the role of cyclin E-CDK2 and cyclin A-CDK2 in G1/S transition. Here, 
synchronised 3T3 cells are stimulated to re-enter the cell cycle. During cell 
cycle re-entry CDK2 activity is inhibited and the effects on pre-RCs, pre-IC 
and replisome will be monitored. In addition, effects on cell cycle regulation 
by DBF4 dependent kinase will also be monitored. For comparison protein 
levels and transcript levels by qRT-PCR will be monitored. These approaches 
will give a better understanding of the role of cyclin-CDK2 and DDK activity 
in late G1 phase and their role in replication complex assembly in the G1/S 
transition. 
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3.3	 Experimental	 approach	 synchronization	 of	 mouse	 fibroblasts	 to	
monitor	cell	cycle	re-entry	from	G0	
This study utilises synchronisation of the cells at the G0 stage of the cell 
cycle by contact inhibition and serum starvation (Coverley et al., 2002; 
Copeland et al., 2010; Copeland et al., 2015; Langan, 2011). Quiescent cells are 
released from starvation and passage into diluted subsequent concentration 
of cells. Synchronisation of cells was confirmed by incorporation of EdU, a 
nucleotide analogue that allows monitoring of the number of cells in S-phase. 
In addition, as a control to demonstrate synchronisation; expression levels of 
proteins were studied by western blot and transcript levels were analysed by 
quantitative real time polymerase chain reaction (qRT-PCR) (Figure 3.1). 
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Mouse fibroblasts (3T3) are synchronised by contact inhibition and serum 
starvation. Cell-cell contacts are disrupted by trypsinization and cells are 
diluted to facilitate cell-cycle re-entry. Comparison of siRNA transfected/ 
chemical inhibitor treated sample and control cells enable comparison of 
replication complex assembly by western blot and S phase entry (EdU) at 
defined time-points in G1 and S phase.  
 
 	
Figure 3-1 Experimental overview for analysis of cell cycle progression 
from G1 to S phase. 
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3.4	 Synchronisation	 of	 mouse	 fibroblasts	 to	 monitor	 cell	 cycle	 re-entry	
from	G0	
To investigate cell cycle progression in a mammalian system, the 
physiologically relevant quiescence release method is used. This drug free 
protocol enables study of the cell cycle between G0 and S-phase to monitor 
the early steps in DNA replication using cell-based assays and to produce 
material for cell-free DNA replication assays (Copeland et al., 2010; Coverley 
et al., 2002). Regulation of the cell cycle by reversible cell cycle exit into a 
quiescent state is a key regulatory event in stem cells and somatic tissues. This 
approach yields tight synchronized populations of cells to enable temporal 
analysis of stages within G1 that facilitate that mediate DNA replication 
complex assembly to proceed. Isolation of the cell population at defined time 
points (Figure 3.2.A), enables analysis of the transcript (Figure 3.3) and 




























A: Experimental overview identifies time points for analysis and 
quantification of EdU time points. B: Line graph showing percentage of cells 
in S –phase at indicated time points where N=3+/-S.D. C: Representative 
images of the EdU labelled nuclei from 10 hour to 24 hour with increase in 
EdU positively labelled nuclei from 18 hour post release.  
Figure 3-2 Establishing cell cycle re-entry kinetics after synchronization in 
G0. 




Transcriptional regulation of regulators of DNA replication is 
mediated by E2F family of transcription factors. As a control to ensure 
synchrony of cell population a selection of E2F regulated genes were analysed 
at transcript and protein levels. Expression of E2F target genes were followed 
from G0 to S-Phase at 0, 4, 8, 12, 16, 20 and 24 Hrs. Samples were processed 
and qRT-PCR performed (Section 2.10). Transcript level of pre-RC proteins 
CDC6, MCM2, Pre-IC protein MCM10, cell cycle regulators cyclin E1/E2 and 
cyclin A2 as well as the replisome protein PCNA were monitored for 24 hours 
post release from quiescence. There is steady increase in transcript levels with 
a peak at 20 hour time point and going down again at 24 hour post release 

























Relative quantification of E2F target genes standardised to GAPDH. Cells 
were harvested at indicated time points and transcript levels quantified by 
qRT-PCR for E2F target genes. Cumulative of each of the E2F gene transcripts 
(Cyclin A2, CDC6, Cyclin E1, Cyclin E2, PCNA, MCM2, MCM10) show same 
trend. Data shows mean, where N=3. 
 
Similarly, to detect changes in protein levels in cells re-entering the cell 
cycle from G0, cells were harvested at different time points ranging 0-24hrs. 
Cells were harvested and samples were prepared and analysed by western 
blotting (Figure 3.4). Expression of proteins appears to have increased with 
increasing time post release, consistent with the synchronised population of 
cells preparing to enter S –Phase and commit to DNA replication. 
 
 
Figure 3-3 Transcription of E2F target genes after release from quiescence. 
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Whole cell extracts were prepared at indicated time points and analysed by 
western blot. Replication assembly proteins including MCM2, PCNA, CDC6 
and cell cycle regulator cyclin A start to accumulate from around 16 hour time 
point post release from quiescence. 
Protein analysis during G1/S transition (Figure 3.4) reveals cyclin E 
starts to accumulate as soon as 8 hours after release from G0 phase, prior to 
the restriction point. This is consistent with temporal analysis of cyclin E 
expression (Figure 3.3), and with the existing literature suggesting that cyclin 
E – CDK2 complex was responsible for early G1/ S transition events, such as 
transition through the restriction point (Foster et al., 2010), and for pre-
replication complex activation at the end of G1 phase (Coverley et al., 2002). 
Additionally, the regulatory protein, for CDC7 kinase activation, Dbf4 was 
shown to accumulate prior the restriction point, around 12 hours after release 
Figure 3-4 Analysis of replication assembly of proteins in cells entering 
cell cycle from quiescence 
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from quiescence. Dbf4 along with CDC7 as Dbf4 dependent kinase (DDK) 
was also proposed to be involved in G1/S transition and DNA replication 
initiation (Sheu and Stillman, 2006; Tanaka and Araki, 2010), thus the data 
were consistent with a tightly synchronised population of cells. Interestingly, 
cyclin E–CDK2 and DDK are expressed at 12 hours where they function to 
promote activation of DNA replication complex assembly in G1 phase (Bruck 
et al., 2015; Deegan and Diffley, 2016; Nougarede et al., 2000). Importantly, 
cyclin A accumulates post-restriction point, 16 hours after release from G0 
phase, which is distinct from its transcript levels (Figure 3.3). This is due to 
APC/CCdh1 mediated degradation of cyclin A in G1 phase (Choudhury et al., 
2016). Cyclin A – CDK2 complex is responsible for DNA replication firing in 
the early S phase that occurs around 18 hours after release from quiescence 
(Coverley et al., 2002).   
The data presented here shows that the synchronisation of cells by 
serum starvation and contact inhibition enables synchronous transcript 
accumulation, protein levels and S-phase entry demonstrating that this 
approach enables reproducible cell cycle re-entry after release from 
quiescence. This method of cell synchronisation and release therefore is an 
effective method to study pre-replicative proteins and their regulation by 
cyclin -CDK2 in G1-S transition and initiation of DNA Replication. 
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3.6	 CDK2	 inhibition	 destabilises	 replication	 assembly	 of	 proteins	 and	
blocks	S	phase	entry	in	synchronised	cell	population.	
Protein phosphorylation by kinases plays a very important role in 
regulation of various cell processes including, proliferation, cell cycle, 
differentiation and apoptosis. Cyclin dependent kinases (CDK) play an 
important role in control of cell cycle and proliferation. Initially, the CDK1/2 
specific inhibitor Roscovitine (Meijer, 1997) was used to assess how CDK2 
activity promotes cell cycle progression in an asynchronous population of 
cells. Using an asynchronous population of cells at 70-80% confluency, cells 
were treated with Roscovitine for 4 hours, scrape harvested and whole cell 
extract analysed by Western blot (Figure 3.5). Analysis of the protein samples 
revealed a reduction in replication complex assembly proteins (CDC6, MCM2, 
PCNA) in absence of CDK2 activity. 
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A: Western blot analysis of the MCM2, PCNA and CDC6 in asynchronised 
cell system with roscovitine treatment of 4 hours. B: As for A using a 
synchronized population of cells released from quiescence +/- roscovitine for 4 
hours and cells harvested at 24hours post release and analysed by western 
blot analysis for MCM2, PCNA and CDC6. C: Histogram showing S phase 
cells at 24 hour post release and CDK2 inhibition by roscovitine where N=3+/- 
S.D. 
Figure 3-5 CDK2 inhibition with roscovitine destabilises replication 
complex assembly of proteins (MCM2, CDC6, PCNA and MCM10) and 
blocks S phase entry. 
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As roscovitine is both a CDK1 and CDK2 inhibitor, this effect could be 
caused by either kinase, in any phase of the cell cycle. As MCM2, PCNA and 
CDC6 accumulate in mid G1 phase, we next examined whether CDK2 
inhibition affects protein accumulation in a synchronized late G1 population 
of 3T3 cells (Figure 3.5.B). Synchronization in G1 phase also examined the 
activity of CDK2 more precisely as CDK1 is inhibited at this phase of the cell 
cycle. Consistent with the results using asynchronous population of cells, 
inhibition of CDK2 activity reduced CDC6, MCM2 and PCNA levels 
following addition of roscovitine, which correlates with a reduction in S-
phase cells (Figure 3.5.C). 
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3.7	DDK	 inhibition	 destabilises	 replication	 complex	 assembly	 of	 proteins	
and	blocks	S	phase	entry	from	quiescence	
DDK is a two subunit Serine-threonine kinase composed of CDC7 
kinase and DBF4 regulatory subunits. DDK is a key regulator of changes in 
MCM2-7 helicase via phosphorylation leading to helicase activation and 
template unwinding (Hardy et al., 1997; Hoang et al., 2007). In cells re-
entering cell cycle from quiescence, DBF4 protein levels peak during G1/S 
transition and is associated with CDC7 kinase for substrate recognition 
(Labib, 2010). Chemical inhibition of CDK2 by roscovitine (Section 3.5), 
demonstrates reduction in regulatory proteins of DNA replication in both 
asynchronous and synchronized cell population (Figure 3.5) Interestingly, 
CDK2 inhibition also blocks S phase progression of quiescently release cells 
there by inhibiting DNA replication.  
To test whether DDK activity is required for accumulation of CDC6, 
PCNA and MCM2 in late G1 phase a chemical inhibitor of DDK PHA-767491 
(PHA)(Poh, 2014) was used in an asynchronous population of cells. 
Asynchronous cells were treated with DDK inhibitor PHA-767491 and 
harvested 4 hours after treatment. Western blot analysis of these protein 
samples revealed a reduction in replication complex assembly proteins (DBF4, 
cyclin A, CDC6, MCM2 and PCNA) (Figure 3.6.A). Additionally, DBF4 one of 
the components of pre-initiation complex is destabilised in absence of DDK. 
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There was also an effect of DDK inhibition on cyclin A protein levels but not 
on cyclin E and PCNA levels in asynchronous cell system. 
A: Western blot analysis of the MCM2, PCNA and CDC6 in asynchronous cell 
system with roscovitine treatment of 4 hours. B: Western blot analysis of the 
MCM2, PCNA and CDC6 in synchronised cell system with roscovitine 
treatment of 4 hours. C: Histogram showing percentage of S phase cells at 20 
and 24 hours timpoints post release and DDK inhibition by PHA 767491. 
  
Figure 3-6 DDK inhibition prevents DNA replication and destabilises 
replication complex assembly of proteins. 
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Quiescent cells were released into fresh medium and incubated with 
PHA 767491 at 16 and 20 hours post-release and harvested after 4 hours of 
treatment. Addition of PHA 767491 reduced the number of cells entering S-
phase at 20-24 hour time points (Figure 3.6.C), that correlated with a 
reduction in replication complex assembly proteins MCM2, Dbf4 and Cyclin 
A at 20 hours. However, little effect was noted at the 24hour time point 
(Figure 3.6.B).  
Formation of pre-initiation complex (pre-IC) requires activation of 
MCM2-7 helicase by DDK and Cyclin E-CDK2 mediated phosphorylation 
(Labib, 2010). The results presented here showing inhibition of CDK2 (Figure 
3.5) and DDK (Figure 3.6) reveal destabilisation of replication complex 
assembly of proteins (MCM2, MCM10, CDC6 and PCNA). 




 Cell synchronisation may enable dissection of the role of Cyclin 
dependent kinases in replication complex assembly and initiation of DNA 
replication. Chemical inhibition of CDK2 by roscovitine and DDK inhibition 
by PHA 767491 suggest that phosphorylation mediated by CDK2 and DDK is 
required for replication protein accumulation and progression to S phase in 
post-quiescent cells. However, since CDK2 inhibition and DDK inhibition 
were carried out by chemical inhibitors, a genetic approach was also used to 
exclude off target effects. In order to determine if the inhibition of specific 
CDK2 complexes promote accumulation of replication complex assembly 
proteins, cyclin isoforms E1 and E2 were simultaneously depleted. Targeted 
depletion of cyclin E (cyclin E1/E2) was performed by siRNA transfection, 
and the effect on the G1 to S phase transition monitored at the protein and 
RNA level, and by EdU incorporation to determine the number of S phase 
cells. 
Cyclin E knockdown was confirmed by transcript analysis performed 
for cyclin E1 and cyclin E2 by qRT-PCR with reduction of 90% transcript of 
cyclin E1 and 80% reduction of Cyclin E2 (Figure 3.7.A). Cyclin E knockdown 
significantly reduces the number of cells entering S-Phase (Figure 3.7.B). 
Approximately 40% of cells were found to be in S phase from the proliferation 
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assay performed on control cells, whereas cells transfected with Cyclin E 
siRNA fail to enter S-phase as less than 5% cells entered S-Phase (Figure 
3.7.B).   
Figure 3.7.C demonstrates that reduction of cyclin E-CDK2 activity 
leads to a reduction of DNA replication complex proteins CDC6, PCNA, 
MCM10, cyclin A and MCM2 by western blot analysis post cyclin E1 and E2 
siRNA transfection. Cyclin E levels appear to have reduced post cyclin E1/E2 
siRNA transfection at both timepoints (20 hours and 24 hours) post release. 
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A: Transcript levels for control and siRNA treated cells were determined by 
quantitative reverse transcriptase PCR confirming effective depletion of 
Cyclin E1 and Cyclin E2. B: Control and Cyclin E1 and Cyclin E2 siRNA 
treated cells were labelled with EdU to determine number of cells in S-phase 
at indicated time points (15hrs-24hrs).  C: Western blot showing an effect of 
siRNA mediated depletion of Cyclin E at two different time points 20hrs and 
24hr, compared to control cell lysates prepared from untreated cells. 
Replication complex assembly of proteins MCM2, MCM10, CDC6 and PCNA 
appear to be reduced at 24 hour time point. 
Figure 3-7. Cyclin E inhibition reduces replication complex assembly 
proteins CDC6, MCM2, MCMC10, PCNA abundance. 




Both CDK2 inhibition and cyclin E depletion have resulted in a 
reduction in replication assembly proteins (MCM2, CDC6, MCM10 and 
PCNA) and exit from G1 phase. Next the contribution of cyclin A-CDK2 
activity in regulation of accumulation of replication proteins was assessed by 
siRNA mediated depletion of Cyclin A. Quiescent cells were treated with 
cyclin A2 siRNA and stimulated to re-enter the cell cycle. Cyclin A2 transcript 
levels were reduced by >95% (Figure 3.8.A) and cyclin A protein levels were 
undetected. The percentage of S-phase cells was ~45 % in control cells to less 
than 10 % for cyclin A depleted cells (Figure 3.8.B). Furthermore, there was a 
clear reduction in CDC6, MCM2 and PCNA at 20 and 24 hours post-release 
and siRNA transfection. The results are consistent with CDK2 inhibition by 
roscovitine (Figure 3.5) and siRNA mediated depletion of cyclin E1 and E2 
(Figure 3.7). In addition, there was a reduction in DBF4 at 20 hour that was 
less apparent at 24 hours. Importantly, cyclin A2 depletion did not affect 
accumulation of cyclin E suggesting that cyclin A2 activity is also required for 
accumulation of CDC6, PCNA and MCM2 in fibroblasts. 
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A: Transcript levels for control and siRNA treated cells were determined by 
quantitative reverse transcriptase PCR confirming effective depletion of 
Cyclin A. B: Western blot showing an effect of siRNA mediated depletion of 
Cyclin A2 at two different time points 20 hours and 24 hours, compared 
against control cell lysates. C: Control and Cyclin A siRNA treated cells were 
labelled with EdU to determine number of cells in S-phase at indicated time 
points (15hrs-24hrs). D: Immunoblot showing replication protein abundance 
in control and cyclin A2 depleted cells. 
 
Figure 3-8 Cyclin A is required to promote accumulation of pre-RC 
proteins in post quiescent fibroblasts. 
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The apparent decrease in CDC6, PCNA and possibly DBF4 was 
unexpected after depletion of cyclin A. The reduction in protein levels for 
each protein could prevent licensing of replication origins and prevention of 
DNA replication, as seen in the reduced number of cells that can accumulate 
in S-phase after depletion of cyclin A (Figure 3.8.C). CDC6 is a key component 
of the pre-RC and is essential for replication complex assembly formation 
(Mailand and Diffley, 2005) as reduction in CDC6 could reduce assembly of 
Pre-RC and restrict replication licensing. Dbf4 is required for the regulation 
and activation of the replicative helicase MCM2-7. In addition, depletion of 
the DNA polymerase sliding clamp PCNA would drastically reduce 
processivity of DNA polymerases (Kath et al., 2014; Takeda and Dutta, 2005). 
Reduction in protein levels for CDC6, Dbf4 and PCNA may provide a 
mechanistic basis for the failure of cells to enter S-Phase after cyclin A2 and 
cyclin E1/E2 depletion. This apparent reduction in protein level could 
conceivably be due to transcriptional down regulation or potentially a 
destabilisation of the protein level post-translationally, perhaps by 
proteasomal degradation.  
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3.10	 Inhibtion	 of	 CDK2	 or	 DDK	 reduces	 CDC6,	 MCM2,	 PCNA	 and	 cyclin	
expression	by	inhibition	of	E2F	mediated	transcription.		
As a first step to identifying the mechanism by which CDC6, MCM2 
and PCNA levels are regulated, the transcript levels were compared for 
control cells and cells after CDK or DDK inhibition. 
To assess whether CDK2 inhibition and DDK inhibition affects 
transcription qRT-PCR was performed on cells 20 and 24 hours post release 
after roscovitine and PHA treatments. Roscovitine reduced transcription of 
cyclin E1, E2, MCM10 and CDC6 by 80%; MCM2, cyclin A2 and PCNA 
transcript levels were less affected. Similarly, DDK inhibition reduced cyclin 
E1, E2, CDC6 and MCM10 by approximately by 75% and cyclin A2, MCM2 
and PCNA were less affected. These results suggest kinase inhibition results 
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Transcript analysis of replication proteins MCM2, CDC6, PCNA and MCM10 
along cell cycle regulatory proteins cyclin E1/E2 and cyclin A2 post CDK2 
inhibition by Roscovitine at 20 hour time point (A) and 24 hour time point (B). 
Transcript analysis of replication proteins MCM2, CDC6, PCNA and MCM10 
along cell cycle regulatory proteins cyclin E1/E2 and cyclin A2 post DDK 
inhibition by PHA 767491 at 20 hour time point (C) and 24 hour time point 
(D). Data shows Mean, Where N=3. 
  
The chemical inhibitors used to block CDK2 and DDK are known to 
have off target effects, for example roscovitine is potential CDK1 inhibitor as 
well as CDK2. Even though the CDK1 is inhibited in early G1 phase and 
hence roscoivitine effects are likely to be primarily due to CDK2 inhibition.  
Figure 3-7  Transcript analysis of replication assembly proteins after 
CDK2 and DDK inhibition. 
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DDK inhibitor PHA 767491 on the other hand is a CDK2 inhibitor (Ki =230 
nM) in addition to its DDK inhibitor activity. Consequently the inhibitory 
effect on transcript levels using PHA 767491 is potentially via inhibition of 
CDK2 mediated regulation of the Rb-E2F pathway. Therefore, we do not have 
direct evidence of a role for DDK activity in regulation of transcription of the 
E2F pathway due to potential crosstalk with CDK2 activity at concentrations 
used here.  
Targeted depletion of indivdual cyclins (E1/E2 and A2), have a more 
deterimental effect on cell cycle progresssion of post-quiesencent cells (Figure 
3.7.B and Figure 3.8.B) through destabilisation of replication assembly 
proteins MCM2, CDC6, MCM10 and PCNA. Transcript analysis of these 
cyclins post siRNA mediated knockdown shows 90% reduction in cyclin 
E1/E2 or A2 transcript levels (Figure 3.7.A and Figure 3.8.A). This suggests 
that targeted depletion of cyclin E1/E2 and cyclin A2 and transcript analysis 
of potentially affected proteins would enable us to understand the possible 
mechansim behind regulation of these proteins in absence of Cyclin-CDK 
activity during G1/S transition in mammalian system. 
 	




To test whether reduction of replication complex proteins is mediated 
at the level of transcription in absence of cyclin E1 and cyclin E2, quiescent 
cells were transfected with cyclin E1/E2 siRNAs. 24 hours post-transfection 
cells were harvested and transcript levels for E2F regulated genes MCM2, 
MCM10, CDC6, PCNA were determined by qRT-PCR (Figure 3.10). 
Consistent with its role in regulation of the Rb-E2F pathway, cyclin E1/E2 
depletion led to the reduction in E2F regulated genes PCNA, MCM2, MCM10 
and CDC6, that correlates with protein expression levels (Figure 3.10.A).  
The data presented demonstrate that CDK2 inhibition by roscovitine 
(Figure 3.9.A, B) and cyclin E1/E2 depletion reduced expression of E2F 
pathway genes. The canonical role of cyclin E-CDk2 is well established for 
cyclin E1/E2-CDK2 but cyclin A-CDK2 is not required for Rb inhibition, rather 
cyclin A-CDK2 further supresses the activity of Rb through S-phase but is not 
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Transcript analyses of replication proteins MCM2, CDC6, PCNA and MCM10 
along regulatory proteins cyclin E1/E2 post Cyclin E knockdown (A). 
Transcript analyses of replication proteins MCM2, CDC6, PCNA and MCM10 
post Cyclin A knockdown (B).  
 
 
Figure 3-10 Transcript analysis of replication assembly proteins after 
siRNA mediated depletion of cyclin E1/E2 and cyclin A2. 
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To determine the role of cyclin A-CDK2 in regulation of E2F target 
genes, cyclin A knockdown was performed by transfecting synchronous 
quiescent cells with Cyclin A siRNA. Cells were harvested 24 hours post 
transfection with Cyclin A siRNA and transcript levels determined by 
quantitative reverse transcriptase PCR (Figure 3.10.B). The transcript levels of 
genes PCNA, MCM2, MCM10 and CDC6 are unaffected by cyclin A2 
depletion. Importantly, the detected protein levels for CDC6, MCM2, MCM10 
and PCNA were found to be reduced by Cyclin A knockdown. This suggests 
that cyclin A is required for accumulation of CDC6, PCNA, MCM2 via a 
distinct mechanism from cyclin E1/E2. There is a need to better understand 
how cyclin A2 contributes to the accumulation of important regulators of the 
replication licensing system. These data suggest that their abundance is 
regulated at the level of post-translational modification, potentially via the 
UPS. 
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3.12	Discussion	
Cell synchronisation studies mediated by contact inhibition and serum 
starvation enabled the study of DNA replication complex assembly in late G1 
to S-Phase (Copeland et al., 2010; Coverley et al., 2002). Initial studies on cell 
synchronisation were performed to determine the correct time course for 
subsequent experiments (Figure 3.2). Monitoring the proportion of cells in S-
phase and protein levels enabled correlation of cell cycle stage with 
replication complex assembly. Synchronised cells were released from 
quiescence and synchrony confirmed by monitoring transcript levels, protein 
expression and S–Phase entry. This approach serves as the basis to analyse 
and dissect the function of cyclinE-CDK2, cyclin A-CDK2 and DDK in late G1. 	
The apparent reduction in CDC6 protein levels after inhibition of 
CDK2 activity is consistent with previous works that have identified that 
CDK2 regulates CDC6 levels at the transcriptional level and post-
translationally by the ubiquitin proteasome system (UPS) (Mailand and 
Diffley, 2005). CDK2 activity has been shown to be required for both CDC6 
and Cdc7 expression in cell re-entering the cell cycle from quiescence 
(Chuang et al., 2009).To evaluate the contribution of transcriptional regulation 
on CDC6 protein levels quantitative real time PCR (qRT-PCR) was performed 
monitoring MCM2, MCM10, CDC6 and Cyclin A after CDK2, DDK and 
individual Cyclin depletion. This approach demonstrated that transcripts 
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levels remain unchanged after siRNA mediated depletion of cyclin A2, but 
inhibition of CDK2 kinase activity or cyclin E1/E2 depletion revealed a 
reduction in transcription of these proteins mediated by the Rb-E2F pathway. 
Inhibition of DDK also blocks S phase entry in quiescent release cells 
(Figure 3.9). However, the DDK inhibitor used in these experiments is PHA 
767491, which is also a CDK2 inhibitor (Albanese et al., 2010). The data 
presented here cannot determine that PHA is not inhibiting transcription 
through inhibition of CDK2 activity. Consequently, the datasets are similar 
for both roscovitine and PHA767491 with respect to transcriptional 
regulation, cell cycle progression and protein abundance (Figure 3.9). In 
future studies use of an alternative DDK inhibitor such as XL 413 (Sasi et al., 
2017; Sasi et al., 2014)or depletion of Dbf4 or Cdc7 would potentially resolve 
whether DDK activity contributes to transcriptional regulation of the Rb-E2F 
pathway.  
Chemical inhibition and genetic inhibition of CDK2 activity lead to a 
reduction in protein levels of CDC6, MCM2 and PCNA. More detailed 
analysis identified that CDK2 inhibition by roscovitine and cyclin E1/E2 
depletion led to a reduction in transcript levels, potentially identifying the 
mechanism that reduced protein levels. However, cyclin A2 depletion reduces 
S-phase entry and reduces CDC6, PCNA and MCM2 levels by a yet to be 
identified mechanism (Figure 3.10.B). A striking observation in Figure 3.8 
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showed that cyclin A2 depletion does not affect cyclin E levels. As cyclin E is 
unaffected by cyclin A2 depletion this suggest that cyclin E-CDK2 could 
mediate hyperphosphorylation of Rb, thereby promoting expression of E2F 
regulated genes. Surprisingly, MCM2, CDC6 and PCNA levels are much 
reduced relative to controls, despite apparently normal transcript levels 
(Figure 3.10). This suggests that cyclin E and cyclin A may perform specific 
functions in G1 phase as cells re-enter the cell cycle from quiescence. Cyclin 
A-CDK2 activity appears to contribute to accumulation of DNA replication, 
potentially by protection from degradation mediated by Ubiquitin 
proteasome system. This forms the hypothesis for the next chapter, where the 
role of the UPS in degradation of the replication assembly proteins is assessed 






system and cyclin A-CDK2 
regulates CDC6 and MCM2 
levels in late G1 phase 
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4.1	Introduction:	Ubiquitin	proteasome	system	regulates	G1	to	S	transition	
Global analysis of transcript and protein abundance reveal that 
approximately 50% of proteins correlate with their transcript abundance, 
suggesting that the proteome is more dynamic than the transcriptome during 
cell cycle (Weintz et al., 2010; Ning, 2012). This highlights that intrinsic 
protein stability and the role of UPS mediated degradation contribute to 
regulation of protein levels within the cell. 
The proteasome contributes to regulation of the cell cycle and 
facilitates temporal organization of the replication complex assembly as cells 
exit mitosis (Chang et al., 2015; Sivakumar and Gorbsky, 2015). Replication 
licensing is tightly regulated, as new licensing during late S phase and G2 
phases can lead to re-replication that ultimately promotes genome instability. 
The consequences of re-replication include gene amplification and aneuploidy 
that drive oncogenesis (Shen et al., 2012). Therefore, it is imperative that cells 
prevent re-replication. Origin licensing is restricted to G1 phase, primarily 
through low CDK activity that enables pre-RC formation and ubiquitin-
mediated proteolysis of licensing components and cell cycle regulators in later 
phases of the cell cycle (Chen et al., 2011;  Diril et al., 2012; Walter et al., 2016; 
Johansson et al., 2014; Bassermann et al., 2014) 
The transition from G1 to S-phase results from decreasing 
APC/CCdh1activity, activating the SCF complex leading to decreased CKIs 
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levels, rising cyclin expression, and therefore increasing CDK activity, 
phosphorylation and inactivation of Rb (retinoblastoma) protein family 
members, and activation of E2F transcription factor family members 
(Bassermann et al., 2014; Yang et al., 2012). The inactivation of APC/CCdh1 at 
the G1/S transition is critical for the accumulation of cyclin A for S-Phase 
progression. Cyclin A levels accumulate in part due to E2F regulated 
expression of Emi1, an APC/C pseudosubstrate that inhibits its activity in late 
G1 phase (Prosser et al., 2012; Yang et al., 2012). Emi 1 is degraded following 
phosphorylation by PLK1 and ubiquitination by SCF and this allows 
activation of APC/C that is critical for progression through M Phase and G1 
Phase (Hatano and Sluder, 2012; Machida and Dutta, 2007) (Figure 4.1).  
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The UPS controls the cell cycle. The cell division cycle is regulated primarily 
by the activity of cyclin-dependent kinases (CDKs) and protein degradation 
by the ubiquitin–proteasome system (UPS). Each CDK complex contains one 
of many activating subunits, termed cyclins, the levels of which oscillate 
during the cell cycle. CKIs (CDK inhibitors), such as p27 and p21, inhibit CDK 
activity and promote cell cycle arrest and/or delay. SCF complexes and the 
APC/C (anaphase-promoting complex/cyclosome) provide the specific, rapid 
and timely proteolysis of cell cycle regulators, which ultimately controls 
CDK1 and CDK2 to finely modulate their activities during cell cycle 
progression. 
 	
Figure 4-1 APC/C and SCF mediated G1/S transition. 
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4.2	APC/Ccdh1	mediated	ubiquitination	in	G1	phase	
 Cdh1 levels remain low from G2 and early mitosis due to 
phosphorylation (Oakes et al., 2014; Choi et al., 2014). Cdh1 is 
dephosphorylated at mitotic exit and is activated resulting in ubiquitination 
of Cdc20 (Huang et al., 2001), Aurora kinases (Littlepage et al., 2002; Stewart 
et al., 2005) and polo-like kinase 1 (PLK1) (Lindon et al., 2004) ensuring low 
kinase activity for mitotic exit (Singh et al., 2014; Kao et al., 2014; Zhang et al., 
2016). During G1 phase, APC/Ccdh1 polyubiquitinates many proteins including 
mitotic cyclins CDC25A (Donzelli et al., 2002), Skp2 and Cks1 (Bashir et al., 
2004) leading to proteasome mediated degradation. In addition, APC/Ccdh1 
regulates destruction of replication regulators including Geminin (McGarry et 
al., 1998) and CDC6 (Mailand and Diffley, 2005); as well as its own E2, Ube2C 
and UbcH10 (Rape et al., 2004; Williamson et al., 2009). This leads to its 
inactivation of APC/Ccdh1 and resulting stabilization of cyclin A (Oakes et al., 
2014). This suggests that APC/Ccdh1 plays an important role in regulation of 
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4.3	Chapter	aims	
 This chapter aims to investigate whether CDK activity contributes to 
regulation of protein abundance through inhibition of the Ubiquitin 
Proteasome System (UPS). Chapter 3 identified that inhibition of CDK2 and 
DDK with Roscovitine and PHA 74756 along with genetic inhibition of cyclin 
E and cyclin A individually have shown to block cell cycle progression and S 
phase entry in cells released from quiescence. Inhibition of CDK2 activity in 
G1 phase leads to reduction in pre-RC proteins MCM2, CDC6; Pre-IC protein 
MCM10 and replisome protein PCNA in absence of cyclin –CDK2 and DDK 
activity. As observed in chapter 3, Cyclin E-CDK2 appeared to regulate 
transcription of MCM2, MCM10, CDC6 and PCNA; however, it is not clear 
how cyclin A –CDK2 depletion led to a reduction in MCM2, CDC6, MCM10 
and PCNA abundance.  
The aim of the chapter is to investigate the potential role of ubiquitin –
proteasome system in degradation of proteins in the absence of cyclin-CDK2 
and DDK activity. Secondary aim of the chapter is to investigate whether the 
E3 ligase Cdh1, that is active throughout G1 phase, contributes to the 
destabilization of MCM2, CDC6 and PCNA in G1 phase after inhibition of 
cyclin-CDK activity. 
Chapter 4: Results 
 108 
4.4	 Proteasomal	 inhibition	 promotes	 stabilisation	 of	 MCM2,	 CDC6	 and	
PCNA	in	G1	phase	after	CDK2	inhibition.	
 The observation that inhibition of cyclin-CDK2 and DDK activity 
reduces the abundance of DNA replication proteins (MCM2, CDC6 and 
PCNA) suggests that CDK and potentially DDK mediated phosphorylation in 
G1 phase regulate protein. The reduction in protein levels suggest that there 
are two possible mechanisms that mediate the reduction these proteins in 
absence of kinase activity.  
Transcriptional regulation was tested in Chapter 3 and it was observed 
that cyclin E-CDK2 regulated the transcription of replication proteins (MCM2, 
CDC6, MCM10 and PCNA) via E2F mediated pathway. The focus of this 
chapter is to test the second hypothesis involvement of ubiquitin proteasome 
system (UPS) and its potential role in regulation of CDC6, MCM2 and PCNA 
abundance.  
To test whether the UPS contributes to protein stability, a proteasomal 
inhibitor (MG132) was used. Initially, cycling asynchronous or synchronous 
3T3 cells were co-incubated with the CDK2 inhibitor roscovitine with or 
without MG132 in independent experiments (Figure 4.2). 
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A: Asynchronous 3T3 cells were incubated with 30µM roscovitine and 10µM 
of MG132 for four hours and harvested in lysis buffer and analysed by 
western blot for recovery in destabilized MCM2, CDC6 and PCNA with 
proteasomal inhibition. B: Synchronous 3T3 cells were incubated with 30µM 
roscovitine +/- 10µM of MG132 for four hours from at 20 hours and harvested 
in lysis buffer at 24 hours post release and analysed by western blot for 
recovery in destabilized MCM2, CDC6 and PCNA with proteasomal 
inhibition. 
 
Inhibition of CDK2 activity in asynchronous cells, levels show a reduction 
in MCM2, CDC6 levels and PCNA to a lesser degree (Figure 4.2.A) consistent 
with observations from chapter 3. Importantly, in lane 3 (Cell lysate prepared 
from co-incubation with Roscovitine and MG132) of this western blot we see 
recovery in destabilized MCM2, CDC6 and PCNA with proteasome inhibition 
by MG132. Lane 4 shows proteasome inhibition and accumulation of MCM2, 
CDC6 and PCNA in absence of CDK2 inhibitor indicating positive activity of 
proteasome inhibitor MG132 (Figure 4.2A).   
Figure 4-2 Proteasome inhibition recovers destabilised proteins in absence 
of CDK2 activity. 
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Similarly, to determine whether the proteasome potentially degrades this 
approach was repeated in a synchronised late G1 population using CDK and 
proteasomal inhibitors (Figure 4.2.B). The western blot shows a reduction of 
pre-RC proteins MCM2, CDC6 and replisome protein PCNA with incubation 
of roscovitine and a partial recovery with co-incubation with MG132. These 
results are consistent with a proteasomal mediated degradation of MCM2, 
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A: Synchronous 3T3 cells were incubated with 10µM PHA 74756 and 10µM of 
MG132 for four hours post restriction point around 20 hours and harvested in 
lysis buffer at 24 hours post release and analysed by western blot for recovery 
in destabilized MCM2, CDC6, CDC45 and PCNA with proteasomal 
inhibition. 
 
For comparison with roscovitine mediated CDK2 inhibition, PHA 767491 
(PHA) a DDK/CDK2 inhibitor was added to a synchronized late G1 
population of cells. PHA inhibits DDK when used at 10µM and destabilizes 
pre-RC proteins MCM2, CDC6; pre-IC proteins CDC45, MCM10 and 
Figure 4-3 Proteasome inhibition recovers destabilised proteins in the 
absence of DDK activity. 
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replisome protein PCNA (Figure 4.3). Interestingly, DDK inhibition also 
affects cyclin A accumulation but not cyclin E. Similarly, inhibition of DDK 
activity reduces MCM2, MCM10, CDC6 and PCNA (Figure 4.3) that is 
reversed by inhibition of the proteasome by MG132. This suggests that CDK2 
and potentially DDK mediated phosphorylation may promote stabilisation by 
direct phosphorylation or indirectly by potential regulation of E3 ligase and 
by inhibition of ubiquitination. Interestingly, CDC45 appears to be 
destabilized with DDK inhibition. Individual inhibition of CDK2 and DDK 
affects accumulation of pre-RC proteins MCM2, CDC6; Pre-IC proteins 
CDC45, MCM10 and replisome protein PCNA required for initiation of DNA 
replication and G1/S transition. Importantly, in both asynchronous and 
synchronous G1 population cells CDK/DDK inhibition appears to promote 
UPS mediated degradation that can be reversed by inhibition of the 
proteasome. 
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4.5	 Cyclin	 A	 depletion	 destabilises	 replication	 complex	 proteins	 (CDC6,	
PCNA,	MCM2,	MCM10),	by	proteasomal	mediated	degradation	
 The use of small molecule inhibitors of CDK2 and DDK suggests that 
both CDK and DDK kinase activity promotes and facilitates accumulation of 
replication proteins in mid-late G1 phase and that this can be reversed by 
proteasomal inhibition (Figure 4.2 and Figure 4.3). In principle, roscovitine 
may destabilize the regulatory proteins by inhibition of cyclin E –CDK2 and 
cyclin A-CDK2. To ensure that effects observed were due to reduction in 
CDK2 mediated phosphorylation and not due to off target inhibition, siRNA 
mediated targeted depletion of cyclin A was performed in synchronized cells.  
Cyclin A knockdown destabilized replication proteins CDC6, PCNA, 
MCM as observed in Chapter 3 (Figure 3.8, 3.10) potentially suggesting 
proteasomal regulation of proteins. To test this hypothesis, the proteasomal 
inhibitor MG132 was used and the effects on protein stability monitored. Cells 
were synchronized in G0 and transfected with cyclin A siRNA or control 
siRNA. Each reaction was performed in parallel; a control reaction and 
MG132 treated sample that were monitored as cells re-entered the cell cycle. 
There is a clear reduction in cyclin A2 transcript levels as determined by q-
RT-PCR (Figure 4.4.A). Consistent with these observations there was a 
significant decrease in the number of cells that entered S-phase as determined 
by EdU labelling staining positively replicating cells (Figure 4.4.B).  
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A: Histogram generated from q-PCR analysis indicating cyclin A transcript 
depletion. B: Histogram showing block in S phase analysed by EdU labelling. 
C: Western blot analysis showing recovery in destabilized proteins with 
addition of MG132. 
 
Analysis of protein levels was performed by western blot. Depletion of 
cyclin A show inhibition of cyclin A-CDK2. The results presented here shows 
destabilization of DNA replication proteins CDC6, PCNA and MCM2 (Figure 
4.4). Again, consistent with earlier results using CDK2 and DDK inhibition 
Figure 4-4 Destabilized replication proteins are degraded by proteasome 
mediated system in absence of cyclin A. 
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this destabilisation in reversed by addition of proteasomal inhibitor MG132. 
Interestingly, Cyclin E, p27, DBF4 remain unaffected in absence of cyclin A 
and that protein levels of these proteins remain consistent even with addition 
of MG132. These data suggest that cyclin A-CDK2 activity prevents 
degradation by ubiquitin proteasome system in late G1 phase in post-
quiescent cells. 
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4.6	Analysis	of	ubiquitination	of	MCM2,	CDC6	and	PCNA.	
 The data presented suggest that the proteasome may degrade CDC6, 
MCM2 and PCNA after inhibition of CDK2 activity in late G1 phase. To 
determine whether CDC6, MCM2 and PCNA are poly-ubiquitinated a 
plasmid expressing a hexa-histidine-tagged ubiquitin (His(6)-Ub) was 
transfected with 3T3 cells to enable enrichment and isolation of ubiquitinated 
substrates. Detection of multiple bands would be consistent with poly-
ubiquitination and suggest that UPS regulates their abundance.  
Cell lysates were prepared from GFP transfected cells to ensure 
efficient transfection and, and from His(6)-Ub transfected cells with and 
without MG132. The addition of MG132 will enrich for poly-ubiquitinated 
proteins through inhibition of their degradation. Ubiquitinated proteins are 
then partially purified using Ni2+-NTA resin, washed extensively and bound 
proteins analysed by immunoblotting (Figure 4.5).  
For both CDC6 and MCM2, GFP transfected and His-Ub transfected 
cells recovered little protein, but addition of MG132 lead to an increase in 
recovered proteins, consistent with an UPS mediated degradation. 
Furthermore, addition of MG132 uncovered the number of bands that were 
detected between 110-150 kDa for MCM2 (Figure 4.5.A) and 60-70 kDa for 
CDC6 (Figure 4.5.B), consistent with poly-ubiquitination.  





3T3 cells were transfected with GFP or His-Ub and cell lysates produced 24 
hours after transfection. His6- Ub labelled proteins were recovered by 
Immobilised metal affinity chromatography (IMAC) +/- MG132. 
Ubiquitinated proteins were detected by western blot A: for MCM2. B: CDC6 
and C: PCNA. 
 
 As Ub-PCNA was not detected it remains to be determined how PCNA 
levels are regulated. Multiple experiments show that inhibition of CDK2 
activity reduces PCNA levels, as it could not be directly detected here using a 
His tagged ubiquitin, perhaps PCNA stability is regulated by an alternative 
mechanism. Nevertheless, this approach could detect poly-ubiquitinated 
MCM2 and CDC6, consistent with UPS mediated degradation.   
 	
Figure 4-5 His6-Ub mediated pull down of MCM2, CDC6 and PCNA with 
MG132. 
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4.7	 Cdh1-	 potential	 E3	 ligase	 regulating	 degradation	 of	MCM2,	 CDC6	 and	
PCNA	in	absence	of	cyclin	dependent	kinases.	 
 To further support a UPS mediated degradation of MCM2 and CDC6, 
preliminary experiments were performed targeting a G1 ubiquitin E3 ligase. 
E3 ligases transfer ubiquitin moieties to the target proteins and marking them 
for degradation via 26S proteasome. There are more than 600 E3 ligases (Li et 
al., 2008) that regulate cellular homeostasis and contribute to mechanisms that 
maintain DNA replication once and once per cell cycle.  
 Cyclin dependent kinases mediated phosphorylation of CDC6 could be 
responsible for stabilization. CDC6 is a substrate of cyclin E-CDK2 and cyclin 
A-CDK2 mediated phosphorylation at three serine residues (Herbig et al., 
2000); two of these lie in the close proximity of APC/C destruction boxes. 
Serine 54 is next to RXXL-type destruction box and serine 74 is near a KEN 
type destruction box (Petersen et al., 2000). APC/CCdh1 recognizes the KEN box 
motif for destruction and that CDC6 is regulated by APC/CCdh1 mediated 
degradation in absence of kinase activity (Mailand and Diffley 2006).  
 Figure 4.6 shows co transfection of Cdh1 siRNA with cyclin A siRNA 
in synchronized cell system in comparison with proteasomal inhibitor MG132 
with cyclin A siRNA transfection. Relative quantitation of cyclin A and Cdh1 
was tested post transfection relative to GAPDH (Figure 4.6.A). Cyclin A 
transcript levels were depleted in both cyclin A transfected alone and co 
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transfected with cyclin A and Cdh1 siRNA (Figure 4.6.A). Similarly, Cdh1 
transcript levels were depleted as well in Cdh1 siRNA transfection alone and 
with co-transfection of cyclin A and Cdh1. The cell cycle kinetics in post-
quiescent cells was determined after cyclin A, Cdh1 and co-transfection cells 
(Figure 4.6.B). Depletion of cyclin A alone reduced S-phase entry to the 
greatest extent, less than 20 % of cells in S-phase at 24 hours after release. 
However, Cdh1 and Cdh1 co transfection with cyclin A had an intermediate 
effect with less than 30% of cells in S phase compared to 45% in control 
reactions. Analysis of protein levels after cyclin A2 or Cdh1 siRNA 
transfections show efficient depletion of cyclin A but Cdh1 was not detected.  
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A: Transcript analysis of cyclin A, Cdh1 in individual transfection and co-
transfection of cyclin A and Cdh1. B: Histogram showing number of S phase 
cells in absence of cyclin A, Cdh1 and in combination of cyclin A and Cdh1. 
C: Western blot analysis for combination of cyclin A and Cdh1 co-
transfection.  
 
To assess whether Cdh1 depletion prevents loss of CDC6, MCM2 or 
PCNA quiescent cells were transfected with Cdh1 siRNA and roscovitine was 
used to inhibit CDK activity (Figure 4.7).  
  
Figure 4-6 Cdh1 a potential E3 ligase destabilising replication complex 
assembly in absence of cyclin A. 

















A:Transcript analysis of Cdh1 after Cdh1 depletion. B: EdU analysis of cells 
re-entering cell cycle and in S phase with Cdh1 depletion in comparison with 
control cells. C: Western blot analysis of CDC6, MCM2, PCNA for samples 
prepared in reactions with CDK2 inhibitor and Cdh1 depletion. The 
inconclusive western blot with Cdh1 depletion as protein levels could not be 
equalised due to low cell recovery post-transfection after Cdh1 depletion. 
 
 Figure 4.7.A shows effective Cdh1 depletion with a 95% reduction in 
transcript levels post Cdh1 siRNA transfection in synchronized cells. To 
assess whether Cdh1 depletion affects cell cycle progression EdU labelling of 
cells was performed. As observed in Figure 4.7.B shows nearly 35% of cells 
enter S phase in absence of Cdh1 compared to 45% of cells in S phase in 
Figure 4-7 CDK2 inhibition and Cdh1 depletion in synchronized cell 
population. 
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control transfections. To determine whether CDK2 inhibition destabilises 
CDC6, MCM2 or PCNA after Cdh1 depletion roscovitine was used. Western 
blot analysis showed MCM2 was effectively reduced by addition of 
roscovitine, whereas CDC6 and PCNA were not affected. Addition of MG132 
and roscovitine increased CDC6 and MCM2 levels (Figure 4.2) appear to be 
affected with CDK2 inhibition and recovery in the destabilized proteins with 
MG132. However, with Cdh1 depletion was inconclusive because there was a 
reduction in cell number after Cdh1 depletion and it was not possible to 
balance the protein loads in multiple experiments.  
To assess whether the expression of Cdh1 correlates with cell cycle 
stage where cyclin A-CDK2 is active, the mRNA and protein levels of Cdh1 
were determined in a synchronised population of 3T3 cells (Figure 4.8.A). RT-
qPCR of cyclin A2 and Cdh1 were in synchronised 3T3 cells re-entering cell 
cycle every 4 hours post-release. Cyclin A expression was determined in 
Chapter 3. Its transcript levels increase throughout G1 phase and peak after 
restriction point around 18-20 hours post release. This contrasts with Cdh1, 
which is transcribed in early G1 phase and is reduced prior to restriction 
point. With transcript levels of Cdh1 appear to be at the peak when cells are 
in quiescence or G0 and the levels appear to fall with the cells re-entering cell 
cycle and S-phase.  
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A: Transcript levels of Cyclin A and Cdh1 in cells re-entering cell cycle from 
quiescence. B: western blot analysis of Cdh1 and cyclin A over the time course 
of release from quiescence indicating increase in protein levels of cyclin A 
with a peak at 24 hours post release and Cdh1 levels decrease as the cells re-
entering cell cycle from quiescence.  
 
Western blot analysis of Cdh1 and cyclin A show opposing results, 
Cyclin A levels increase with cells re-entering cell cycle and peak at 24 hour 
time point post release, whereas Cdh1 levels decrease as cells re-entering cell 
cycle. The temporal expression of Cdh1 does not correlate with expression of 
cyclin A2 suggesting that Cdh1 is not abundant during late G1 phase where 
we detect a UPS mediated degradation in late G1, suggesting that Cdh1 is 
unlikely to be the E3 ligase involved in regulation of protein abundance in 
late G1 phase.  
  
Figure 4-8 Cdh1 transcript and protein levels in cells released from 
quiescence. 
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4.8	Discussion	
 In this chapter, the role of Ubiquitin proteasome system in absence of 
active kinases during G1/S transition and potential mechanism by which 
cyclin A-CDK2 regulate the replication assembly proteins was assessed. 
APC/C and SCF being the key E3 ligases regulating cell cycle progression 
(Rikardi and Cook, 2012), and that absence of kinase activity upregulates the 
APC/C activity to degrade substrates to promote transition from G1 to S 
phase. 
As observed in Chapter 3 and Figure 4.2 inhibiting CDK2 with 
roscovitine reduced DNA replication proteins CDC6, MCM2 and PCNA 
similar to the effect of cyclin A knockdown (Figure 4.5). This suggests that 
Cyclin A-CDK2 complex is responsible for appropriate accumulation of CDC6 
and MCM2 during late G1 phase. Roscovitine predominantly inhibits CDK1, 
CDK2 and in G1 phase CDK1 is inactive due to inhibitory phosphorylation 
(Jang et al., 2016). Inhibition of CDK2 in late G1 phase reduced CDC6, MCM2 
and PCNA levels but addition of MG132 reverses protein degradation, 
suggesting involvement of the UPS in their degradation. These experiments 
lead to intriguing area of research to understand mechanism of ubiquitin 
ligases in maintaining and regulating the process of replication licensing.  
The G1/S transition is regulated by two main ubiquitin proteasome 
complexes, APC/CCdh1 and SCF regulating the protein degradation during cell 
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cycle (Araki et al., 2005).  APC/C and SCF work in coordinated fashion in 
regulating the protein concentration depending upon the requirement of cell 
cycle (Bashir et al., 2004). Understanding mechanism by which cyclin A 
functions in coordination with ubiquitin system was studied in detail in this 
chapter. The cyclin A2 specific role in destabilisation of CDC6 and MCM2 was 
restricted to late G1 to S-phase transition in post-quiescent cells. As protein 
stability can be increased by addition of MG132 suggests a role of ubiquitin 
proteasome mediated regulation in stabilizing replication assembly proteins 
MCM2, CDC6, PCNA during G1/ S transition and DNA replication. 
In addition to CDK2 inhibition, there was also a reduction of CDC6, 
MCM2 and PCNA when incubated with the DDK inhibitor PHA 767491. As 
this inhibitor also inhibits CDK2 and due to the similarity between the results 
with roscovitine and PHA, we cannot exclude that PHA is inhibiting the 
CDK2 network leading to the reduction in CDC6, MCM2 and PCNA. 
Nevertheless, for both roscovitine and PHA mediated inhibition respectively, 
the reduction in protein levels could be reversed by addition of MG132. 
Consistent results indicate a role for the UPS in regulation of CDC6, MCM2 
and PCNA abundance in absence of kinase activity during G1/S transition. To 
further support the UPS mediated degradation His-tagged ubiquitin was 
used to identify ubiquitinated substrates. After CDK2 and proteasomal 
inhibition, there was an enrichment of poly-ubiquitinated CDC6 and MCM2 
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(Figure 4.5) but PCNA was not detected using this approach. The failure to 
detect PCNA suggests that PCNA may be destabilised by a different 
mechanism that is yet to be identified. 
Taken together this data demonstrates that Cyclin A2 depletion 
prevents G1 exit in post-quiescent cells (Figure 3.7, Figure 4.4). This 
observation is distinct from those of the cyclin A2 null mouse fibroblasts that 
showed no requirement for cyclin A2 for cell cycle progression (Geng et al., 
2007). These differences may be related to technical differences in our 
approaches or perhaps relate to the differences in cycling and post-quiescent 
populations. Here we are using post-quiescent cells to investigate cyclin A2 
cell cycle regulation. The results clearly show that depletion of cyclin A2 
prevents initiation of DNA replication in post-quiescent cells. These data 
presented here suggest that cyclin A-CDK2 prevents UPS mediated 
degradation of CDC6 and MCM2 that appears to be required for efficient 
initiation of DNA replication in post-quiescent cells.  
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4.8.1	Analysis	of	Cdh1	activity	in	regulation	of	CDC6,	MCM2	and	PCNA.	
Preliminary experiments aimed at investigating the role of Cdh1 in 
degradation of MCM2 and CDC6 were unsuccessful due to a consistent loss 
of cells following Cdh1 transfection. Other approaches would be required to 
address this question. However, temporal analysis of Cdh1 and cyclin A 
expression found an inverse correlation, consistent with Cdh1 mediated 
destruction in G1 phase and cyclin A-CDK2 mediated destruction of Cdh1 at 
the G1/S transition. The temporal analysis of Cdh1 expression suggests that 
another E3 ligase is responsible for poly-ubiquitination of CDC6 and MCM2. 
Further analysis is required to identify and characterise the E3 ligase that 






Analysis of Ciz1 and DHX9 in 
synchronized post-quiescent 
mouse fibroblasts  
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5.1	Ciz1	Discovery	and	structural	characterization	
Ciz1 (Cip1- interacting zinc finger protein) is a protein unique to 
vertebrates and is conserved in mammals. It was first identified as Cip1-p21 
interacting protein in S. cerevisiae yeast two hybrid assay (Mitsui et al., 1999). 
Ciz1 not only interacts with p21 but also to cyclin E-CDK2, cyclin A, and 
CDC6 resulting in contribution to regulation of cellular proliferation and 
transcriptional regulation (Coverley et al., 2005; Copeland et al., 2010; 
Copeland et al., 2015). 
The domain structure of Ciz1 is consistent with the role in spatial 
coordination of DNA replication complex assembly (Ainscough 2007). The C-
terminus contains nuclear matrix binding domains (Copeland et al., 2010) and 
N terminus contains the binding sites for pre-RC protein CDC6 and cyclin A-
CDK2 and the nuclear matrix (Copeland et al., 2015). The C-terminal domain 
contains three C2H2- type zinc finger, an acidic patch, with a nuclear matrix 
association domain similar to matrin 3 (MH3 domain) (Mitsui et al., 1999; 
Warder and Keherly, 2003) Figure 5.1.A. 	  
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A: The figure shows the regions corresponding to the glutamine-rich domain 
(QD1 and QD2), the acidic domain (AD), the zinc finger domains (ZF), and 
MH3 domain (MH3) of the Ciz1. Black dots indicate the phosphorylation sites 
of Ciz1 (Mitsui et al., 1999). B: the phosphorylation sites in the N-terminal are 
presented in black (6 out of total 14 are presented), cyclin-binding domains 
are shown in light blue ovals, and the dark blue oval indicates the interaction 
site of cyclin E and cyclin A, required for the regulation of DNA replication 
function of Ciz1 (Copeland et al., 2015). The minimal functional fragment of 
Ciz1, named N471, is depicted as yellow and red parts combined.	
  
5.2	Ciz1	function	in	initiation	of	DNA	replication	during	G1/S	transition	
It was determined that Ciz1 is involved in cell cycle regulation and 
potentially carcinogenesis by interacting with p21-Cip1 and regulating its 
availability at G1/S checkpoint. Consecutive experimentation determined that 
mRNA of Ciz1 was abundant in many human cell lines and in a variety of 
tissues. Ciz1 mRNA was most abundant in kidney and testis tissues in mice 
(Mitsui et al., 1999). Later, it was independently isolated from human 
medulloblastoma and described as a DNA replication factor and potential 
A	
B	
Figure 5-1 Structural representation of Ciz1 
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driving force in tumorigenesis (Warder and Keherly, 2003). The Ciz1 is 
known to associate with the consensus DNA sequence ARYSR(0–2)YYAC 
where, (A: adenine; R: purine; Y: pyrimidine; S: either purine or pyrimidine; 
C: cytocine) (Liu et al., 2016; Warder and Keherly, 2003).  
Ciz1’s association with nuclear matrix contributes to temporal and 
spatial regulation of DNA replication (Berezney et al., 1975; Ainscough et al., 
2007). The nuclear matrix is the insoluble structure that associates with cell 
cycle regulators and enzymes required for DNA replication (Berezney et al., 
1975). Replisomes are directly associated with the nuclear matrix and retain 
activity after nuclear fractionation (Radichev et al., 2005; Munkley et al., 2011). 
Ciz1 is localized to the nuclear matrix by matrin-like zinc finger domains in 
the C-terminus of Ciz1 (Mitsui et al., 1999; Ainscough et al., 2007), where it 
colocalizes with PCNA in S-phase cells, contributing to the G1/S transition 
and increased cellular proliferation (Coverley et al., 2005). The localization of 
Ciz1 proximal to active replication factories in G1 phase and colocalization 
with PCNA during S phase (Ainscough et al., 2007) suggests that Ciz1 may 
contribute to localization and recruitment of cell cycle regulators for efficient 
initiation of DNA replication at the nuclear matrix. 
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Ciz1 binds to the pre-replication complex via CDC6 interactions during G1 
phase. Cyclin A (A) displaces cyclin E formerly bound to Ciz1, bringing 
activated kinase CDK2 (K2) proximal to its targets. Increasing local 
concentrations of cyclin A – CDK2 promotes initiation of DNA replication 
and inactivation of Ciz1 by hyper-phosphorylationCiz1. This provides a 
window of opportunity whereby Ciz1 contributes to activation of the 
replisome and hyper-phosphorylation prohibits re-replication (Copeland et 
al., 2015). 
 
Ciz1 accumulates throughout the G1 phase, and its abundance 
correlates with accumulation of cyclin activity in G1 phase.  siRNA mediated 
depletion of Ciz1 inhibits cell progression and blocks entry into S phase 
(Coverley et al., 2005). The requirement of Ciz1 in DNA replication was 
explained by its specific and sequential association with cyclin E and cyclin A 
on different sites, bringing them near their targets, such as CDC6, CDT1, and 
MCM further suggests active role in cell proliferation (Copeland et al., 2010; 
Copeland et al., 2015). Ciz1 is proposed to promote initiation of DNA 
replication by recruiting cyclin E and cyclin A-CDK2 to putative replication 
sites (Copeland et al., 2010).  
Figure 5-2 A Model for the role of Ciz1 in initiation of DNA replication. 
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The Ciz1 protein is phosphorylated by Cyclin – CDK complexes at 
various sites (Copeland et al., 2010; Copeland et al., 2015) (Figure 5.1. B).The 
phosphorylation of different sites contributes to the activation of Ciz1 or 
inhibition of its DNA replicative function (Copeland et al., 2015). The 
phosphorylation on T293 site by cyclin A – CDK2 was shown to inhibit Ciz1 
function, thus contributing to mechanisms that prevent DNA re-replication 
(Copeland et al., 2015). There are 6 CDK phosphorylation sites in N471 
minimal functional fragment of Ciz1, and their phosphorylation potentially 
provides different effects on Ciz1 (Ainscough et al., 2007, Coverley et al., 2005; 
Copeland 2015). 
Importantly, Ciz1 can only associate with Cyclin A-CDK2 in a hypo-
phosphorylated state to promote initiation of DNA replication, as 
phosphorylation at >3 sites prevent cyclin binding in vitro and in vivo. This 
contrasts with CDC6 binding that are independent of the phosphorylation 
status of Ciz1 (Copeland et al. 2015). Hyper-phosphorylation of Ciz1 prevents 
successive recruitment of cyclin A to replication origins that have already 
fired, preventing further initiation events  (Copeland et al., 2015) (Figure 5.2). 
As Ciz1 can prevent replication initiation in a hyper-phosphorylated form, 
this suggests that phosphorylation of Ciz1 contributes to genome stability by 
regulation of initiation of DNA replication and to mechanisms that prevent 
re-replication (Copeland et al., 2015; Figure 5.2). 




Ciz1 is known to promote cell cycle progression. Here, the 
accumulation of Ciz1 in G1 phase will be investigated and the role of cell 
cycle kinases CDK and DDK in its accumulation will be investigated. In 
addition, the role of the UPS in regulation of Ciz1 abundance will be 
investigated. 
A second objective is to characterise the role of DHX9 in regulation of 
the G1/S transition. Preliminary evidence demonstrated that Ciz1 and DHX9 
associate in S-Phase extracts suggesting a common function. Therefore, cell 
cycle kinetics will be analysed in DHX9 depleted cells and replication 
complex assembly monitored. 
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5.4	 Ciz1	 protein	 and	 transcript	 levels	 remain	 constant	 during	 G1/S	
transition: 
Ciz1 interacts with cyclin E-CDK2 and cyclin A-CDK2 and promote 
DNA replication (Copeland et al., 2010; Copeland et al., 2015). To determine 
the cell cycle dynamics of Ciz1 expression, 3T3 mouse fibroblasts were 
synchronized by contact inhibition and serum starvation. After release from 
quiescence the protein and transcript levels of Ciz1 were monitored during 
cell cycle re-entry from G1 to S-phase. Rabbit polyclonal antibody (N471) 
raised against the N-terminal domain of Ciz1 was used to monitor Ciz1 
protein levels in cells released from quiescence (Figure 5.3.A.). Two 
phosphorylation sites within Ciz1 were also monitored to determine temporal 
regulation by CDK2. Cyclin A–CDK2 mediated phosphorylation on T293 site 
inhibits Ciz1 function and increases in S phase (Copeland et al., 2010; 
Copeland et al., 2015). However, phosphorylation on S331 site was selected as 
it was readily modified by cyclin A -CDK2 in vitro, but it did not inhibit DNA 
replication function (Copeland et al., 2010). Therefore, phosphorylation of 
Ciz1 at S331 may regulate alternative functions, such as Ciz1 activation or 
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A: Graph showing an increase in S phase cells from 0-24 hour time points 
measured by EdU incorporation in positively replicating cells.  B: Comparison 
of Ciz1 transcript levels with E2F regulated cyclin A and cyclin E, 
Ciz1expression is consistent through G1 phase whereas cyclin E and cyclin A 
show a 10-fold increase in expression (N=3). C: Western blot analysis of Ciz1 
along with phospho-specific sites S331, T293 in comparison with cyclin E and 
cyclin A after release from quiescence through 0-24 hour time course. D: 
Relative Quantification of the band intensities’ of the proteins presented in 




Figure 5.3 Ciz1 transcript levels remain constant during G1/S transition: 
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Cell cycle synchronization was confirmed by EdU incorporation 
(Figure 5.3.A), with an increase in S phase cells with approximately 50% of 
cells in s phase at 24 hours post-release showing efficient synchrony. Cyclin E-
CDK2 levels remain constant in cells released from quiescence (Geng et al., 
2003; Geng et al., 2007; Chapter 3; section 3.4). However, cyclin A protein 
levels start accumulating from 16 hour onwards post release from quiescence 
as observed previously (Figure 3.4). Interestingly transcript levels of Ciz1 do 
not correspond to the protein levels as Ciz1 accumulates up to 12 hours post-
release from quiescence despite little change in transcript abundance (Figure 
5.3.B). Ciz1 transcript levels do not fluctuate in comparison with E2F 
regulated genes cyclin E1/E2 and cyclin A2, show that a large increase in 
transcript levels as cells progress into S-phase. These data suggest that Ciz1 
accumulation is not mediated by transcriptional regulation but may be related 
to post-translations mechanisms, as Ciz1 protein levels and phosphorylation 
status Ciz1 corresponds to that of cyclin E and cyclin A levels (Copeland et 
al., 2010; Copeland et al., 2015). 
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5.5	Ciz1	is	destabilised	in	absence	of	CDK2	during	G1-S	transition	
 To investigate whether Ciz1 accumulation is dependent upon CDK 
activity, cells were synchronized by contact inhibition and serum starvation. 
After release from quiescence Ciz1 protein levels and its phosphorylation 
status followed after CDK2 inhibition using roscovitine (Figure 5.4).  
 A: Histogram showing block in S phase cells with inhibition of CDK2, with 
statistically significant (P<0.05) less than 10 % cells in S phase measured with 
EdU incorporation at 20 hour and 24 hour time point post release from 
quiescence. B: Western blot of whole cell extracts were prepared 4 hours after 
treatment with roscovitine at 20 and 24 hours post release from quiescence 
respectively.  Ciz1 phospho-threonine 293 (pT293) and phospho-serine 331 
(pS331) were monitored in synchronous G1 cells. CDK2 inhibition reduces 
both T293 and S331 phosphorylation. 
 
 
Figure 5-4 Ciz1 is destabilised in absence of CDK2 activity during G1-S 
transition. 
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Roscovitine addition reduces S phase cells progression at both time 
points (16hr-20hr and 20hr-24hr), as measured by EdU incorporation. 
Interestingly, (Figure 5.4.B) demonstrates that inhibition of CDK2 activity by 
roscovitine Ciz1 leads to a reduction in Ciz1 protein levels at both 20 and 24 
hours but this effect is more evident in the 24 hour time-point. Importantly, 
the levels of CDK mediated phosphorylation of Ciz1 particularly at the T293 
site is markedly reduced at both 20 and 24 hour time points. These data 
suggest that Ciz1 protein levels increase as a consequence of CDK mediated 
phosphorylation at multiple sites.  
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5.6	Cyclin	inhibition	destabilizes	Ciz1	during	G1/S	transition:	
 Chemical inhibition of CDK2 by roscovitine inhibits S phase 
progression of cells released from quiescence. As observed in (Figure 5.4) 
CDK2 inhibition destabilizes Ciz1 protein levels as CDK2 inhibition blocks 
Ciz1 phosphorylation at S331 and T293 site. CDK2 is cognate partner to both 
cyclin E and Cyclin A and hence to ensure specific effect of CDK2 inhibition, 
targeted depletion of cyclin E and cyclin A was performed by siRNA 
mediated transfection.  
Cyclin E-CDK2 and cyclin A-CDK2 activity, as discussed in chapter 3 
and Chapter 4, promote accumulation of CDC6 and MCM2 by distinct 
mechanisms. Cyclin E-CDK2 promotes their transcription via the Rb-E2F 
pathway and cyclin A2 appears to regulate UPS mediate proteasomal 
degradation. (Figure 3.8-Figure 3.11, Figure 4.4). To further investigate the 
role of cyclin E and cyclin A in the regulation of Ciz1 accumulation, each 
cyclin was depleted by siRNA mediated transfection and the effect on Ciz1 
protein levels analysed by western blot. 
Figure 5.5.A shows the western blot analysis of depletion of cyclin 
E1/E2 in synchronized 3T3 cells. Ciz1 protein levels appear to be destabilized 
at both time points 20 hour and 24 hour post release and transfection, 
suggesting Ciz1 is destabilized in absence of cyclin E activity similar to 
replication assembly proteins MCM2, MCM10, CDC6, PCNA (Figure 3.10). 
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RT-qPCR was performed to determine the transcript analysis of cyclin E1/E2 
and Ciz1 as observed in (Figure 5.5.B). Cyclin E1/ E2 transcript levels are 
effectively depleted by siRNA mediated depletion. Interestingly, Ciz1 
transcript levels were moderately affected with depletion of cyclin E1 and E2 
in comparison to cyclin A depletion.  However, statistical analysis of the Ciz1 
transcripts is not significant as P>0.05 calculated by performing T-test. This 
suggests that Ciz1 transcript levels are not regulated by cyclin E-CDK2 
activity.  
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A: Western blots showing cyclin E1/E2 inhibition destabilizing Ciz1 protein 
levels. B: Transcript analysis performed by qPCR analysis of cyclin E1, E2 and 
Ciz1 showing Ciz1 transcript levels in absence of cyclin E1 and E2 at 24 hour 
time point post transfection and release from quiescence. C:  Western blots 
showing cyclin A2 inhibition destabilizing Ciz1 protein levels. D: Transcript 
analysis performed by qPCR analysis of cyclin A2 and Ciz1 showing Ciz1 
transcript levels not affected in absence of cyclin A2 at 24 hour time point post 
transfection and release from quiescence at 24hour time point (N=3). 
 
Interestingly, cyclin A2 depletion also destabilizes Ciz1 protein levels 
but does not affect the transcript levels, suggesting that cyclin E and cyclin A 
activity is required for Ciz1 protein accumulation during G1/ S transition in 
synchronized post-quiescent mouse fibroblasts.  
Figure 5-5 Ciz1 protein is destabilised in absence of cyclin E and cyclin A. 




Cyclin E-CDK2 and cyclin A-CDK2 activity independently 
phosphorylate Ciz1 protein during G1/S transition indicating a significant 
role in initiation of DNA replication (Copeland et al., 2015). The data 
presented here suggest that CDK mediated phosphorylation of Ciz1 promotes 
its accumulation. To evaluate the role of the proteasome in regulation of Ciz1 
abundance during G1 / S transition, MG132 was used to inhibit the 
proteasome concurrently with CDK inhibition (Figure 5.6). 
A: Western blot analysis of asynchronised cells co-incubated with roscovitine 
±MG132. B: Histogram showing block in S phase cells with inhibition of 
CDK2, with statistically significant less than 10% cells in S phase measured 
with EdU incorporation at 24 hour time point post release. C: Western blot 
analysis of synchronised cells co-incubated with roscovitine ±MG132 20 hours 
after release from quiescence and harvested at 24 hours post release, showing 
recovery in Ciz1 protein levels with addition of MG132. 
Figure 5-6 Ciz1 protein is proteasomally regulated in absence of CDK2. 
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A: Histogram showing cyclin A transcript levels depleted with cyclin A2 
siRNA transfection. B: Line graph showing block in S phase cells with 
depletion of Cyclin A, with statistically significant less than 5 % cells in S 
phase measured with EdU incorporation at 24 hour time point post release. C: 
Cyclin A siRNA mediated depletion was performed by transfection and 
harvested at 24 hours post release from quiescence Western blot analysis of 
cyclin A2 depleted synchronised cells ±MG132. D: Quantification of intensity 
of Ciz1 abundance from western blot (C). 
  
Figure 5-7 Ciz1 is proteasomally regulated in absence of Cyclin A. 
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To avoid potential artefacts from the use of small molecule inhibitors, 
siRNA mediated depletion of cyclin A was also used to reduce CDK activity 
in late G1 phase of the cell cycle (Figure 5.7). Inhibition of CDK2 activity by 
addition of roscovitine (Figure 5.6A) and cyclin A depletion (Figure 5.7) 
promoted a reduction in Ciz1 protein levels consistent with earlier 
experiments (Figure 5.4 and Figure 5.5). siRNA mediated cyclin A depletion 
reduced transcript levels by more than 95 % (Figure 5.7.A) and reduced the 
number of cells from approximately 45% to approximately 10% in cyclin A2 
depleted cells. In parallel reactions monitoring cyclin A levels, siRNA 
mediated depletion reduced cyclin A levels to undetectable levels (Figure 
5.7.C). 
The reduction in cyclin A reduced Ciz1 levels relative to control 
samples, that was reversible by inhibition of proteasome, suggesting that 
ubiquitin mediated degradation regulates Ciz1 protein levels. MG132 
increased Ciz1 levels for both roscovitine treated and siRNA depleted cells 
suggesting that CDK mediated phosphorylation of Ciz1 promotes its 
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5.8	Ciz1	interacts	with	other	cell	cycle	regulators	including	DHX9	
 Proteomic analysis identifying Ciz1 interacting partner has been 
performed using S –Phase cellular extracts (Data not shown). One of the 
significant hits that appeared from this screen identified a DNA helicase 
(DHX9) that has been shown to associate with putative replication origins and 
contribute to regulation of DNA replication (Lee et al., 2014). 
DHX9 is a DEXH box helicase exhibiting both RNA and DNA helicase 
activity. It also shows triple helical DNA unwinding activity (Zhang, 1994; 
(Jain, 2010). It was originally isolated from bovine tissue. DHX9 structure 
consists of two RNA-binding domains at the N-terminus, a core helicase 
region consisting of seven conserved helicase motifs and a DNA-binding 
domain and nuclear localisation signal at the C terminus (Jacob et al., 1991; 
Zhang, 1997). DHX9 is a multifunctional protein with implications in several 
biological processes (Lee, 2014). Its interacting partners include EGF receptor, 
BRCA1, cAMP response element binding protein and RNA polymerase II 
(Nakajima et al., 1997; Huo et al., 2010).  
Ciz1 and DHX9 have been implicated in contributing to accurate DNA 
replication (Copeland et al., 2010; Copeland et al., 2015; Coverley et al.,  2005;  
Lee  et  al.,  2014). DHX9 is associated with replication origins in cells and 
contributes to S phase progression (Lee et al., 2014). Ciz1 promotes initiation 
of DNA replication through interactions with cyclin A during the G1/S 
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transition and enhances cyclin A-CDK2 recruitment to chromatin during 
initiation of DNA replication (Copeland et al., 2010). 
To assess the role of DHX9 in cell cycle regulation mouse fibroblasts 
were synchronized in G0 using contact inhibition and serum starvation and 
the requirement for DHX9 in entry into  S-phase was  determined (Figure 5.8).  
Quiescent 3T3 cells were transfected with control siRNA and anti-DHX9 
siRNAs and the proportion of cells in S-Phase determined. Both DHX9 
transcript (Figure 5.8.A) and protein levels (Figure 5.8.C) were efficiently 
depleted and this resulted in a moderate decrease in cells entering S-phase 
compared to control (Figure 5.8.B). 
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A:	Transcript analysis of DHX9 post siRNA mediated depletion of DHX9 in 
synchronized mouse embryonic fibroblasts. B: Reduction in number of cells 
entering S phase post DHX9 depletion measured by EdU analysis. C: Western 
blot analysis showing DHX9 depletion, Ciz1 and cyclin A protein reduction in 




Figure 5-8 Ciz1 interacts with cell cycle regulator DHX9. 
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Depletion of DHX9 leads to a reduction in cyclin A levels and a 
moderate reduction in Ciz1 levels. Both Ciz1 and cyclin A accumulate as cells 
transit from G1 to S-Phase (Copeland et al., 2015) (Figure 5.3), therefore the 
results are consistent with a delay in cell cycle progression as a result of 
DHX9 depletion. As prolonged depletion of DHX9 was previously shown to 
promote senescence via p53 activation (Lee et al., 2014), the levels of p53 were 
monitored (Figure 5.8.C). After acute depletion of 24 hours p53 levels were 
unaffected and p21 levels were reduced suggesting that p53 is not activated 
by acute depletion of DHX9 (Lee et al., 2014). Taken together these data 
suggest that Ciz1 and DHX9 share a common function in regulation of the 
G1/S transition and further studies are required to fully understand how they 
contribute to efficient cell cycle progression in murine fibroblasts. 
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5.9	Discussion 
In mouse fibroblasts, Ciz1 interacts with temporal cell cycle regulators, 
including CDC6, cyclin E, cyclin A, and CDK2 proximal to the origin of 
replication (Coverley et al., 2005; Ainscough et al., 2007; Copeland et al., 2010; 
Copeland et al., 2015). The data presented here are consistent with earlier 
works that shows that Ciz1 accumulation is required for successful initiation 
of DNA replication and cell entry to S phase in normal cells (Coverley et al., 
2005; Copeland et al., 2010). Ciz1 protein accumulated through G1 phase that 
mirrors E2F regulated genes (Figure 5.3). However, Ciz1 transcription levels 
are relative constant during the G1 to S-phase transition in mouse fibroblasts. 
The correlation between Ciz1 phosphorylation and its abundance suggest that 
Ciz1 accumulation may be CDK regulated. These data suggest that Ciz1 is 
regulated by CDK2 mediated phosphorylation to promote its accumulation as 
well as regulating its function in regulation of the initiation phase of DNA 
replication.  
Targeted inhibition of CDK2, cyclin E and cyclin A individually lead to 
reduction in Ciz1 protein accumulation (Section 5.4-5.6). CDK2 inhibition 
mediated by roscovitine affects Ciz1 stability around 24 hours post-release 
from quiescence, whereas DDK inhibitor affected Ciz1 stability at around 20 
hour time point post release. Interestingly, CDK2 inhibitor inhibited Ciz1 
phosphorylation at T293 and S331 at 24 hour time point, suggesting 
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requirement of kinase activity for regulation of Ciz1 during G1/S transition. 
As observed in section 5.5, however, cyclin E appears to affect Ciz1 transcript 
levels more than cyclin A depletion. However, statistical analysis performed 
by T-test reveals P value > 0.05 and thus transcript reduction of Ciz1 is not 
statistically significant. It is however evident from section 5.5 that targeted 
inhibition of cyclin E and cyclin A independently destabilize Ciz1 protein 
levels and that phosphorylation mediated by cyclin E-CDK2 and cyclin A-
CDK2 is required for Ciz1 stability during G1/S transition. 
Additionally, Ciz1 levels could be recovered with addition of MG132 
concomitantly with roscovitine, suggesting that Ciz1 protein is regulated by 
proteolytic degradation in absence of active kinases during G1/S phase. These 
observations suggest that Ciz1 levels are positively regulated 
phosphorylation, and negatively regulated proteolytic degradation. Further 
characterization of Ciz1 regulation by CDK and UPS mediated regulation. In 
addition, greater insight into the regulatory network that governs Ciz1 levels 
could be gained from identification of potential E3 ligase(s) that regulates 
Ciz1 levels. 
The data presented here demonstrate for the first time that Ciz1 is 
regulated by phosphorylation leading to its accumulation in G1 phase most 
likely through protection by UPS mediated degradation in a low CDK kinase 
environment. The data are consistent with a model whereby Ciz1 accumulates 
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in response to increasing CDK activity in G1 phase. Phosphorylation of Ciz1 
promotes Ciz1 accumulation that facilitates in recruitment of cyclin E-CDK2 
and cyclin A-CDK2 to putative replication sites (Copeland et al., 2015). This 
model suggests CDK activity regulates Ciz1 accumulation, activation for 
DNA replication initiation, and the inactivation of Ciz1 by hyper-
phosphorylation during S phase to prevent DNA re-replication (Ainscough et 
al., 2007; Copeland et al., 2010; Copeland et al., 2015; Coverley et al., 2005). 
Further investigation of the role of S331 and T293 in Ciz1 accumulation is 
required to identify whether there is a site specific temporal order to site 
phosphorylation in G1 phase. 
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5.9.1	 Preliminary	 characterization	 of	 DHX9	 in	 regulation	 of	 the	 G1/S	
transition  
Unpublished data identified that Ciz1 interacts with DHX9 in late G1 
phase and early S-phase. To better understand whether DHX9 contributes to 
regulation of cell cycle re-entry from quiescence, cell cycle kinetics was 
monitored in DHX9 depleted cells. Targeted depletion of DHX9 by siRNA 
mediated transfection in synchronized cells re-entering the cell cycle from 
quiescence produced a statistically significant decrease in the number of S-
phase cells suggesting a defect in cell cycle progression. These data suggest 
that DHX9 and Ciz1 may be active within the same pathway as siRNA 
mediated depletion of Ciz1 also markedly reduces cell cycle progression 
(Coverley et al., 2005; Copeland et al., 2010). However, as we only monitored 
cell cycle progression in  the  cell  cycle  following  transfection, our  data  is  
distinct  from  other  studies monitoring  the  effects  of  prolonged DHX9 
depletion (22 hours) that led to a stabilization of p53 and senescence (Lee et 
al., 2014). The data therefore suggest that DHX9 contributes to efficient cell 
cycle progression directly as acute depletion reduces cell cycle progression in 
post-quiescent mouse fibroblasts (Figure 5.8). These data further expand the 
cell cycle regulators that associate with Ciz1 during S-phase. Full 
characterisation of the Ciz1-DHX9 complex will aid our understanding of 






In vitro analysis reveals distinct 
roles for Cyclin E and cyclin A 
regulation of initiation of DNA 
replication 
Chapter 6: Results 
 155 
6.1	Introduction	to	cell-free	replication	assay:	
A long-standing goal is the full description of the molecular pathways 
that precisely regulate the duplication of the genome, as a failure to do this 
can promote accumulation of mutations, and genomic instability. The 
fundamental regulatory proteins that facilitate this process have recently been 
identified through a combination of genetic and biochemical approaches, 
identifying the minimal set of regulatory proteins and enzymes that are 
sufficient to accurately copy DNA in a semi-conservative manner in vitro 
(Yeeles et al., 2015; Yeeles et al., 2017). In this system, template DNA with an 
ARS is incubated with ORC, CDC6, CDT1-MCM2-7 initially followed by DDK 
for another 20 minutes followed by firing factors (Sld3/7, Sld2, Dpb11, S-CDK 
(cyclin A-CDK2), GINS, CDC45, MCM10) and replication proteins (Topo II, 
Pol alpha, RPA, Ctf4) in replication buffers and this entire reaction is 
quenched and analysed on agarose gel. With this assay, the specific 
requirement of different polymerases in sequential leading and lagging strand 
synthesis and optimise the reaction rates with addition of PCNA with RFC in 
leading and lagging strand synthesis (Yeeles et al., 2017). 
The biochemical reconstruction of this process defined the minimal 
protein chemistries that mark putative sites of replication, activation of 
replication origins and copy the genomic template in the absence of other 
components of the nuclear structure (Yeeles et al., 2015). This seminal work 
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suggests that this process could be reconstituted using mammalian proteins 
and enzymes in future. The increased complexities of mammalian genomes 
and the increased number of regulatory factors that contribute to the 
regulation of DNA replication in vitro, make reconstitution more challenging 
in a mammalian context. These considerations have necessitated an 
amalgamation of a semi-purified nuclei and cytosolic extracts that enable 
reconstitution of DNA replication in vitro and will be discussed in this section. 
One of the widely used assays to understand the complex mammalian 
replication system is the cell-free in vitro replication assay (IVRA). IVRA can 
provide a snapshot of the regulatory mechanisms controlling replication in 
higher eukaryotes (Krude, 2000). Direct biochemical analysis of replication 
initiation in eukaryotic somatic cells has been impeded by the lack of an 
efficient mammalian cell-free DNA replication system to complement cellular 
and genetic approaches. Cell-free DNA replication assays were established 
approximately 30 years ago however, these early experimental in vitro 
replication assays had their limitations and new and improvised techniques 
have been developed henceforth.  
Initially, metazoan cell-free systems derived from activated eggs of the 
frog Xenopus laevis can replicate vertebrate cell nuclei under early embryonic 
cell cycle control (Lohka and Masui, 1983; Blow and Laskey, 1986; Newport, 
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1987; Murray, 1989). These early embryonic cycles differ significantly from 
somatic vertebrate cells that are regulated by internal transcriptional 
networks. In the Xenopus system, both proteins and transcripts are present 
within the extracts that provide pools and de novo production of regulatory 
proteins that facilitate very rapid alternating S and M phases without 
intervening G1 and G2 phases. Therefore, key regulatory steps of the somatic 
cycle, the G1/S and the G2/M transitions, are formally absent in early 
embryonic cycle. The lack of extensive G1 and G2 phases enable an extremely 
rapid cell cycle of approximately 25 minutes, which is more than an order of 
magnitude shorter than in the somatic cell cycle that is typically 24 hours in 
length (Li et al., 2012). Although these cell-free systems are valuable for 
identifying enzymatic and structural aspects of DNA replication, they are 
limited when studying the somatic cell cycle control of initiation. 
 In higher eukaryotes, DNA replication initiates from developmentally 
controlled chromosomal sites that lack conserved sequence elements. 
Moreover, specific DNA sequences may be altogether dispensable for 
metazoan origin function, as origin usage is promiscuous during the early 
embryonic cleavage stages of Drosophila, Xenopus and during plasmid 
replication in mammalian cells (Spradling and Orr-Weaver, 1987; Hyrien et 
al., 1995; Schaarschmidt et al., 2004). Heterologous DNA templates replicate 
Chapter 6: Results 
 158 
efficiently in Xenopus (Harland and Laskey, 1980; Mechali and Kearsey, 1984), 
and artificial tethering of initiation factors to DNA can be sufficient to specify 
an origin in Drosophila and mammalian cells (Takeda et al., 2005; Crevel and 
Cotterill, 2012). The dependency of origin function on a conserved DNA 
sequence element, the ARS, in budding yeast has therefore often been 
contrasted to the heterogeneous origins of higher eukaryotes. The mechanistic 
basis for this difference is not clear, yet it may be unexpected given the 
general conservation of basic eukaryotic replication initiation factors.  
The first mammalian in vitro cell-free DNA replication assay was 
derived from Simian Virus 40 (SV40) and its somatic host cell (Krude et al., 
1997). The activation of bidirectional DNA replication requires the trans-
acting initiator proteins T antigen and depends on essential viral control 
elements, namely cis-acting DNA viral sequences (reviewed by Challberg and 
Kelly, 1989; Stillman et al., 1989). Utilisation of viral control elements serve to 
overcome the strict once per cell cycle replication of the host chromosomal 
DNA replication in the infected cell nucleus. However, this system is limited 
in the functional analysis of the regulatory events of an unaltered cell cycle. 
To gain more insight into the regulatory events that ensure once per 
cell cycle duplication of the genome several different approaches were 
developed to investigate events at the G1/S transition. Mammalian cell-free 
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DNA replication methodologies utilise alternative mechanisms to synchronise 
at precise stages of the cell cycle. There are three reconstituted DNA 
replication strategies that have been utilised for investigation the regulation of 
DNA replication.  
(i) G1 nuclei generated from post mitotic cells: Template nuclei preparation 
utilizes the addition of Nocodozole to arrest cells and synchronize in 
mitosis. Utilization of this approach identified that early G1 nuclei 
initiated poorly compared to late G1 nuclei and G2 phase nuclei were 
completely inactive (Krude 1997). The ability to determine replication 
competence highlights the importance of cell-free DNA replication assays 
to investigate the temporal regulation of replication licensing (Krude 
1997). The use of template nuclei from post-mitotic cells can be restrictive 
because of complex chemical synchronisation protocols and the need for 
tight synchrony to achieve good ratios of signal to noise (Krude et al., 
1997, Krude 2006) 
(ii) G1 nuclei generated from mimosine arrested cells: Mimosine is a rare 
plant amino acid derivative isolated from Leucaena seeds, can be used to 
synchronise cells at G1/S transition by preventing the formation of 
replication forks (Krude, 1997; Lalande, 1990). Efficient template nuclei for 
the initiation of chromosomal DNA replication in vitro are prepared from 
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human cells treated for 24 hr with 0.5 mM mimosine, or with an 
appropriately high concentration of other iron chelators (Krude, 1999; 
Szuts et al., 2004). Nuclei from mimosine-arrested late G1 phase cells are 
licensed to replicate and contain assembled pre-RCs. Nuclei isolated from 
the mimosine-arrested cells do not contain active DNA replication forks, 
as measured in nuclear run-on replication assays (Krude, 1999; Krude, 
2000). In vitro DNA replication assays utilise the rapid initiation of DNA 
replication upon restoration of free iron levels in vivo and can be exploited 
for the study of chromosomal DNA replication in vitro. Furthermore, in 
vivo pre-labelling studies have shown that they do not contain stalled or 
abandoned DNA replication forks that were active during the mimosine 
treatment (Keller et al., 2002). These template nuclei have enabled the 
identification of Y-RNA in the initiation process of mimosine arrested 
nuclei (Krude et al., 2006; Langley et al., 2016).  
(iii) G1 nuclei generated from post quiescent cells:  Utilization of murine 
fibroblasts synchronised through contact inhibition circumvents potential 
artefacts mediated by chemical synchronisation approaches. In addition, 
contact inhibition enables isolation at any time point in G1 or S phase. This 
enables temporal regulation of cell cycle progression to be studied in detail 
(Chapter 3, Chapter 4). Synchronisation can be achieved by using 
confluent 3T3 cells arrested by contact inhibition in quiescence (G0), and 
Chapter 6: Results 
 161 
subsequent stimulation to re-enter the proliferative cell cycle by sub-
cultivation at lower cell densities (Stoeber et al., 1999). Template nuclei for 
chromosomal DNA replication in vitro were therefore prepared from 
quiescent and stimulated cells at various times after release. Initially, 
mouse 3T3 cells were used (Stoeber et al., 1999), but similar results were 
also obtained with human WI38 cells. (Stoeber et al., 2001) Quiescent 
mammalian cells are characterized by loss of CDC6 protein and 
dissociation of MCM proteins from chromatin (Stoeber et al., 1999; Stoeber 
et al., 2001; Williams et al., 1999). Nuclei isolated from quiescent cells do 
not support DNA replication in human cell extracts in vitro (Stoeber et al., 
1999; Stoeber et al., 2001).  
The competence of isolated nuclei from stimulated quiescent cells to 
initiate DNA replication in S phase cytosol (extract) arises gradually between 
16 hours and 18 hours after stimulation, in late G1 phase, about 3 hour before 
entry into S phase in vivo (Kingsbury et al., 2005). This gain of initiation 
competence coincides with the restriction point in vivo, when cell cycle 
progression becomes serum-independent (Coverley et al., 2002). The timing of 
this ‘window of opportunity’ varies with experimental conditions, especially 
serum concentration and batch, and requires being determined for each 
preparation of template nuclei. Initiation competence correlates to validation 
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to avoid batch to batch variation with the maximal induction of CDC6 protein 
expression following stimulation, and it follows an association of the pre-RC 
proteins CDC6 and MCM2, 3, 5 and 7 with chromatin (Kingsbury et al., 2005, 
Coverley et al., 2000). 
The mammalian cell-free systems have turned out to be highly 
versatile and adaptable experimental tools for biochemical investigations of 
the initiation of chromosomal DNA replication. Isolation of late G1 phase 
nuclei supports initiation of DNA replication (Coverley et al., 1998; Coverley 
et al., 2002; Copeland et al., 2010). This system established so far has led to the 
functional identification of novel DNA replication initiation factors, which 
can be characterised biochemically in vitro and in intact cells in vivo (Krude 
2006). In addition, recombinant cyclin-CDK complexes can be utilized to 
facilitate replication licensing (Coverley et al., 2002) and initiation of DNA 
replication (Coverley et al., 2002; Copeland et al., 2010). This well 
characterized system enables temporal regulation of replication licensing and 
replisome assembly (Copeland et al., 2015). This system also enabled 
identification of Ciz1 as a factor that promotes cell cycle progression in 
complex with cyclin A-CDK2 (Coverley et al., 2005; Copeland et al., 2010) and 
characterisation of the adenosine dinucleotide Ap4A acting to inhibit the 
initiation phase of DNA replication (Marriot et al., 2015).   
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6.2	Chapter	aims	
In Chapter 3, evidence was presented that demonstrated that inhibition 
of cyclin dependent kinase activity promotes loss of pre-RC proteins CDC6, 
MCM2, MCM10 and replisome protein PCNA that indicated with a loss of 
Replication initiation. To identify the role of cyclin E-CDK2 and cyclin A-
CDK2 in the initiation phase of DNA replication, nuclei will be prepared from 
cyclin E1/E2 and cyclin A2 depleted cells. The cyclin depleted nuclei will be 
assessed in their ability to initiate DNA replication. By dissecting requirement 
of individual cyclins using cell-free replication assays, we aim to identify 
whether cyclin E and cyclin A have distinct roles in the regulation DNA 
replication complex assembly and for initiation of DNA replication.  The main 
aims of this chapter are: 
1. Produce synchronized G1 extracts, S phase extracts and replication 
licensed nuclei. 
2. Prepare cyclin depleted nuclei and assess whether S phase extract can 
induce initiation. 
3. Evaluate whether there are cyclin specific events that enable initiation 
in cyclin depleted nuclei. 
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6.3	 Analysis	 of	 replication	 complex	 assembly	 and	 initiation	 of	 DNA	
replication	in	vitro	
 The cell free system used here combines synchronized cell extracts 
prepared by the biologically relevant quiescence release method. This 
approach enables purification of nuclei from a late G1 population of cells that 
can initiate DNA replication. To initiate DNA replication nuclei are 
supplemented with recombinant cyclin A-CDK2 kinase (Coverley et al., 2002; 
Copeland et al., 2010) or S-phase cytosolic extracts that contain active cyclin 
CDK complexes (Krude, 1997; Coverley et al., 2002). This system has 
identified key components involved in DNA replication, specifically the 
distinct roles of cyclin E and cyclin A regulation of the replication licensing 
and initiation phases respectively (Coverley et al., 2002) that were later 
confirmed in mouse genetic ablation models (Geng et al., 2003; Geng et 
al.,2007). 
 To initiate DNA replication G1 nuclei are combined with S-phase 
extract, an energy regenerating system and nucleotides (dNTPS) (Section 2.14; 
Figure 6.1.A). This assay requires incorporation of control reactions to identify 
the proportion of nuclei that are already in S-phase.  To do so G1 nuclei are 
incubated in G1 cytosolic extracts that are incapable of promoting initiation of 
DNA replication. Positive reactions in this context identify nuclei that have 
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engaged in run on synthesis i.e. nuclei that have initiated DNA replication 
and have engaged and processive replisome complexes are already formed.  
Replication competent nuclei are activated by addition of S phase 
extract to licensed G1 nuclei, identifying nuclei that can initiate DNA 
replication in vitro (Figure 6.1.B). Analysis of the chromatin fraction before 
and after addition of S-phase cytosolic extract demonstrates that in vitro DNA 
replication assay facilitate the loading of replication factors (Figure 6.1.C).. 
Consequently, quantitative analysis of protein abundance on chromatin after 
incubation G1 extract and S-phase extracts identifies loading factors that 
correlate with increased initiation.  Incubation of replication licensed nuclei in 
S phase extract increased chromatin loading of replication assembly proteins 
MCM2, CDC6, PCNA along with cyclin A and cyclin E (Figure 6.1.C). The 
increased loading of replication factors in S phase extract, relative to parallel 
reactions in G1 extract suggests that licensed nuclei are deficient in MCM2, 
CDC6, PCNA, cyclin A and cyclin E rendering G1 nuclei incompetent of DNA 

























A:Experimental layout for preparation of G1 nuclei and G1 cytoplasmic 
extract and S phase extract. B: Histogram showing representative percentages 
for in vitro initiation of DNA replication with S phase extract relative to G1 
phase extract. C: Western blot analysis of replication complex assembly 
proteins MCM2, CDC6, PCNA, Cyclin A and Cyclin E on chromatin in G1 
control and S phase extract. D: Immunofluorescence images of replicating G1 
nuclei with G1 extract and S phase extract stained against biotin-dUTP from 
the reaction.  
  
Figure 6-1 Mammalian cell-free DNA replication assay. 
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Western blotting found that levels of MCM2 and CDC6 were 
unaffected by addition of S-phase extracts. However, phospho-specific 
antibodies against CDK and DDK sites S40, S41 respectively (denoted P-
MCM2) were phosphorylated at a higher level in S-phase extracts that 
promote replication relative to G1 extracts cell free replication assays (Figure 
6.1C). In addition, these data suggest that cyclin E, cyclin A and PCNA levels 
increase on chromatin during incubation in S-phase cytosolic extracts and 
correlate with initiation of DNA replication (Figure 6.1.C). Having produced 
replication competent G1 nuclei, these nuclei were then to be used as positive 
controls for comparison with cyclin depleted nuclei to further characterise 
alterations in chromatin bound fractions.  
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6.4	Cyclin	E	depleted	nuclei	are	replication	incompetent	
 Cyclin E –CDK2 is required for transcriptional regulation of MCM2, 
CDC6, PCNA and MCM10 via regulation of the E2F-Rb pathway (section 
3.10). Cyclin E-CDK2 activity is required for loading of MCM2-7 complex 
facilitated by CDC6 (Coverley 2002) and for cell cycle re-entry from 
quiescence via defects in MCM2-7 recruitment (Geng et al., 2003; Geng et al., 
2007). Initiation of DNA replication and progression to S phase in post-
quiescent cells are blocked in cyclin E null cells due to an arrest in G1 phase 
due to a failure of MCM2-7 chromatin loading (Geng et al., 2007). Previously, 
it was established that nuclei at restriction point could initiate DNA 
replication after sequential addition of cyclin E-CDK2 and then cyclin A-
CDK2 (Coverley et al., 2002). However, whether S phase extract is sufficient to 
initiate DNA replication in absence of cyclin E1/E2 remains to be studied in 
vitro.  
 Cyclin E depleted nuclei were prepared by transfecting G0 
synchronized cells with mixed cyclin E1 and cyclin E2 siRNAs in cells 
released into fresh medium for 24 hours prior to harvesting nuclei. The cell 
free DNA replication assays are prepared by reconstituting cyclin E depleted 
nuclei with G1 phase extract and in second reaction with S phase extract 
(Figure 6.2.A). As the reactions are prepared in the same components as with 
G1 nuclei, positive replicating nuclei are counted by labelling with modified 
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nucleotide biotin conjugated dUTP.  Cyclin E1/E2 depleted nuclei fail to 
initiate DNA replication with G1 phase extract (Figure 6.2.B). Interestingly, 
these nuclei fail to initiate DNA replication even with S phase extract which 
has both cyclin E-CDK2 and cyclin A-CDK2 kinases within the cytosolic 
extracts (Copeland et al., 2010). This supprts observations that demonstrated 
that sequential cyclin E-CDK2 and cyclin A-CDK2 activity is required to 
promote initiation of DNA replication in vitro (Coverley et al., 2002) 
Confocal immunofluorescence microscopy (Figure 6.2.C) of cyclin E 
depleted nuclei show minor distortion in nuclear shape, but nuclei retain 
ability to incorporate biotinylated dUTP with ~5-10% of cyclin E depleted 
nuclei in S-phase after cyclin E depletion in a G1 extract (Figure 6.2.C). The 
number of nuclei in S-phase after addition of S-phase extract is ~10% (Figure 
6.2) compared with ~40% of G1 nuclei that are replication competent in 
control reactions (Figure 6.1). The failure to initiate DNA replication was 
previously attributed to a failure to load MCM complexes in the absence of 
cyclin E in in vitro replication assays (Coverley et al., 2002) or failure of 
MCM2-7 loading onto chromatin in a cyclin E null cell line (Geng et al., 2007). 
Western blot analysis of cell free replication assays showed that pre-
replication proteins MCM2, CDC6, replisome protein PCNA and cyclin A and 
cyclin E appears to be efficiently loaded onto chromatin from S phase extract 
(Figure 6.2.D). This effect may be due to cyclin E-CDK2 activity in the S-phase 
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extract used. This approach reveals that loading of DNA replication factors 
from S-phase extract was insufficient to promote initiation at similar levels 
seen in control reactions in cyclin E1/E2 depleted nuclei.  
Western blot analysis revealed an inconsistent loading pattern for 
cyclin E in cyclin E depleted nuclei. The previous cyclin E antibody that was 
used (Abcam ab1979) was discontinued and other antibodies that were used 
contradict the qRT-PCR data for protein levels. Despite extensive antibody 
testing we were unable to get consistent protein and transcript levels. As such 
both protein and transcript levels are shown for each experiment. 
Furthermore, we cannot exclude that the differences are related to different 
time points for harvesting nuclei (17 hours for control vs 24 hours for cyclin E 
depleted) as cyclin E protein levels accumulate in G1 phase and decrease 
thereafter (Figure 3.7, 3.10) Despite this we found that S-phase extracts were 
able to promote chromatin loading of MCM2 and that this was insufficient to 
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A: Experimental overview for preparation of cyclin E depleted nuclei (αE) 
and G1 cytoplasmic extract and S phase extract. B: Histogram showing qRT-
PCR of cyclin E1/E2 transcript analysis post cyclin E1/E2 siRNA transfection. 
C: Histogram depicting initiation of DNA replication with S phase extract as 
contrast to G1 phase extract in cyclin E depleted nuclei. D: Western blot 
depicting chromatin loading of replication complex assembly proteins MCM2, 
CDC6, PCNA, Cyclin A and Cyclin E from S phase extract. E: 
Immunofluorescence images of replicating cyclin E depleted (αE) nuclei with 
G1 extract and S phase extract stained against biotin-dUTP from the reaction.   
Figure 6-2 Cyclin E depleted nuclei are replication incompetent. 
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 These data demonstrate that cyclin E is required for efficient transition 
from G1 into S-phase. The loading of MCM2 and apparent phosphorylated 
CDC6 form in S-phase extract is insufficient to promote initiation. The data 
presented here are consistent with the requirement of cyclin E1/E2 for 
replication licensing at the level of CDC6 and MCM2-7 loading onto 
chromatin prior to exposure of cyclin A-CDK2 to initiate DNA replication 
(Coverley et al., 2002, Geng et al., 2003, Geng et al., 2007).  
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6.5	Cyclin	A2	depleted	nuclei	are	replication	competent	
 Cyclin E-CDK2 levels accumulate prior to G1/ S transition and are 
degraded after entry to S phase promoting cyclin A accumulation. Cyclin A 
depletion blocks S phase entry of cells re-entering cell cycle from quiescence 
(Figure 3.8 and Figure 4.5). Ablation of cyclin A in fibroblasts does not affect 
the cell cycle proliferation (Kalaszczynska et al., 2009); however, we have 
found that siRNA mediated depletion of cyclin E1/E2 and cyclin A2 blocks 
fibroblast proliferation (Figure 3.7, Figure 3.8, Figure 4.4). The major technical 
difference between evidence from this study and mouse ablation studies is 
the utilisation of quiescence as a synchrony step was not assessed in other 
studies (Kalaszczynska et al., 2009; Spencer et al., 2013; Barr et al., 2016).  
In post-quiescent mouse fibroblasts cyclin A depletion blocks S phase 
entry of cells (Chapter 3 section 3.8). The data showed a block in S phase cells 
that correlated with destabilization of pre-RC protein MCM2, CDC6, Pre-IC 
protein MCM10 and replisome protein PCNA as seen for cyclin E1/E2 
depleted cells (Figure 3.7). Interestingly cyclin E levels remains unaffected 
after depletion of cyclin A2 (Figure 3.8) and consequently, transcript levels of 
E2F genes are unaffected. This suggests that cyclin A2 depleted nuclei may be 
replication competent. To identify whether cyclin A2 depleted nuclei retains 
replication competence, in vitro replication assays with cyclin A2 depleted 
nuclei were performed.  
Chapter 6: Results 
 174 
 To analyse the replication competency of cyclin A depleted nuclei, cells 
were synchronized and siRNA was used to deplete cyclin A2 in quiescent 
cells. Cyclin A2 depleted nuclei were assessed to initiate DNA replication in 
cell-free replication assays.  Comparison with cyclin A2 depleted nuclei and 
replication competent late G1 nuclei when incubated with G1 extracts as the 
negative control reaction, Figure 6.3 show that cyclin A2 depleted nuclei are 
restricted in their ability to initiate DNA replication. In fact, cyclin A2 
depleted nuclei showed less than 5% of nuclei in S-phase when reconstituted 
with G1 extract. However, cyclin A2 depleted nuclei can initiate DNA 
replication when supplemented with S phase extract to a comparable level to 
control replication licensed nuclei with ~40% nuclei in S phase (Figure 6.3.C). 
Representative immunofluorescence assay images of cyclin A depleted nuclei 
reconstituted with G1 extract and S phase extracts show punctate 
incorporation of biotinylated dUTP consistent with replisome activity (Figure 
6.3.E).  
Parallel western blot analysis of chromatin fraction was performed to 
compare chromatin fractions of control and cyclin A2 depleted nuclei (Figure 
6.3D). In cyclin A2 depleted nuclei MCM2, CDC6, PCNA and cyclin A protein 
levels were decreased relative to control reactions. The chromatin associated 
protein levels of the replication assembly proteins MCM2, CDC6 and PCNA 
increased by addition of an S-phase extract to greater than levels seen in 
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control reactions. Comparison of Cyclin E and Cyclin A depleted nuclei reveal 
that chromatin fractions are capable of efficient chromatin loading of CDC6, 
MCM2, PCNA and indeed cyclin E and cyclin A. As both cyclin E1/E2 
depleted nuclei and cyclin A2 depleted nuclei have comparable loading of 
pre-RC proteins, consistent with efficient replication licensing and 
recruitment of the replisome component PCNA, it was unexpected that there 
were clear differences in the replication competence for cyclin E1/E2 and 
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A: Experimental layout for preparation of cyclin A depleted nuclei (αA) and 
G1 cytoplasmic extract and S phase extract. B: Histogram depicting relative 
quantitation of cyclin A2 transcript levels for control and cyclin A2 depleted 
cells. C: Histogram showing percentage of nuclei in S-phase for control nuclei 
incubated in G1 extract and cyclin A2 depleted nuclei in G1 and S-phase 
extracts showing replication competence. D: Western blot depicting loading 
of replication complex assembly proteins MCM2, CDC6, PCNA, Cyclin A and 
Cyclin E on to chromatin from S phase extract. E: Immunofluorescence images 
of replicating cyclin A depleted (αA) nuclei with G1 extract and S phase 
extract stained against biotin-dUTP from the reaction.   
 
Figure 6-3 Cyclin A depleted nuclei are replication competent. 
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These observations are consistent with earlier data showing a 
reduction in replication licensing as a consequence of CDK inhibition in G1 
phase and reveal that there are specific activities of cyclin E and cyclin A in 
the replication licensing and initiation phase of DNA replication.  The specific 
activities of cyclin E and cyclin A are consistent with earlier work using 
quiescence release to prepare replication competent late G1 phase nuclei 
(Coverley et al., 2002) and reveal differences with mitotic cell cycle in mouse 
cyclin A2 null fibroblast studies (Kalaszczynska et al., 2009).  
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6.6	 Active	 kinases	 in	 S	 phase	 extract	 are	 required	 for	 initiation	 of	 DNA	
replication	in	cell-free	replication	assays.	
To assess whether CDK activity was required for chromatin loading of 
replication factor cell free replication assays were performed using cyclin A2 
depleted nuclei in presence and absence of CDK/2 inhibitor- roscovitine. The 
percentage of replicating cyclin A2 depleted nuclei with G1 phase extract, S 
phase extract and S phase extract with roscovitine in comparison with G1 
nuclei with G1 extract (Figure 6.4.A). In cyclin A2 depleted nuclei, G1 extract 
identifies 5% of cells are in S phase, whereas addition of S-phase extract 
promotes initiation in 45% of nuclei, that could be inhibited by addition of 
roscovitine where ~7% were in S phase (Figure 6.4.A). Analysis of the 
chromatin bound fraction in parallel reaction a reduction in loading of 
MCM2, CDC6 and PCNA on to chromatin in cyclin A2 depleted nuclei with 
G1 extract (Figure 6.4.B). Addition of S phase extract to cyclin A2 depleted 
nuclei promotes chromatin loading of replication factors independent of CDK 
activity, demonstrating that CDK2 activity is not required for chromatin 
binding in this context. In addition, this suggests that loading of replication 
factors onto chromatin is CDK2 independent in this context but demonstrates 
that initiation of DNA replication required CDK2 activity. 
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A: histogram showing percentage of nuclei in S-phase in cyclin A2 depleted 
nuclei incubated with G1, S-phase and S-phase extracts + roscovitine. B: 
Western blot showing loading of MCM2, CDC6 and PCNA onto chromatin in 
cyclin A depleted nuclei with S phase extract and inactivated S phase extract. 
C: histogram showing percentage of nuclei in S-phase in cyclin E1/E2 
depleted nuclei incubated with G1, S-phase and S-phase extracts + 
roscovitine. D: western blot showing loading of MCM2, CDC6 and PCNA 
onto chromatin in cyclin E depleted nuclei with S phase extract and 
inactivated S phase extract. 
Figure 6-4 CDK2 activities are required for initiation of DNA replication 
but not for loading of proteins MCM2, CDC6 and PCNA on to chromatin. 
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To test whether CDK2 was required for loading of MCM2, CDC6 and 
PCNA on to chromatin a Cyclin E1/E2 depleted nuclei reconstituted with G1 
phase extract, S phase extract and S phase extract with roscovitine in 
comparison with G1 nuclei with G1 extract (Figure 6.4). Cyclin E depleted 
nuclei were incapable of initiating DNA replication (Figure 6.4.C).   
 Similarly, western blot analysis of chromatin fraction in cyclin E1/E2 
depleted nuclei (Figure 6.4.D) showed loading of MCM2, cyclin A. However, 
CDC6 levels were equivalent in all cyclin E1/E2 depleted nuclei and PCNA 
was reduced in S phase extract with roscovitine relative to S phase alone. 
These data suggest that both cyclin E1/E2 depleted nuclei and cyclin A2 
depleted nuclei efficiently load DNA replication factors from licensed S-phase 
cytosolic cellular extracts, even in absence of CDK2 activity but only cyclin A2 
depleted nuclei retain replication competence suggesting that they contain 
‘licensed’ replication origins.  
 
 	
Chapter 6: Results 
 181 
6.7.	Cyclin	E1/E2	depletion	deregulates	MCM2	Compartmentalisation	in	G1.	
 The nuclear matrix contributes to nuclear compartmentalization of the 
factors responsible for temporal and spatial regulation of transcription and 
DNA replication (Berezney et al., 1997). The nuclear matrix associates with 
cell cycle regulators and enzymes required for DNA synthesis (Radichev et 
al., 2005; Munkley et al., 2011). 
Localization of MCM2 to nuclear matrix occurs in late G1 phase and 
correlates with potential to initiate DNA replication. This 
compartmentalisation is transient and after initiation of DNA replication 
MCM2 is released from the nuclear matrix (Hesketh et al., 2015). Previous 
work (Coverley et al., 2002; Geng et al., 2003; Geng et al., 2007) and data 
presented here (Figure 6.2, 6.3) suggest that replication licensing in deficient 
in cyclin E1/E2 depleted nuclei and this leads to hypothesis that this may 
affect the localization of MCM2-7 complex.  
To test this hypothesis using in vitro DNA replication assays, it is 
necessary to determine whether MCM2 nuclear matrix compartmentalisation 
is present in this context. Initially, in vitro assays were performed to determine 
whether the localization of MCM2-7 complex on the nuclear matrix is 
correctly regulated in this context. After reactions were complete, comparison 
between chromatin loading fraction and sub nuclear localisation was 
investigated by high salt fractionation in the presence and absence of 
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roscovitine (Figure 6.5). Comparison of chromatin loading of MCM2, CDC6, 
cyclin A in G1 nuclei with G1 extract, S phase extract with and without 
roscovitine are consistent with (Figure 6.4.A). Analysis of the nuclear matrix 
fraction in parallel reactions comparing G1/G1, G1/S and G1/S with 
roscovitine reveals an increase in MCM2 in nuclear matrix fraction in the 
presence of roscovitine. Importantly, MCM2 is enriched on the nuclear matrix 
prior to initiation and dissociated after initiation of DNA replication. 
Significantly, MCM2 was enriched in S-phase extracts after CDK2 inhibition 
that prevents initiation of DNA replication (Figure 6.5.B). As roscovitine 
effectively reduces initiation of DNA replication in vitro, this demonstrates 
that MCM2 is retained on the nuclear matrix when initiation of DNA 
replication is inhibited (Figure 6.5) as seen elsewhere (Hesketh et al., 2015).  
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A: Histogram showing inactivated S phase extract incubated with replication 
competent nuclei. B: western blot showing loading of MCM2, CDC6 and 
cyclin A onto chromatin in G1 nuclei with S phase extract and inactivated S 
phase extract. C: Western blot of salt fractionated chromatin loading of MCM2 
in inactivated S-phase extract. 
 
The data are consistent with a salt resistant MCM2 fraction in late G1 
cells that can be released by initiation of DNA replication. Next to investigate 
the compartmentalisation of MCM2 in cyclin E1/E2 and cyclin A2 depleted 
nuclei an analogous approach was used. Cell free DNA replication assays 
using cyclin depleted nuclei were used for comparison. In cyclin E1/E2 nuclei 
there was a low level of cyclin E in G1 extracts on chromatin and the nuclear 
matrix fraction. Incubation of cyclin E1/E2 depleted nuclei in S-phase nuclei 
showed enrichment of MCM2 on chromatin fractions (Figure 6.6.A) and was 
absent from the nuclear matrix fraction. In parallel reactions with the addition 
of roscovitine, MCM2 loaded onto chromatin and the nuclear matrix 
Figure 6-5 Compartmentalization of MCM2 is regulated by cell cycle 
stages. 
Chapter 6: Results 
 184 
efficiently. These observations suggest that cyclin E1/E2 depleted nuclei are 
defective in the loading of MCM2 onto the nuclear matrix fraction. 
Comparison with cyclin A2 depleted nuclei revealed similar effects to 
late G1 nuclei (Figure 6.5). Incubation in a G1 extract revealed a low level of 
MCM2 on both chromatin (Figure 6.6.C) and nuclear matrix fractions (Figure 
6.6.D). Incubation of cyclin A2 depleted nuclei in S-phase extracts increased 
the levels of MCM2 on chromatin but not the nuclear matrix fractions. 
Importantly, inhibition of CDK2 activity enriched MCM2 on the nuclear 
matrix fraction (Figure 6.6.D) that correlated with a reduction of cells in S-
phase (Figure 6.4.C). 
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A: Comparison of western blot showing loading of MCM2, CDC6 and PCNA 
onto chromatin in cyclin E1/E2 depleted nuclei with S phase extract and 
inactivated S phase extract and salt fractionated loading. B: Nuclear matrix 
fraction shown on western blot. C: Comparison of western blot showing 
loading of MCM2, CDC6 and PCNA onto chromatin in cyclin A2 depleted 
nuclei with S phase extract and inactivated S phase extract. D: Nuclear matrix 
fraction shown on western blot. 
 
 
Figure 6-6 MCM2 compartmentalisation defective in cyclin E1/E2 depleted 
nuclei in cell free replication assays. 
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Therefore, MCM2 appears to be associated with nuclear matrix when 
cells re-enter cell cycle from quiescence and are preparing for G1/S transition 
and initiation of DNA replication (Hesketh et al., 2015). Analysis of the 
localization of MCM2 reveals subtle differences between cyclin E1/E2 and 
cyclin A2 depleted nuclei and suggests that MCM2 is regulated by CDK 
activity and correlates with replication competence of depleted nuclei. This 
hypothesis suggests that CDK mediated phosphorylation of MCM2 may 
dictate its localisation and replication competence.  
 	




To further investigate whether there may be differences in cyclin E1/E2 
and cyclin A2 activities at the level of MCM2 localization and 
phosphorylation, MCM2 phospho-specific antibodies were used. The 
replicative helicase MCM2-7 complex is regulated by DDK and CDK 
mediated phosphorylation. Data presented here is consistent with the role of 
cyclin E during pre-RC activation. G1 nuclei are replication competent when 
reconstituted with S phase extract. An important feature of cyclin E1/E2 
depleted nuclei is the block in cyclin A2 accumulation (Figure 6.2, Figure 6.5 
and Figure 6.6.A). This in contrast with cyclin A2 depletion where cyclin E is 
present at high levels both cyclin E1/E2 depleted nuclei. In cyclin A2 depleted 
nuclei, there is a consistent reduction in MCM2, CDC6 and PCNA compared 
to control reactions. This accumulation of cyclin E in this context may 
determine the replication competence of the nuclei as cyclin E is required for 
activation of pre-RC (Coverley et al., 2002; Geng et al., 2003, 2007; Copeland et 
al., 2010). The key distinction between cyclin E1/E2 depleted nuclei and cyclin 
A2 depleted nuclei is that only cyclin A2 depleted nuclei can initiate DNA 
replication, suggesting a specific role for cyclin E1/E2 in replication licensing, 
perhaps at the level of MCM2 regulation. To determine whether the 
phosphorylation status of MCM2 is distinct for cyclin E1/E2 and cyclin A2 
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depleted nuclei, MCM2 phosphorylation was monitored in G1 and S phase 
extracts in cell-free DNA replication assays.  
 Cell-free DNA replication assays were performed using cyclin E1/E2 
depleted nuclei and compared with cyclin A2 depleted nuclei. Western blot 
analysis of the chromatin loading of cyclin E, cyclin A, MCM2, CDC6, PCNA 
in G1 nuclei were compared to cyclin E1/E2 depleted nuclei and cyclin A2 
depleted nuclei. Cyclin E levels are distinctly different in all three nuclei. G1 
nuclei are harvested at 17.5 hour and cyclin E1/E2 and cyclin A2 depleted 
nuclei are harvested post 24 hours. Cyclin E protein levels in cyclin E depleted 
nuclei are considerably lower than control and cyclin A2 depleted nuclei 
(Figure 6.7.A). 
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A: Western blot analysis of comparison between G1 nuclei, cyclin E depleted 
nuclei and cyclin A depleted nuclei B: Histogram showing cyclin E depleted 
nuclei are incompetent of initiation of replication when reconstituted with S 
phase, but cyclin A2 depleted nuclei can initiate replication when 
reconstituted with S phase extract. C: Western blot showing difference in 
chromatin loading of p-MCM2, MCM2, CDC6, PCNA in cyclin E depleted 
nuclei and cyclin A2 depleted nuclei with G1 extract and S phase extract. 
 
  
Figure 6-7 Distinct cyclin E-CDK2 dependent phosphorylation of MCM2 
correlates with replication competency. 
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Cyclin E depleted nuclei and cyclin A depleted nuclei were 
reconstituted with G1 phase extract and protein levels determined by western 
blotting (Figure 6.7.A). Consistent with earlier observations there is a 
reduction in chromatin associated MCM2, CDC6, PCNA in cyclin depleted 
nuclei compared to control late G1 nuclei (Figure 6.7A). Cyclin depleted 
nuclei were incubated in G1 extracts or S-phase extracts and the number of 
nuclei that are replicating their DNA was determined by incorporation of 
biotin –dUTP. This showed that only cyclin A2 depleted nuclei retain 
replication competence (Figure 6.7.B). Consistent with earlier observations 
cyclin E1/E2 depleted nuclei were not replication competent and failed to 
initiate in S-phase extract. In parallel reactions, the chromatin association of 
MCM2, CDC6, and PCNA were monitored. In addition, the phospho-specific 
antibody raised against the CDK2 and DDK site ser 40/41 was used for 
comparison. Incubation of cyclin depleted nuclei in S-phase extracts showed 
an increased chromatin association for MCM2, CDC6, and PCNA on 
chromatin. However, comparison between the levels of p-MCM2 (p-S40 and 
p-S41) that monitors DDK and CDK2 phosphorylation demonstrated that p-
MCM2 was only present on chromatin in Cyclin A2 depleted nuclei. Addition 
of S-phase extract promoted loading of p-MCM2 onto chromatin at similar 
levels to those seen in cyclin A2 deleted nuclei. 
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These observations suggest that cyclin E1/E2 is required to enable 
phosphorylation of MCM2 in G1 phase to license DNA replication. Cell free 
DNA replication assays using cyclin E1/E2 depleted nuclei reveal that loading 
of p-MCM2 from S-phase extracts is insufficient to enable initiation of DNA 
replication. This suggests that depletion of cyclin E1/E2 prevents efficient 
phosphorylation of MCM2, potentially reducing MCM2-7 localization and 
activation in the pre-IC assembly. These data suggest that temporal 
separation of p-MCM2 loading from the initiation phase is a key regulatory 
event in the licensing and initiation process of DNA replication.  
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6.9	 Cyclin	 A2	 depleted	 nuclei	 can	 initiate	 DNA	 replication	 when	
supplemented	with	recombinant	cyclin	A-CDK2.	
The specific activities of cyclin E and cyclin A studied here (Figure 6.2, 
6.3 and 6.7) are consistent with earlier work using quiescence release to 
prepare replication competent late G1 phase nuclei (Coverley et al., 2002) and 
reveal differences with mitotic cell cycle in mouse cyclin A2 null fibroblast 
studies (Kalaszczynska et al., 2009). Addition of recombinant cyclin A-CDK2 
to cell free replication assay has previously been analysed by (Coverley et al., 
2002 and Copeland et al., 2010) and these experiment indicate that late phase 
G1 nuclei can initiate DNA replication when supplemented with 0.1ng/µl 
recombinant cyclinA-CDK2 with G1 cytosolic extract in cell free replication 
assay. 
To determine the efficiency of cyclin A2 depleted nuclei to initiate 
DNA replication in detail, recombinant cyclin A-CDK2 was added to G1 
extracts at concentration range as indicated in the (Figure 6.8). Cyclin A2 
depleted nuclei can initiate DNA replication when supplemented with S 
phase extract compared to control reactions using G1 nuclei (Figure 6.8.A). 
For comparison, recombinant cyclin A-CDK2 was added with G1 cytosolic 
extract at concentration range indicated in (Figure 6.8.B) and (Figure 6.8.C). 
Consistent with previous studies G1 nuclei can efficiently initiate DNA 
replication peak at 0.1nM of recombinant cyclin A-CDK2 and concentration 
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higher than 0.1ng/µl appear to be inhibitory as percentage of biotin-dUTP 





















A: Histogram showing percentage of nuclei in S-phase for control nuclei 
incubated in G1 extract and cyclin A2 depleted nuclei in G1 and S-phase 
extracts showing replication competence. B: Line graph showing initiation of 
DNA replication in G1 nuclei with addition of recombinant cyclin A-CDK2 in 
the following range (0.01ng/µl, 0.02ng/µl, 0.05ng/µl, 0.1ng/µl, 0.2ng/µl, 
0.5ng/µl, 1.0ng/µl) with peak at 0.1ng/µl of recombinant cyclin A-CDK2 with 
G1 extract. C: Line graph showing initiation of DNA replication in cyclin A2 
depleted nuclei with addition of recombinant cyclin A-CDK2 in the following 
range (0.01ng/µl, 0.02ng/µl, 0.05ng/µl, 0.1ng/µl, 0.2ng/µl, 0.5ng/µl, 1.0ng/µl) 
with peak at 0.1ng/µl of recombinant cyclin A-CDK2 with G1 extract. 
  
Figure 6-8 Cyclin A2 depleted nuclei can initiate DNA replication in 
addition of recombinant cyclin A-CDK2. 
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Interestingly, cyclin A2 depleted nuclei when supplemented with 
recombinant cyclin A-CDK2 at range of concentration as indicated in (Figure 
6.8.C), can initiate DNA replication and peak at 0.1ng/µl of recombinant 
cyclin A-CDK2 with G1 extract. This further suggests that cyclin A2 depleted 
nuclei can initiate DNA replication with addition of recombinant cyclin A-
CDK2. In addition to peak at 0.1ng/µl concentration of recombinant cyclin A-
CDK2, increasing concentration decreases the replication competency, 
indicating higher concentration of recombinant cyclin A-CDK2 works as 
inhibitory concentration to initiate DNA replication similar to observations in 
G1 nuclei (Figure 6.8.B) However, this is a preliminary observation and needs 
further analysis to understand the mechanism in detail.  
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6.10	Discussion		
 The data presented in this chapter demonstrates the requirement of 
cyclin E –CDK2 for efficient initiation of DNA replication. Cell-free DNA 
replication assays using replication competent late G1 phase extract 
reconstituted with S phase extract is long established (Krude et al., 1996).  
However, the work presented here shows for the first time that genetically 
depleted nuclei can be used in cell-free DNA replication assays; greatly 
increasing capacity in future experiments. Cyclin E1/E2 depleted nuclei and 
cyclin A2 depleted nuclei were prepared by siRNA transfection in 
synchronized fibroblasts and reconstituted with S phase extract to study 
replication initiation in absence of cyclin activity. The data presented in 
(Figure 6.1) suggests efficiency of the experimental system with the use of S 
phase extract to reconstitute initiation of DNA replication in G1 nuclei. In 
vitro replication assays using cyclin E1/E2 depleted nuclei revealed that in 
both G1 extract and S phase extract that cyclin E1/E2 depleted nuclei are not 
licensed correctly and cannot initiate DNA replication. However, S phase 
extract was sufficient to load replication factors onto chromatin (Figure 6.3, 
6.7). This further suggests a strict requirement for cyclin E in initiation of 
DNA replication, consistent with previous observations by (Coverley et al., 
2002; Geng et al 2007; Copeland et al., 2010). Cyclin E–CDK2 activity is 
required for formation and activation of the pre-initiation complex and is 
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required for recruitment of CMG complex onto chromatin. Formation of the 
pre-IC then leads to helicase activation leading to recruitment of polymerases 
and formation of replisome and DNA replication. 
DNA replication is multi-step process involving loading and unloading of 
various proteins in timely manner in G1 phase. First step involves formation 
of Pre-RC which is initiated by recruitment of ORC onto putative replication 
origins. CDC6 and Cdt1 then interact with ORC in ATP dependent manner in 
order to recruit MCM2-7 complex (Helicase) onto the chromatin leading to the 
formation of Pre-RC. MCM10, Cdc45 along with GINS are recruited on to Pre-
RC to form Pre-initiation complex. Recruitment of these proteins is facilitated 
by cyclin E-CDK2. Completion of the Pre-RC at the origin is referred to as 
replication licensing. Cyclin E-CDK2 along with Dbf4 dependent kinase 
(DDK) recruit’s replisome factors leading to helicase activation. Cyclin A-
CDK2 then facilitates loading of polymerase with PCNA and results in 
Replisome formation. 
 
Figure 6-9 Replication licensing. 
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Cyclin A accumulates around restriction point in cells released from 
quiescence (Figure 3.2). Cyclin A-CDK2 is required for initiation of DNA 
replication as cyclin A depletion blocks in S phase entry in cells re-entering 
the cell cycle from quiescence (Figure 3.8, Figure 4.4). However, to understand 
the role of cyclin A-CDK2 in initiation of DNA replication, in vitro cell-free 
replication assay with cyclin A2 depleted nuclei was performed.  Cyclin A2 
depleted nuclei are replication competent and S phase extract is sufficient to 
load replication complex assembly proteins MCM2, CDC6 and PCNA onto 
chromatin and initiate DNA replication. In addition to S phase extract, cyclin 
A depleted nuclei were reconstituted with G1 extract supplemented with 
recombinant cyclin A-CDK2 (Figure 6.8) and 0.1 ng/µl concentration of cyclin 
A-CDK2 gave the highest percentage of replicating nuclei, with increase in 
concentration of recombinant cyclin A-CDK2 increase in replicating nuclei 
and peak at 0.1nM/µl. Interestingly, concentration above 0.1 ng/µl appeared 
to be inhibitory concentration as number of replicating nuclei decreased. This 
is similar to previous observations (Coverley et al., 2002; Copeland et al., 
2010). This suggests that cyclin A-CDK2 above a certain concentration inhibits 
initiation of DNA replication. However, more analysis needs to be done in 
using recombinant cyclin A-CDK2 with cyclin A depleted nuclei to 
understand the role of cyclin A –CDK2 alone in initiation of DNA replication.  
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 Initiation of DNA replication involves kinase independent loading of 
pre-RC proteins MCM2, CDC6, CDT1 once ORC is bound to replication 
origins leading to formation of pre-RC. Cyclin E-CDK2 mediated 
phosphorylation furthers helps recruitment of CMG complex and MCM10 
leading to formation of pre-IC. Late G1 nuclei are harvested in a pre-licensed 
state and hence are replication competent and with addition S phase extract 
can initiate DNA replication (Figure 6.2, Figure 6.3). As observed in Figure 6.4 
and 6.5 it is evident that loading of replication proteins MCM2, CDC6 from 
active S phase extract is not sufficient for initiation of DNA replication. 
Interestingly, inhibition of CDK2 activity in S-phase extracts prevents 
initiation of DNA replication but does not affect the chromatin loading of 
replication proteins (pre-RC) MCM2, CDC6 and replisome protein PCNA. 
This may suggest that CDK2 inhibition facilitates phosphorylated proteins 
from S phase extract to load on to chromatin.  
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6.10.1	CDK	activity	regulates	MCM2	compartmentalisation	in	G1	phase.	
 The Nuclear matrix is an insoluble structure of chromatin that 
associates with cell cycle regulators to assist in DNA replication. Here, 
nuclear matrix association was determined by performing high salt washes on 
the chromatin fraction and revealed salt resistant MCM2 loading and 
accumulation of MCM2 in CDK2 inhibited reaction under high salt 
conditions. These observations were consistent with other studies performed 
on MCM2 association with nuclear matrix in late G1 phase (Hesketh et al., 
2015).  
Initially, the localisation of MCM2 to the nuclear matrix was 
investigated using cell-free DNA replication assays. In late G1 licensed nuclei, 
MCM2 efficiently associates with the nuclear matrix. Addition of an S-phase 
extract led to a dissociation of MCM2 from the nuclear matrix that was CDK2 
dependent as roscovitine prevented its release (Figure 6.5). This analysis was 
extended using cyclin E1/E2 and cyclin A2 depleted nuclei. Cyclin E1/E2 
depleted nuclei are replication incompetent that appears to due to defects in 
the licensing of MCM2-7 via CDK2 and DDK mediated phosphorylation in G1 
phase (Figure 6.7). Comparison with Cyclin A2 depleted nuclei that are 
replication competent and express cyclin E at levels similar to control cells 
showed nuclear matrix localisation that was reduced by CDK2 activity as cells 
enter S-phase (Figure 6.6). 	  




The data presented here demonstrate that Cyclin E1/E2 and cyclin A2 
expression is required for G1 exit in fibroblasts re-entry in the cell cycle from 
quiescence. In this context Cyclin E and cyclin A have specific functions in 
stabilizing the regulatory factors required for efficient DNA replication. In 
particular, Cyclin E is required for correct regulation of MCM2-7 via 
phosphorylation at Ser40/41 of MCM2 (Figure 6.7) and phosphorylation at 
these sites correlate with replication competence in vitro.  In addition, Cyclin E 
contributed to transcriptional regulation of pre-RC (MCM2, CDC6), pre-IC 
(MCM10) and replisome protein (PCNA) and to the correct licensing of the 
MCM2-7 complex in G1. Our data suggest that only after cyclin E-CDK2 
activity leads to p-MCM2 loading making nuclei replication competent to 
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Chapter 7: General Discussion 
 Regulation of replication complex assembly of proteins is mediated by 
cyclinE-CDK2 and cyclin A-CDK2 (Reviewed Pauzaite et al., 2016). Here 
chemical and genetic inhibition of CDK2 activity was found to reduce 
accumulation of several DNA replication factors including: pre-RC 
components MCM2 and CDC6; Pre-IC protein MCM10 and replisome protein 
PCNA. siRNA mediated depletion of cyclin E in post-quiescent cells reduced 
transcription of E2F factor regulated genes CDC6, MCM2, MCM10 and 
PCNA. These observations are entirely consistent with canonical role of cyclin 
E-CDK2 in regulation of the Rb-E2F pathway. However, data presented here 
suggests an additional novel role for cyclin A- CDK2 in late G1 phase that 
protects components of the pre-RC from Ubiquitin proteasome system (UPS) 
mediated degradation. It remains to be addressed whether cyclin A-CDK2 
phosphorylates CDC6, MCM2 directly or acts via inhibition of the E3 ligase 
that mediates polyubiquitination. Nevertheless, this additional layer of 
regulation could enable cells to respond to genetic stress post-restriction point 
in G1 phase. Further work is required to investigate whether induction of the 
p53 pathway via p21 expression could result in degradation of DNA 
replication factors and prevent S-phase entry. 
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 Cell-free replication assays using late G1 phase nuclei supplemented 
with S phase extract revealed differences in MCM2 localization and licensing 
regulated by distinct cyclin-CDK2 complexes. Cyclin E1/E2 depleted nuclei 
are replication incompetent, whereas cyclin A2 depleted nuclei are replication 
competent when supplemented with S phase extract. Our data support a 
model where specific cyclin-CDK2 complexes regulate the temporal 
separation of replication licensing and initiation of DNA replication. These 
observations are consistent with earlier work using post-quiescent cells and in 
vitro DNA replication assays (Coverley et al., 2002). The data support the 
following model: cyclin E-CDK2 activates E2F regulated genes and activates 
the MCM2-7 helicase in coordination with DDK to license putative origins of 
DNA replication. These events render nuclei replication competent, but in 
post-quiescent mouse fibroblasts only the specific activity of cyclin A2-CDK2 
can promote initiation of DNA replication. 
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7.1	 Chemical	 inhibition	 of	 CDK2	 and	 DDK	 destabilizes	 pre-RC	 and	
replisome	proteins.		
Synchronised post-quiescent mouse fibroblasts enable study of 
replication complex assembly in late G1 to S-phase (Copeland et al., 2010; 
Coverley et al., 2002). Initial studies on cell synchronisation were performed 
to determine the correct time course for subsequent experiments (Figure 3.2). 
Monitoring the proportion of cells in S-phase and protein levels enabled 
correlation of cell cycle stage with replication complex assembly. The 
expression level of protein remains consistent with transcript levels with time 
further confirms synchronisation of quiescent cells. This further serves as a 
basis to analyse and dissect the function of cyclinE-CDK2, cyclin A-CDK2 and 
DDK activities in late G1 phase.  
 Cyclin-CDK activity is critical for regulation of the initiation of DNA 
replication and suppressing re-replication of genome by inhibiting replication 
during S phase and later phases of the cell cycle. (Hua et al., 1997; Coverley et 
al., 2002; Mimura et al., 2004). As observed in Chapter 3, inhibition of CDK2 in 
both asynchronous and late G1 synchronized cells resulted in reduced protein 
levels for MCM2, CDC6 and PCNA. CDK2 mediated phosphorylation of 
CDC6 protects it from APCcdh1 mediated degradation (Mailand and Diffley, 
2005), setting a precedent for this mechanism. Here this observation is 
extended to show that CDK2 mediated phosphorylation stabilizes MCM2, 
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PCNA and CDC6 during G1/S phase transition and promoting initiation of 
DNA replication.  Similarly, inhibition of DBF4 dependent kinase (DDK) with 
PHA 767491 (PHA) synchronous late G1 cells revealed destabilization MCM2, 
DBF4, CDC6, CDC45, Cyclin A and a reduction in S-phase entry. 
However, chemical inhibition of CDK2 and DDK can result in off 
target effects. Roscovitine is also a potent CDK1 inhibitor but as CDK1 is 
inhibited at that time point of cell cycle, roscovitine would inhibit CDK2 at the 
concentration used. The IC50 of roscovitine for cyclin E-CDK2 and cyclin A-
CDK2 is 0.70µM (Cicenas et al., 2015; De Azevedo et al., 1997). Unfortunately 
the DDK inhibitor used here, PHA 767491, is also a CDK2 inhibitor (Albanese 
et al., 2010). PHA has IC50 for CDK2 at 270 nM. The data presented here 
cannot exclude that the effects of PHA may be due to off-target CDK2 
inhibition. In future, this could be resolved through use of XL 413, a potent 
DDK inhibitor that does not affect CDK2 activity for comparison and 
depletion of Dbf4/Cdc7 to investigate this effect in detail.   
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7.2	 Cyclin	 E-CDK2	 regulates	 transcription	 of	 replication	 assembly	 of	
proteins	
Destabilization of the replication assembly proteins suggests that 
phosphorylation mediated by kinases in G1/S transition is involved in 
maintaining stability and initiation of DNA replication. This analysis 
determined that CDK activity promotes accumulation of CDC6, MCM2 and 
PCNA by 2 mechanisms: (i) Rb-E2F mediated transcriptional regulation or (ii) 
post-translational modification by ubiquitin-proteasome mediated 
degradation.  
Quantitative reverse transcriptase polymerase chain reaction (qRT-
PCR) of replication assembly proteins MCM2, CDC6, MCM10, PCNA 
transcripts from drug mediated kinase (CDK2, DDK) inhibited cells revealed 
a reduction in transcription of each gene (Figure 3.9). Similarly, siRNA 
mediated depletion of cyclin E1/E2 reduced CDC6, MCM2, MCM10 and 
PCNA transcript levels, likely via the canonical cyclin E-CDK2 regulated RB-
E2F pathway.  
Next, we investigated the requirement of cyclin A in quiescently 
synchronized mouse embryonic fibroblasts. Contrary to the findings in cyclin 
E1/E2 depleted nuclei, siRNA mediated depletion of cyclin A2 in post-
quiescent cells did not affect E2F1-3 regulated transcripts (Figure 3.10). 
Further investigation using proteasomal inhibitors reversed the loss of CDC6, 
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MCM2 and PCNA in cyclin A2 depleted (Figure 4.4) and CDK2 inhibited cells 
(Figure 4.2), consistent with a role for the proteasome in regulation of protein 
abundance. Therefore, this analysis has identified distinct mechanisms for 
cyclin E-CDK2 and cyclin A-CDK2 in regulation of the G1/S transition. In 
mouse fibroblasts re-entering the cell cycle from quiescence cyclin E-CDK2 is 
required for transcription of replication assembly proteins in order to 
maintain their stability during G1 phase and cyclin A promotes accumulation 
and stabilization of replication assembly of protein in late G1 phase.  
  




The cell cycle is regulated by ubiquitin proteasome system (UPS) 
mediated degradation that contributes to irreversible cell cycle transitions. 
Here we investigated the role of ubiquitin proteasome system during the G1/S 
transition in absence of kinase activity in initiation of DNA replication as a 
potential mechanism of regulation of destabilized replication assembly 
proteins.  
Inhibition of CDK2 and DDK using small molecule inhibitors and 
depletion of cyclin A2 by siRNA resulted in destabilization of replication 
complex assembly proteins and blocks S phase entry in post-quiescent cells. 
Two independent experiments support a role for the UPS in regulation of the 
pre-RC components CDC6 and MCM2. Importantly the reduction of CDC6 
and MCM2 levels after CDK2 inhibition could be reversed by addition of 
proteasomal inhibitor MG132. In addition, using a His-tagged ubiquitin 
construct, pulldown of ubiquitinated proteins included poly-ubiquitinated 
MCM2 and CDC6 (Figure 4.5). These data suggest that if CDK2 activity is 
perturbed during G1 phase, cells could prevent S-phase entry prior to 
restriction point bypass by regulation by cyclin E-Rb-E2F network. In 
addition, these results suggest that cells have an additional regulatory control 
that responds to perturbations in CDK activity leading to degradation of 
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CDC6 and MCM2 post-restriction point in late G1. This could prevent 
inappropriate S-phase entry and contribute to mechanisms that maintain 
fidelity of the genome. This data presented here used manipulations in CDK 
activity to reveal the UPS system actively degrades replication proteins in the 
absence of CDK activity. This response could potentially be recapitulated by 
activation of p53 after genotoxic stress in post-restriction point cells. Induction 
of the DNA damage response and p53 mediated transcription of the CDKI 
p21, may reduce CDK activity. Further work is required to establish whether 
this mechanism induces a G1 checkpoint in post-quiescent cells. 	
CDK2 activity in G1 and S phase regulates the loading and 
stabilization of the proteins involved in DNA replication (Choudhury et al., 
2016; Mailand and Diffley, 2005). Here the depletion of cyclin A and 
inhibition of CDK2 was found to result in proteasomal mediated degradation 
CDC6 and MCM2 by direct ubiquitination (Figure 3.6) and stabilization by 
addition of a proteasomal inhibitor, MG132 (Figure 4.2). These results suggest 
that CDK prevents ubiquitin proteasome system mediated degradation by 2 
potential mechanisms: (i) Kinases phosphorylate the replication complex 
assembly proteins there by stabilising them or protecting them from ubiquitin 
proteasome system (UPS) (Figure 7.1.A) (ii) Kinases phosphorylate E3 ligases 
there by marking them for self-destruction or by subsequent E3 ligases in the 
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cell system which in turn inhibits the activity on these proteins (Spruck and 
Strohmaier, 2002) (Figure 7.1.B).  
 
 
Two models postulating the mechanism by which G1/S kinases regulate 
replication complex assembly proteins (CDC6, Ciz1, MCM2 and PCNA). In 
model A, CDK phosphorylates each protein, and the phosphoprotein is 
protected from ubiquitylation by the E3 ligase. This is consistent with CDK 
mediate protection of CDC6 from APC/Ccdh1 (Mailand and Diffley, 2005). In 
model B, CDK mediates phosphorylation of the E3 ligase directly, thereby 
inactivating it and protecting target substrates. This is consistent with 
phosphorylation of the E3 ligase Cdh1 that is regulated by cyclin A-CDK and 
Plk1 in S-phase (Spruck and Strohmaier, 2002). 
 
Phosphorylation can regulate ubiquitination enzymes to influence E3-
substrate interactions (Vittal et al., 2015). Phosphorylation can inhibit the E3 
from interacting with E2, dynamically affecting the dynamics and specificity 
of the E3 (Craney et al., 2016; Brown et al., 2016). Phosphorylation can directly 
Figure 7-1 Postulated mechanism of action for effect of Cyclin A or CDK 
depletion in synchronised mouse fibroblasts. 
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influence the ubiquitination of the substrates (Zhu et al., 2005) or 
phosphorylation can enable recognition of the substrate later marked for 
degradation by SCF (Strack et al., 2000). Detailed analysis is the interplay 
between CDK and the UPS is required to distinguish between these 
possibilities in future work. 
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7.4	 Ciz1	 is	 regulated	 by	 UPS	 in	 absence	 of	 Cyclin-CDK2	 during	 G1/S	
transition	
The data presented here demonstrate for the first time that Ciz1 is 
regulated by phosphorylation leading to its accumulation in G1 phase 
(Chapter 5). Ciz1 accumulates through G1 phase and correlates with 
expression of cyclin E and cyclin A (Figure 5.3). The protein levels for Ciz1 
mirror those of E2F pathway genes but surprisingly, the transcription of Ciz1 
is stable through G1 phase in comparison to E2F regulated genes (Figure 
5.3.B). The data presented here show that Ciz1 is regulated by CDK2 activity 
and possibly by the UPS. CDK2 inhibition by small molecule inhibition or 
siRNA mediated depletion reduces Ciz1 levels that can be reversed by 
inhibition of the proteasome (Figure 5.4). The data are consistent with a model 
whereby Ciz1 accumulates in response to increasing CDK activity in G1 
phase. Ciz1 is known to be a cyclin E-CDK2 and cyclin A-CDK substrate 
(Copeland et al., 2015). These data suggest that Ciz1 is regulated by CDK2 
mediated phosphorylation to promote its accumulation as well as regulating 
its function in regulation of the initiation phase of DNA replication. Further 
investigation of the role of S331 and T293 in Ciz1 accumulation is required to 
whether there is a temporal order to Ciz1 site specific phosphorylation and to 
test how this regulates Ciz1 activity  
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7.5.	DHX9	contributes	to	regulation	of	the	G1/S	transition.	
A proteomic screen identifying Ciz1 interaction partners, recovered 
DHX9 a DNA/RNA helicase that performs numerous functions including 
binding to replication origins (Lee et al., 2014). To better understand whether 
DHX9 contributes to regulation of cell cycle re-entry from quiescence siRNA 
mediated depletion of DHX9 was performed here.  Reduction of DHX9 in 
synchronized post-quiescent cells produced a statistically significant decrease 
in the number of S-phase cells suggesting a defect in cell cycle progression. 
These data suggest that DHX9 and Ciz1 may be active within the same 
pathway as siRNA mediated depletion of Ciz1 also markedly reduces cell 
cycle progression (Coverley et al., 2005; Copeland et al., 2010). However, as 
we only monitored cell cycle progression in the  cell  cycle  following  
transfection, our  data  is  distinct  from  other  studies monitoring  the  effects  
of  prolonged DHX9 depletion that led to a stabilization of p53 and 
senescence (Lee et al., 2014). The data therefore suggest that DHX9 
contributes to efficient cell cycle progression (Figure 5.8) and prolonged 
depletion of DHX9 induces a replication stress response leading to p53 
activation and senescence (Lee et al., 2014). 
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7.6	In	vitro	analysis	of	initiation	of	DNA	replication	
Cell-free replication assays have previously identified that cyclin E-
CDK2 was required for MCM2 and CDC6 loading on to chromatin to license 
replication origin activation by cyclin A-CDK2 (Coverley et al., 2002). Here, 
chemical and genetic inhibition of cyclin E-CDK2 and cyclin A-CDK2 resulted 
in reduction of MCM2, CDC6 and PCNA protein levels in G1 phase, thereby 
preventing S-phase entry. To further investigate whether cyclin depleted 
nuclei were ‘licensed’ to replicate i.e. retain replication competency a siRNA 
approach was used to deplete specific cyclins. After developing this approach 
cyclin E1/E2 depleted nuclei and cyclin A2 depleted nuclei were assessed to 
identify differences in replication complex assembly and replication 
competence.  
Cell free replication assay using late G1 phase nuclei reconstituted with 
S phase extract can initiate DNA replication and load replication assembly 
proteins on to chromatin (Figure 6.1). It is first time that genetically depleted 
nuclei are used in cell-free DNA replication assays. Cyclin E1/E2 depleted 
nuclei and cyclin A depleted nuclei were prepared by siRNA transfection in 
synchronized fibroblasts and reconstituted with S phase extract to study 
replication initiation in absence of cyclin activity. Cyclin E1/E2 depleted 
nuclei were unable to replicate when incubated in S-phase cellular extracts, 
whereas cyclin A2 depleted nuclei can initiate DNA replication when 
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supplemented with S phase extract containing active kinases and 
phosphorylated proteins. Evaluation of the chromatin fraction in cyclin E1/E2 
and cyclin A2 depleted nuclei showed that both nuclei could ‘load’ CDC6, 
MCM2, PCNA, cyclin E and cyclin A onto chromatin in cell-free replication 
assays from S-phase extracts. These observations suggest that loading of these 
factors is not sufficient for DNA replication on Cyclin E1/E2 template nuclei. 
Interestingly, S phase extract is sufficient to load replication assembly 
proteins on to chromatin for both cyclin E1/E2 depleted nuclei and cyclin A2 
depleted nuclei (Figure 6.2, 6.3). 
As MCM loading is a key licensing event, the localisation of MCM2 
was determined in Cyclin E1/E2 depleted nuclei. MCM2 loads onto chromatin 
in late G1 phase and early S–phase and is enriched on the nuclear matrix prior 
to initiation in late G1 phase (Hesketh et al., 2015). Cell free DNA replication 
assay was further used to investigate nuclear matrix association of replication 
assembly proteins. The Nuclear matrix is a sub-nuclear insoluble that 
associates with cell cycle regulators to assist in DNA replication. Here we 
found cyclin E1/E2 depleted nuclei retain MCM2 on the nuclear matrix in S-
phase extract, whereas cyclin A2 depleted nuclei initiate and release MCM2, 
suggesting that cyclin E depleted nuclei are defective in MCM2-7 localisation 
to the nuclear matrix (Figure 6.6).  
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Further analysis of MCM2 regulation was performed by analysing the 
phosphorylation of MCM2 in cyclin A2 depleted nuclei. MCM2 levels are low 
on chromatin fractions and nuclear matrix fractions when incubated in G1 
extract. MCM2 loads efficiently onto chromatin in S-phase extracts but as cells 
initiate DNA replication the nuclear matrix fraction remains low. Importantly, 
CDK2 inhibition prevents initiation of DNA replication in this context and 
shows an enrichment of MCM2 onto the nuclear matrix under these 
conditions. These data suggest that MCM2 localises to the correct sub-nuclear 
compartments during late G1 and early S-phase in cyclin A2 depleted nuclei 
(Figure 6.6), consistent with their replication competence. 
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7.7	 Cyclin	 E1/E2	 expression	 is	 required	 for	 phosphorylation	 of	MCM2	 to	
license	DNA	replication	
DNA replication complex assembly is separated into distinct phases 
(Figure 7.2). The phosphorylation of MCM2-7 complex by the combined 
activities of DDK and CDK is an essential step in replication licensing through 
loading of the pre-IC (Tanaka and Araki, 2013). The phosphorylation status of 
MCM2 at a regulatory CDK/DDK (p-Ser40/p-Ser41) sites in the N-terminal 
region of MCM2 was evaluated. Depletion of cyclin E1/E2 prevents efficient 
phosphorylation of MCM2 on chromatin, whereas cyclin A2 depleted nuclei 
contained chromatin associated p-MCM2 (Figure 6.7). Therefore, the 
phosphorylation status of MCM2 correlates with the replication competence 
of cyclin depleted nuclei (Figure 6.7). The data suggests that cyclin E-CDK2 
and DDK mediated phosphorylation of MCM2 is required to promote the 
formation of pre-IC (Tanaka and Araki, 2013), and this is a critical step in 
promoting replication competence in S-phase extracts.  
In cyclin E1/E2 depleted nuclei that data suggest that the absence of 
cyclin E-CDK2 activity prevents formation of the pre-IC rendering cyclin E 
depleted nuclei replication incompetent. Conversely, in cyclin A2 depleted 
cyclin E-CDK2 levels are similar levels to unperturbed late G1 nuclei, leading 
to the cyclin E-CDK2 mediated phosphorylation of MCM2 at S40 and S41 
(Figure 6.7). Cyclin A2 depleted template nuclei are therefore replication 
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competent and initiate DNA replication when supplemented with S phase 
extract (Figure 6.7.B). 
However, from the Figure 6.6 we can interpret here that cyclin E-CDK2 
mediated phosphorylation of MCM2 at S40 and S41 is required for initiation 
of DNA replication. This analysis is limited by the availability of phosphor-
specific antibodies for the MCM2-7 complex and could be complimented by 
global phosphor-proteomic analysis of cyclin E-CDK2 and cyclin A-CDK2 
substrates to identify the full repertoire of cyclin specific substrates. The 
identification of initiation specific CDK substrates remains elusive and would 
be far more informative on the precise role of each of the cyclin E and cyclin A 
initiation of DNA replication. 
7.7.1	Working	Model	
With cell-free replication assay in cyclin E depleted nuclei and cyclin 
A2 depleted nuclei, we were able to identify that cyclin E depleted nuclei are 
replication incompetent. This leads to generation of working model as 
described in Figure 7.2. As cyclin E1/E2 depleted nuclei cannot carry out 
cyclin E mediated phosphorylation of MCM2, which is required for formation 
of pre-initiation complex, and that cyclin A depleted nuclei are replication 
competent as they have cyclin E mediated phosphorylation of MCM2 
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allowing the formation of pre-IC and active kinases from S phase extract are 
able to carry out DNA replication in cyclin A depleted nuclei.  
Figure 7.2 shows distinction between the nuclei (late G1 nuclei, cyclin 
E1/E2 depleted nuclei and Cyclin A2 depleted nuclei) postulated from the 
observations in Figure 6.6 showing phosphorylation of MCM2 at S40 and S41 
site mediated by cyclin E-CDK2 and DDK. Figure 7.2.A demonstrates possible 
mechanism by which G1 nuclei can initiate DNA replication when 
supplemented with S phase extract containing all active kinases and 
phosphorylated proteins involved in DNA replication. As observed in the 
Figure 7.2.A. G1 nuclei are replication competent as they have active cyclin E-
CDK2 and cyclin A-CDK2 leading to formation of pre-IC and replisome 
leading to initiation of DNA replication when supplemented with S phase 
extract. Interestingly, in cyclin E1/E2 depleted nuclei we postulate from the 
observations of Figure 6.6 that, as it lacks cyclin E-CDK2 activity it does not 
have active pre-IC and replisome making it replication incompetent even 
when supplemented with S phase extract. Conversely, in cyclin A2 depleted 
nuclei, there is cyclin E-CDK2 activity leading to formation of active pre-IC 
complex with the phosphorylation status of MCM2 at S40 and S41 (Figure 
6.6.), making Cyclin A depleted nuclei replication competent and can initiate 
DNA replication when supplemented with S phase extract. 
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A: Composition of G1 nuclei leading to formation of active pre-initiation 
Complex and replisome and when supplemented with S phase extract can 
initiate DNA replication. B:  Composition of Cyclin E1/E2 depleted nuclei 
with lack of Cyclin E-CDK2 leading to inactivation of pre-IC due to loss of 
phosphorylation at S40 and S41 of MCM2 and thereby making Cyclin E1/E2 
depleted nuclei replication incompetent even when supplemented with S 
phase extract. C: Composition of Cyclin A2 depleted nuclei with formation of 
active pre-Initiation complex with phosphorylation of MCM2 at S40+S41 
making the nuclei replication competent when supplemented with S phase 
extract. 
Figure 7-2 Working models of distinct mechanisms involved in initiation of 
DNA replication in G1 nuclei, Cyclin E1/E2 depleted nuclei and cyclin A2 
depleted nuclei. 
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This analysis suggests that cyclin E-CDK2 and DDK mediated 
phosphorylation of MCM2 at Ser 40 and Ser 41 is indicative of the replication 
statuses of the template nuclei. In addition, cyclin E1/E2 is required to 
facilitate relocalization of MCM2 away from the nuclear matrix. These data 
strongly implicate MCM2-7 as being the major regulatory target of cyclin E-
CDK2 consistent with other in vitro studies (Coverley et al., 2002) and in vivo 
analyses (Geng et al., 2003; Geng et al., 2007). 
In further support of the formation of pre-IC in cyclin A2 depleted 
nuclei, it was found that addition of recombinant cyclin A-CDK2 could 
initiate DNA replication. Cyclin A2 depleted nuclei were reconstituted with 
G1 extract supplemented with recombinant cyclin A-CDK2 (Figure 6.8) and 
0.1 ng/µl concentration of cyclin A-CDK2 gave the highest percentage of 
replicating nuclei, with increase in concentration of recombinant cyclin A-
CDK2 increase in replicating nuclei and peak at 0.1 ng/µl. Interestingly, 
concentration above 0.1 ng/µl appeared to be inhibitory concentration as 
number of replicating nuclei decreased. This is similar to previous 
observations seen by Coverley et al., 2002 and Copeland et al., 2010. This 
suggests that cyclin A-CDK2 above a certain concentration works as 
inhibitory phosphorylation for initiation of DNA replication. It remains to be 
addressed whether recombinant cyclin E-CDK2 to cyclin E1/E2 depleted 
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nuclei would confer replication competency. Further analysis would help 
identify cyclin E-CDK2 substrates there by helping understand the process of 
DNA replication in detail.  
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7.8	Future	work	
Mechanism of action of DDK in initiation of DNA replication is not 
very well understood as the experiments presented here were performed 
using chemical inhibitor with off-target effects on CDK2. Targeted depletion 
of Cdc7-Dbf4 by siRNA mediated depletion would provide more insights into 
understanding mechanism by which DDK mediates regulation of initiation of 
DNA replication. 
Further to understanding the role of UPS in absence of active kinases in 
initiation of DNA replication during G1/S transition. Identification of E3 
ligases regulating ubiquitination of MCM2, CDC6 and PCNA would help 
understand the mechanism in detail. To identify potential E3 ligase a global 
siRNA screen or in vitro ubiquitination assays could be performed. 
Another experimental procedure with Cdc7-Dbf4 inhibited nuclei in 
cell free replication assay would further help understand the process of 
initiation of DNA replication in detail. Additionally, recombinant cyclin E-
CDK2 to cyclin E1/E2 depleted nuclei would confer replication competency. A 
global analysis of cyclin E and cyclin A substrates would be required to 
identify the full repertoire of substrates. This would be a far informative on 
the precise role of cyclin E and cyclin A in initiation of DNA replication. 
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7.9	Concluding	Remarks	
 Genome duplication is the key objective for any dividing cell. All 
nuclear DNA must be duplicated accurately to ensure that the genetic 
information stays preserved for the next generation (Toueille and Hubscher 
2004; Masai et al., 2010). In human cells, DNA replication has to accurately 
copy around 6x 109 bases over approximately 10 hour during S phase (Goren 
and Cedar 2003); therefore, it must be spatiotemporally regulated at different 
levels. It is evident from the data presented in this thesis that sustained cyclin-
CDK activity is required for initiation of DNA replication during G1/S 
transition in Mouse fibroblasts released from quiescence (G0). Cyclin E-CDK2 
and cyclin A-CDK2 both are equally important in cells re-entering cell cycle 
and for initiation of DNA replication. Using genetically inhibited nuclei in cell 
free replication a novel experiment we demonstrated the temporal regulation 
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